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Abstract 
 
The LKB1 protein kinase has previously been implicated in a number of major 
physiological processes including cell proliferation, polarity and energy metabolism. 
LKB1 is an upstream kinase for AMP-activated protein kinase (AMPK) and 12 
members of the AMPK-related family of kinases. In this study, western blotting of 
LKB1 from various mouse tissues indicated the existence of two molecular weight 
bands in testis. This, along with the presence of a potential alternative exon at the 3’ 
end of the gene, led to the discovery that an alternatively-spliced variant of LKB1 is 
present in mice. This new splice variant has been termed the ‘short form’ (LKB1S) 
and the original protein termed the ‘long form’ (LKB1L). The proteins are identical 
in sequence apart from the C-terminus. The overall aim of this study was to 
characterise the LKB1S protein; its activity, regulation and possible physiological 
function, using overexpression studies in mammalian cells and analysis of mice 
lacking LKB1S. 
 
An LKB1S-specific antibody was used to show that LKB1S is primarily expressed in 
testis. It was demonstrated, using overexpression studies, that both forms can activate 
AMPK, form an active complex with the regulatory proteins STRADα, STRADβ and 
MO25 and have a similar sub-cellular localisation. The C-terminus of mouse/human 
LKB1L can be phosphorylated at serine 431/428 (Sapkota et al., 2001). This residue 
is absent from LKB1S and so the effect of phosphorylation was investigated to 
determine if this could lead to differences in activity between the splice forms. 
However, the results suggest that phosphorylation at this site does not affect the 
ability of LKB1L to activate AMPK in cells. 
 
Male mice lacking expression of LKB1S are infertile. The mice display severe sperm 
abnormalities and sperm counts are significantly reduced. Histological analysis of 
testis showed that although early spermatogenesis appears to progress normally, 
abnormalities become apparent later on, culminating in very few spermatozoa 
reaching the epididymis. One possible reason that has been investigated is that there 
is a defect in the release of mature sperm from the seminiferous epithelium 
(spermiation). 
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1 Introduction 
Metabolic disease and cancer are two increasing global health problems. The World 
Health Organisation (WHO) estimates that approximately 200 million people 
worldwide have type 2 diabetes and predict that there will be 2.2 million deaths from 
diabetes in 2030, a doubling from 2005 figures. Globally, cancer is a main cause of 
death, accounting for 13% of all deaths in 2004 and it is estimated that deaths from 
this disease will increase by 45% between 2007 and 2030 (WHO figures). A 
thorough knowledge of the kinases and other molecules involved is important for 
understanding these diseases and creating drug targets. It is becoming increasingly 
clear that the LKB1 protein kinase is involved in many cellular processes relevant to 
human disease. LKB1 is an upstream activator of AMP-activated protein kinase 
(AMPK), a key regulator of energy metabolism. Targeting this pathway has the 
potential to treat metabolic problems like obesity, type 2 diabetes and the metabolic 
syndrome (reviewed in Hardie, 2008). Furthermore, it is estimated that mutations in 
LKB1 are found in 15-35% of lung cancers and 20% of cervical carcinomas 
(reviewed in Shackelford and Shaw, 2009).  
 
In section 1.1 the general background to LKB1 will be described including the 
mechanisms by which it is regulated, its downstream substrates and functions. There 
is potentially still a great deal to learn regarding the functions and regulation of this 
kinase. In this thesis a new role for LKB1 in spermatogenesis is identified. In section 
1.2 the general background to spermatogenesis will be covered including a specific 
process in which LKB1 may be involved; spermiation. It has been estimated that 
infertility affects 10-15% of couples of reproductive age, 40% of these cases are 
thought due to male infertility alone (de Kretser, 1997; Hull et al., 1985; Irvine, 
1998). In many cases the causes of infertility are unknown. Research into possible 
proteins involved may help provide answers. 
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1.1 LKB1 
LKB1 is a serine/threonine protein kinase and the product of a tumour suppressor 
gene. Mutations of LKB1 in humans have been shown to cause a rare disease called 
Peutz-Jeghers Syndrome (PJS) (Figure 1-1) (Jenne et al., 1998). Patients suffer many 
benign hamartomatous polyps of the gastrointestinal tract, show excess pigmentation 
of the mucous membranes and skin, especially the lips and hands, and also display a 
predisposition towards developing malignant tumours (Hemminki et al., 1998). In 
mice, total deletion of LKB1 is embryonic lethal, the embryos displaying 
abnormalities such as defects in closure of the neural tube and in vascular 
development (Ylikorkala et al., 2001). LKB1 has been implicated in a number of key 
cellular processes including the regulation of cell proliferation, cell polarity and 
energy metabolism (reviewed in Alessi et al., 2006), and LKB1 homologues have 
been identified in Caenorhabditis elegans (PAR4), Drosophila melanogaster 
(dLKB1) and Xenopus laevis (XEEK1) (Martin and St Johnston, 2003; Ossipova et 
al., 2003; Watts et al., 2000). In 2003, LKB1 was shown to be a main upstream 
kinase responsible for the activation of AMP-activated protein kinase (AMPK) 
(Hawley et al., 2003; Shaw et al., 2004b; Woods et al., 2003) and later studies 
implicated it in the regulation of 12 other kinases related to AMPK (Jaleel et al., 
2005; Lizcano et al., 2004). 
 
 
Figure 1-1 Peutz-Jeghers syndrome phenotype 
(A) Polyps are shown in small intestine of a PJS patient, as indicated by arrows 
(from Katajisto et al., 2007). (B) Oral mucocutaneous pigmentation in a PJS patient.  
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1.1.1 Structure of the LKB1 gene and protein 
The LKB1 gene is located on chromosome 19 in humans (19p13.3) and chromosome 
10 in mice. It spans over 23 kb and is composed of 10 exons, only 9 of which are 
coding (Hemminki et al., 1997; Jenne et al., 1998; Smith et al., 1999).  
 
The human LKB1 protein has 433 amino acids (436 in mice). Human LKB1 shares 
89.7% identity with the mouse version of the protein (96.2% in kinase domain) 
(Smith et al., 1999). Amino acids 43-309 comprise the catalytic domain and this is 
flanked by N- and C- terminal domains (NTD and CTD), the functions of which are 
not well understood (Figure 1-2A). The NTD has been shown to contain a nuclear 
localisation sequence (Smith et al., 1999), and the CTD has been implicated in the 
tumour suppressor properties of LKB1 as mutations in this region are present in PJS 
patients (Boudeau et al., 2003b). One study has also implicated the CTD in the 
regulation of AMPK activity by LKB1, and in cell polarity (Forcet et al., 2005). It 
has been shown that LKB1 requires association of two regulatory proteins in order to 
be fully active within the cell. 
 
1.1.2 The LKB1:STRAD:MO25 complex 
LKB1 exists as a heterotrimeric complex in cells with the proteins STE20-related 
adaptor (STRAD) and mouse protein 25 (MO25) (Figure 1-2). There are two 
isoforms of both STRAD and MO25 (α and β), both of which are able to form active 
complexes with LKB1 (Boudeau et al., 2003a; Hawley et al., 2003). STRAD and 
MO25 have been shown to stabilise the LKB1 protein and greatly increase its 
catalytic activity. Their binding also causes LKB1 to relocalise from the nucleus to 
the cytoplasm (Baas et al., 2003; Boudeau et al., 2003a; Boudeau et al., 2004; 
Hawley et al., 2003).  Mutations in LKB1 that prevent its binding to STRAD and 
MO25 have also been implicated in PJS. A study looking at mutations in the catalytic 
domain of LKB1 in PJS patients found that 12 out of 30 LKB1 mutants could not 
form a complex with STRAD and MO25 (Boudeau et al., 2003a).  
 
STRAD has been termed a pseudokinase because, although it shares extensive 
sequence identity with protein kinases, it lacks several residues required for catalytic 
activity (Zeqiraj et al., 2009b). It has been suggested that STRAD may have evolved 
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Figure 1-2 Structure of the LKB1:STRAD:MO25 complex 
(A-B) Domain structure of human LKB1, STRADα and MO25α. NTD, amino-
terminal domain; CTD, carboxy-terminal domain; NLS, nuclear localisation 
sequence (adapted from Shackelford and Shaw, 2009). (C) Surface representation of 
the kinase domain of LKB1 in complex with the pseudokinase domain of STRAD 
and full-length MO25α. This was derived from studies of the crystal structure (from 
Zeqiraj et al., 2009a). 
A 
B 
C 
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from a kinase that once phosphorylated LKB1. STRAD binds to the kinase domain 
and amino acids 319-343 in the CTD of LKB1 (Baas et al., 2003) and the presence of 
MO25 has been shown to markedly increase the binding of STRAD to LKB1 
(Boudeau et al., 2003a). MO25 has no sequence homology to other proteins in the 
DNA database (Alessi et al., 2006). Recently the crystal structure of the 
heterotrimeric LKB1 complex has been published (Zeqiraj et al., 2009a). This 
suggested that interactions of LKB1 with both STRAD and MO25 promote the 
active conformation of LKB1. MO25 adopts a horseshoe-shaped conformation and 
acts as a scaffold for the heterotrimer, binding to both LKB1 and STRADα at a 
number of sites. Even though STRAD does not possess catalytic activity, it is 
thought to adopt a conformation characteristic of active kinases for binding LKB1. 
The binding of STRADα to either MO25 or ATP is thought to be essential for this 
conformation and mutants of STRAD that were unable to bind both MO25 and ATP 
were unable to activate LKB1 (Zeqiraj et al., 2009b).  
 
1.1.3 Sub-cellular localisation of LKB1 
A number of studies have suggested LKB1 has a nuclear localisation (Smith et al., 
1999; Song et al., 2008). However, this conclusion was based on expressing LKB1 
alone in cells, without STRAD and MO25. It has been shown in recombinant 
expression systems that, when LKB1 is expressed alone in cells, it shows significant 
nuclear localisation and, when co-expressed with STRAD and MO25, it becomes 
predominantly cytoplasmic (Baas et al., 2003; Boudeau et al., 2003a; Dorfman and 
Macara, 2008). A recent study has proposed a mechanism by which STRAD 
promotes the cytoplasmic localisation of LKB1. STRADα was shown to act as an 
adaptor, linking LKB1 to the nuclear export receptor CRM1 or exportin-7 and 
therefore causing nuclear export of LKB1. STRADα was suggested to play a further 
role in blocking the nuclear import of LKB1 by competing with the import receptor 
importinα/β for binding to LKB1. It was suggested that CRM1 and exportin-7 may 
be present in different cell types and that this may lead to the localisation of LKB1 to 
different parts of the cell (Dorfman and Macara, 2008). The role of phosphorylation 
and acetylation in the regulation of LKB1 localisation will be covered in Section 
1.1.5. 
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LKB1 possesses a consensus site for prenylation at its C-terminus (cysteine 430/433 
in human/mouse) and this site has been shown to be farnesylated in cells (Sapkota et 
al., 2001). Farnesylation occurs when a farnesyl group (isoprenoid) is covalently 
attached to the cysteine residue of a CAAX motif at the C-terminus of a protein. 
Protein prenylation such as this has been suggested to target proteins to cell 
membranes and also to be involved in protein-protein interactions (Zhang and Casey, 
1996). Mutation of this residue in LKB1 prevented farnesylation and inhibited 
membrane localisation (Collins et al., 2000) (Sebbagh et al., 2009). A potential role 
for LKB1 at the cell membrane is in the formation of tight junctions and adherens 
junctions (section 1.1.6) (Amin et al., 2009; Hezel et al., 2008; Zheng and Cantley, 
2007). A recent study suggested that in polarised epithelial cells LKB1 is mainly 
localised at cell-cell contacts (adherens junctions) where it interacts with E-cadherin 
(Sebbagh et al., 2009). 
 
There have been few studies looking at the localisation of endogenously expressed 
LKB1 within cells. Some studies have suggested a predominantly cytoplasmic 
localisation (Conde et al., 2007; Sebbagh et al., 2009), although a  recent study used 
immunofluorescence to suggest that endogenous LKB1 is predominantly nuclear in 
human umbilical vein endothelial cells (HUVECs) (Xie et al., 2009). Another study, 
looking at expression in various human tissues by immunohistochemistry, suggested 
that LKB1 is nuclear in glial cells of the cerebral cortex (Conde et al., 2007).  
 
1.1.4 Downstream substrates of LKB1 
 AMPK 
AMPK plays a key role in the regulation of cellular energy balance in mammals. 
When ATP levels are low, AMPK turns on pathways that generate energy, for 
example, fatty acid oxidation and glycolysis, and turns off pathways that consume 
energy, for example, fatty acid synthesis and cholesterol synthesis (reviewed in 
Carling, 2005). The role of the LKB1-AMPK pathway in the regulation of energy 
metabolism and other cellular processes will be covered in section 1.1.6. 
Homologues of AMPK have been reported in all eukaryotes studied, and  thought to 
have evolved as a response to nutrient starvation in primitive organisms (Towler and 
Hardie, 2007). Until recently, the upstream kinase for mammalian AMPK had 
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remained elusive. The first clue to its identity came from studies of yeast. The 
homologue of AMPK in yeast is known as SNF1, which is activated by three 
kinases; Sak-1 (Snf1-activating kinase-1), Elm1 (elongated morphology-1) and Tos3 
(target of Sbf3). It was discovered that these share significant homology with the 
mammalian kinase, LKB1 (Hong et al., 2003). In 2003, LKB1 was shown to be able 
to phosphorylate and activate AMPK at threonine 172 (T172) of the catalytic subunit 
(Hawley et al., 2003; Hong et al., 2003; Shaw et al., 2004b; Woods et al., 2003). 
Phosphorylation at this residue had previously been shown to be crucial for AMPK 
activity (Stein et al., 2000). The mechanism by which LKB1 regulates AMPK 
activity in response to variations in levels of intracellular AMP will be covered in 
section 1.1.5. 
 
In addition to LKB1, Ca
2+
/calmodulin dependent protein kinase kinase (CaMKK) 
(Hawley et al., 2005; Hurley et al., 2005; Woods et al., 2005) and transforming 
growth factor (TGF)-β-activated protein kinase 1 (TAK1) (Momcilovic et al., 2006) 
have been shown to phosphorylate and activate AMPK. This is supported by the 
finding that in LKB1-deficient cells AMPK still possesses some basal activity 
(Hawley et al., 2003). CAMKK is expressed mainly in neural cells but has also been 
detected in testis and endothelial and haematopoietic lineages. It has been implicated 
in activation of AMPK in response to stimuli that increase levels of intracellular 
calcium (Hawley et al., 2005; Stahmann et al., 2006; Tamas et al., 2006). This is 
thought to allow the cell to anticipate increases in energy demand that often 
accompany increases in calcium, for example, due to the activation of ATP-
consuming ion channels and motor proteins (Hardie, 2007). TAK1 is a member of 
the mitogen activated protein kinase kinase family and can be activated by a number 
of cytokines as well as agents that interfere with the AMP:ATP ratio of cells such as 
AICAR and metformin (Xie et al., 2006a). It  has been shown to activate AMPK in 
vitro and activate the LKB1-AMPK pathway in cardiac muscle (Momcilovic et al., 
2006; Xie et al., 2006a). The physiological role of these other upstream kinases in the 
AMPK cascade is not fully understood. LKB1 knockout studies have suggested that 
LKB1 has a predominant role in activating AMPK in many tissues. For example, 
deletion of LKB1 in liver and pancreas leads to an almost complete loss of AMPK 
activity (Hezel et al., 2008; Shaw et al., 2005).  
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AMPK-related kinases (ARKs) 
Besides AMPK, LKB1 has also been shown to phosphorylate and activate 12 other 
kinases (Jaleel et al., 2005; Lizcano et al., 2004). These are BRSK1 and BRSK2 
(Brain-specific kinases 1 and 2); SIK1, SIK2 and SIK3 (Salt-inducible kinases 1-3); 
NUAK1 and NUAK2; MARK1-4 (Microtubule-affinity-regulating kinase 1-4) and 
SNRK (SNF1-related kinase). These are known as ARKs as they share significant 
sequence homology within the catalytic domain to AMPK, and are phosphorylated 
by LKB1 at an equivalent residue to T172 (Figure 1-3) (Lizcano et al., 2004). The 
stimuli and mechanisms by which the ARKs are activated differ from those of 
AMPK. This will be covered in section 1.1.5.  Some of the main findings regarding 
the function of these kinases are summarised below, although the role of many is not 
well understood.  
 
*A B
Figure 1-3 LKB1 substrates 
(A) Dendrogram showing the AMPK-related kinase subfamily (from Alessi et al., 
2006). (B) Alignments of the activation loop (T-loop) of LKB1 and kinases from the 
AMPK-related kinase subfamily. Above are listed kinases that have been shown to 
be substrates for LKB1 and below are non-LKB1 substrates. The threonine residue 
phosphorylated by LKB1 is indicated by an arrow. A leucine residue at the -2 
position from the T-loop threonine is indicated by an asterisk. This leucine is thought 
vital for recognition and phosphorylation by LKB1 (Shaw et al., 2004b). Dark green 
shading shows identical residues and the lighter green shows those conserved in over 
50% of the aligned sequences (from Alessi et al., 2006). 
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The MARK family of kinases are the best characterised of the ARKs. They are the 
mammalian orthologs of the evolutionary conserved partitioning defective-1 (PAR-
1) kinase family, which plays a major role in cell polarity in diverse organisms from 
yeast to mammals (Bohm et al., 1997; Guo and Kemphues, 1995; Huynh et al., 
2001). The role of the LKB1-MARK kinase pathway in cell polarity will be covered 
in section 1.1.6. MARK2 knockout mice have been generated and implicate this 
kinase in a large variety of physiological processes. Defects such growth retardation, 
reduced male and female fertility, autoimmune disease, impaired learning and 
memory and metabolic disorders have been reported (Bessone et al., 1999; Hurov et 
al., 2007; Hurov et al., 2001; Segu et al., 2008). Although these mice show no overt 
defects in cell polarity, during embryogenesis or in adults, it has been suggested that 
this may be due to redundancy between the different MARK isoforms (Hurov and 
Piwnica-Worms, 2007). MARK3 has been implicated in cell cycle control via the 
phosphorylation of Cdc25 and is phosphorylated by the cell cycle regulator Pim-1 
(reviewed in Bright et al., 2009). 
 
BRSK1 and BRSK2, which have orthologues in C.elegans (SAD-B and SAD-A 
respectively), and Drosophila (CG6114), are primarily expressed in the brain, with 
lower expression detected in testis and pancreas, (Bright et al., 2008; Bright et al., 
2009).  Deletion of either isoform in mice gives no overt phenotype and the animals 
are fertile. Double knockouts die two hours after birth showing thinner cortices and a 
severe defect in neuronal polarisation (Kishi et al., 2005). It was suggested that this 
role in neuronal polarisation may be due, at least partly, to the phosphorylation of 
microtubule associated proteins (MAPS) such as tau, which regulate microtubule 
stability.  A role for BRSK1 has also been proposed in synapse formation (Crump et 
al., 2001; Inoue et al., 2006) and in cell-cycle regulation (Lu et al., 2004). It was 
shown to phosphorylate number of proteins associated with the cell cycle and caused 
cell cycle arrest under DNA-damaging conditions (reviewed in Bright et al., 2009). 
 
SIK1 was first isolated from the adrenal glands of rats fed on a high-salt diet (Wang 
et al., 1999). It was proposed that following activation by Ca2+/calmodulin-
dependent kinase (CAMK), SIK1 increases the activity of the Na
+
/K
+
-ATPase in 
response to high intracellular sodium, therefore helping to maintain cell volume and 
composition (Sjostrom et al., 2007). SIK1 has also been implicated in the regulation 
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of the cyclic AMP responsive element (CRE)-binding protein (CREB) transcription 
factor. The phosphorylation of SIK1 by LKB1 in HeLa cells causes the 
phosphorylation and subsequent nuclear export of transducer of regulated CREB 
(TORC2), also known as CRTC2, which is a CREB co-activator, thus decreasing 
CREB-dependent gene transcription (Katoh et al., 2006; Takemori and Okamoto, 
2008). This SIK1-CREB pathway has been implicated in hepatic gluconeogenesis 
and adrenal steroidogenesis (Katoh et al., 2004a; Koo et al., 2005). SIK1 has recently 
been implicated in p53-dependent apoptosis in response to cell-detachment, and 
suppression of metastasis downstream of LKB1 (Cheng et al., 2009).  
 
SIK2 (alternatively known as QIK) is highly expressed in adipose tissue and has 
been suggested to play a role in adipogenesis (Katoh et al., 2004a). It was shown to 
phosphorylate insulin receptor substrate-1 (IRS-1) in adipocytes (Horike et al., 
2003), and overexpression in these cells caused the repression of lipogenic gene 
expression (Du et al., 2008). SIK2 is also able to phosphorylate TORC2, causing it to 
bind to 14-3-3 in the cytoplasm, thereby preventing it from activating CREB in the 
nucleus (Screaton et al., 2004).  
 
SIK3 (also known as QSK) has been shown, by RNAi knockdown, to play a role in 
the proper formation of the mitotic spindle in Drosophila (Bettencourt-Dias et al., 
2004), but there are no reports of its function in mammalian cells. 
 
NUAK1/ARK5 has been implicated in tumour cell survival under low nutrient 
conditions and tumour invasion and metastasis following its phosphorylation and 
activation by Akt (Kusakai et al., 2004; Suzuki et al., 2003; Suzuki et al., 2004). A 
recent study has identified a role for the LKB1-NUAK1 pathway in senescence and 
genomic stability. shRNA knockdown of NUAK1 increased the replicative lifespan 
of cells in culture and constitutively expressed NUAK1 caused defects in 
chromosomal segregation during mitosis, resulting in aneuploidy. The reason for this 
was proposed to be due to the phosphorylation of the genomic stability regulator, 
LATS1, by NUAK1, leading to instability of the LATS1 protein (Humbert et al., 
2009). 
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NUAK2/SNARK protein has been detected in many rat tissues with the highest 
activity observed in testis (Lefebvre and Rosen, 2005). It is thought to have a nuclear 
localisation where it may play a role in the regulation of gene expression (Kuga et 
al., 2008) and has been shown to be regulated by a number of cellular stresses such 
as glucose-deprivation, hyperosmotic stress, oxidative stress and UV radiation 
(Lefebvre and Rosen, 2005). One study has suggested it plays a role in protecting 
tumour cells from CD95- and TRAIL-induced apoptosis, as well as increasing 
tumour invasiveness (Legembre et al., 2004). In addition, NUAK2 deficient mice 
display metabolic disorders such as mature-onset obesity and increased serum 
glucose levels, and increased susceptibility to tumours of the large intestine 
(Tsuchihara et al., 2008).  
 
Snf-1 related kinase (SNRK) is mainly expressed in the testes of rats (Jaleel et al., 
2005), although no functions have yet been ascribed to it. The kinases SSTK (small 
serine/threonine kinase) and TSSK1-4 (testis specific serine threonine kinase 1-4), 
are also on the same branch of the kinome tree as AMPK and the ARKs (Manning et 
al., 2002), albeit more distantly related, and these also almost exclusively expressed 
in testis. A number of studies have shown them to play a role in spermatogenesis 
(Kueng et al., 1997; Spiridonov et al., 2005; Xu et al., 2008). However, TSSK1 was 
shown not to be a substrate for LKB1, which is thought to be because it does not 
possess a leucine two residues before the threonine residue phosphorylated by LKB1. 
This leucine has previously been shown to be important for LKB1 recognition and 
phosphorylation (Shaw et al., 2004b). The other TSSK isoforms and SSTK also do 
not possess this leucine residue, and neither does HUNK, another kinase related to 
AMPK that is not an LKB1 substrate (see Figure 1-3) (Jaleel et al., 2005). Although 
MELK, another ARK, does possess this leucine residue, it is thought to activate itself 
by autophosphorylation and so its activity is not affected by LKB1 (Lizcano et al., 
2004). 
 
In addition to LKB1, a number of other upstream kinases have been identified for the 
ARKs. For example, the MARK family of kinases can be activated by MARKK (also 
known as thousand and one (TAO1) kinase) (Hutchison et al., 1998), and atypical 
protein kinase C (aPKC /PKCδ) has also been implicated in their regulation 
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(Brajenovic et al., 2004; Hurov et al., 2004). Protein kinase A (PKA) phosphorylates 
SIK1 leading to its translocation to the cytoplasm and the subsequent inactivation of 
CREB (Takemori et al., 2002). SIK1 is also phosphorylated by CAMK under high 
intracellular sodium concentrations (Sjostrom et al., 2007). In a recent study it was 
shown that SIK1-3, MARK1-4 and NUAK2 could not be activated by CAMKKβ, 
despite the fact that the sequence around the activation loop threonine is very similar 
to that of AMPK (see Figure 1-3) (Fogarty et al., 2009). 
 
1.1.5 Regulation of LKB1 and its downstream substrates  
Regulation of LKB1 activity 
Many stimuli that activate AMPK do not alter the catalytic activity of LKB1 
(Hawley et al., 2003; Lizcano et al., 2004; Sakamoto et al., 2004; Woods et al., 
2003). Initially, it was proposed that a preparation of liver AMPKK (presumably 
LKB1), like AMPK, was directly activated by AMP (Hawley et al., 1996). However, 
this idea has subsequently been shown to be incorrect (Sanders et al., 2007; Suter et 
al., 2006). The emerging consensus view is that the LKB1 heterotrimer is 
constitutively active and that regulation occurs at the level of its downstream 
substrates or via changes in its localisation. The recent crystal structure of the 
catalytic domain of LKB1 (residues 43-347), bound to the pseudokinase domain of 
STRADα (residues 59-431) and full length MO25α, provides new insights into the 
mechanism by which LKB1 activity is promoted by these proteins. STRAD and 
MO25 are thought to activate LKB1 allosterically by binding to the active site and 
stabilising it in an active conformation  (Zeqiraj et al., 2009a). In addition, evidence 
suggests that LKB1 activity may not be rate limiting in tissues as large reductions in 
activity do not appear to have significant physiological consequences (Sakamoto et 
al., 2005; Sakamoto et al., 2006). Based on these ideas, it has been suggested that 
increasing LKB1 activity in cells might not have substantial effects (Fogarty and 
Hardie, 2009). Despite this hypothesis, there are a number of conserved residues 
within LKB1 that have shown to be post-translationally modified (Figure 1-4). 
 
The role of posttranslational modification of the LKB1 protein is unclear. Studies 
have shown that LKB1 is phosphorylated on at least nine residues, four of these 
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being autophosphorylation sites. The sites on human/mouse LKB1 that can be 
phosphorylated by upstream kinases are S31, S307, S325, T363/366, and S428/431. 
The S31 site possesses the optimal phosphorylation motif for AMPK, MAP kinase-
activated protein kinase-2 (MAPKAP-K2) and cell cycle checkpoint kinase 1 
(CHK1), and it was suggested that S325 may be phosphorylated by a proline-directed 
kinase as it lies in a proline rich region (Sapkota et al., 2002a).  T366/363 is 
phosphorylated in response to ionising radiation by ataxia telangiectasia mutated 
kinase (ATM) in vivo (Sapkota et al., 2002b). It has been shown that S428/431 can 
be phosphorylated by p90 ribosomal S6 protein kinase (RSK), protein kinase A 
(PKA) and protein kinase C-δ (PKCδ), and that S307 can also be phosphorylated by 
PKCδ (Sapkota et al., 2001; Xie et al., 2006b). A number of studies have looked at 
the effect of mutating many of these sites, but none have shown that this has any 
direct effect on LKB1 catalytic activity (Sapkota et al., 2002a; Sapkota et al., 2001). 
However, T336 and the autophosphorylation site, T366/363, have been suggested to 
play a role in cell cycle arrest (Sapkota et al., 2002a). Phosphorylation at S428/431 
has proved controversial, being implicated in nuclear to cytoplasmic translocation of 
LKB1 and in functions such as axon polarisation and cell cycle regulation (Sapkota 
et al., 2001; Shelly et al., 2007; Song et al., 2008). This will be covered in more 
detail in chapter 3. A recent paper has also suggested that S307 plays a similar role to 
S431 in the translocation of LKB1 out of the nucleus and that it plays a role in 
angiogenesis and apoptosis (Xie et al., 2009). Many of these phosphorylation sites 
are conserved in mouse, human and Xenopus LKB1 homologues suggesting that they 
have an important function (Sapkota et al., 2002a). 
 
In addition to phosphorylation, it has also been shown that LKB1 can be farnesylated 
at its C-terminus (C430/433) (Sapkota et al., 2001) and that this is involved in 
targeting LKB1 to cell membranes (see section 1.1.3) (Collins et al., 2000; Sebbagh 
et al., 2009). Phosphorylation at the neighbouring S431 residue has no effect on 
farnesylation at this site and vice versa (Sapkota et al., 2001). 
 
A recent paper has also suggested that LKB1 is acetylated (Lan et al., 2008). In this 
study, the authors report that overexpression of the histone/protein deacetylase 
SIRT1 increases the proportion of LKB1 that is cytoplasmic, while at the same time 
increasing its association with STRAD and catalytic activity (Lan et al., 2008).  
Chapter 1 – Introduction 
 
25 
 
 
 
Figure 1-4 Post-translational modification of LKB1 
(A). Sites on human LKB1 identified as being post-translationally modified by 
phosphorylation, farnesylation or acetylation are shown. Those sites phosphorylated 
by other kinases are shown in black and autophosphorylation sites are shown in red. 
Upstream kinases and agonists are shown. Phosphorylation sites T363, S402, S428 
and C430 correspond to T366, S404, S431 and C433 in mouse LKB1. Farnesylated 
C433 is shown in green. Acetylated lysines are shown as (*). Adapted from (Alessi 
et al., 2006) and (Lan et al., 2008). 
 
 
Regulation of AMPK activity by LKB1 
AMPK is composed of three subunits; a catalytic α subunit and regulatory β and γ 
subunits (Figure 1-5). Two isoforms of both the α and β subunits and three isoforms 
of the γ subunit have been identified in mammals, combinations of which allow for 
12 different heterotrimeric complexes (Carling, 2004). The different isoforms have 
been shown to have a different tissue distribution (Cheung et al., 2000; Stapleton et 
al., 1996; Thornton et al., 1998). The  subunits have a typical serine/threonine 
kinase domain in the N-terminal half and the C-terminal half is involved in binding 
to the regulatory subunits (Crute et al., 1998). The  subunit is thought to act as a 
scaffold, linking the  and  subunits (Woods et al., 1996), and possesses a glycogen 
binding domain in the central region (Hudson et al., 2003; Polekhina et al., 2003). It 
has been suggested that the glycogen binding domain may allow AMPK to monitor 
glycogen stores within the cell. When glycogen is depleted, α1→6 branch points are 
exposed and are thought to bind to the GBD of AMPK and inhibit AMPK activity. 
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Figure 1-5 Domain structure of AMPK 
Shown is the catalytic α subunit and regulatory β and γ subunits. CTD, carboxy-
terminal domain; GBD, glycogen binding domain; CBS, crystathionine-β-synthase 
domains (adapted from Shackelford and Shaw, 2009). 
 
 
This prevents the inhibition of glycogen synthase by AMPK meaning that glycogen 
stores can be replenished in the cell (McBride et al., 2009; McBride and Hardie, 
2009). The γ subunits have 4 cystathionine β-synthase (CBS) domains which bind to 
adenine nucleotides (Scott et al., 2004). Mutations in the CBS domains cause cardiac 
hypertrophy and the cardiac pre-excitation disorder Wolff-Parkinson-White 
syndrome. These diseases are both characterised by large glycogen accumulation 
(Blair et al., 2001; Daniel and Carling, 2002).  
 
AMPK is regulated by a number of different stimuli including; metabolic stresses 
that increase the AMP:ATP ratio; hormones and cytokines that are involved in the 
regulation of whole-body energy metabolism, for example, leptin and adiponectin, 
(reviewed in Kahn et al., 2005); drugs used in the treatment of type-2 diabetes, for 
example, metformin (Zhou et al., 2001); and certain products derived from plants, for 
example, resveratrol (Baur et al., 2006) and the green tea catechin Epigallocatechin-
3-gallate (Collins et al., 2007) (reviewed in Hardie, 2007). 
 
Overall, most agents that activate AMPK do so by increasing the AMP:ATP ratio. 
AMP levels are amplified in the cell due to the actions of adenylate kinase which 
catalyses the conversion of 2ADP to ATP + AMP. Examples of agents that decrease 
ATP production and activate AMPK are metabolic poisons such as dinitrophenol or 
oligomycin (Corton et al., 1994; Witters et al., 1991) and also pathological stresses 
such as glucose-deprivation, hypoxia and oxidative stress. Pathological stresses are 
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thought to play an important role in certain cell types, for example, certain oxygen 
sensing cells like pulmonary artery smooth muscle cells (Evans et al., 2005a), and 
glucose sensing cells such as β-cells in the pancreas (Salt et al., 1998b). Therefore, 
AMPK is thought to be regulated in certain cell types due to physiological variations 
in oxygen and glucose (reviewed in Towler and Hardie, 2007). Activation of motor 
proteins or ion channels, and muscle contraction/exercise are physiological stimuli 
that activate AMPK due to the depletion of ATP (Hayashi et al., 1998). The 
compound 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) is often used 
as a tool to activate AMPK in experimental situations. AICAR leads to the 
accumulation of ZMP in cells, which mimics AMP to activate AMPK (Corton et al., 
1995). 
 
It has been shown previously that AMP does not directly activate LKB1 (Woods et 
al., 2003) or CAMKKβ (Hawley et al., 2005; Woods et al., 2005). Two mechanisms 
are now recognised by which AMP activates AMPK. Firstly, via binding to the γ 
subunits and causing direct allosteric activation, possibly due to a conformational 
change in the protein. This is thought to increase AMPK activity by 2-5 fold, 
depending on the nature of the  subunit in the complex. Secondly, AMP has been 
shown to inhibit dephosphorylation of T172 by protein phosphatases (Sanders et al., 
2007; Suter et al., 2006). Quantitatively, this effect is much more significant, since 
phosphorylation of AMPK activates the enzyme by 100-1000 fold (Suter et al., 
2006). Recently, a model was proposed by Sanders et al., (2007) (Figure 1-6) to 
explain the regulation of AMPK by LKB1 in response to variations in intracellular 
AMP. 
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Figure 1-6 Regulation of AMPK activity by AMP and LKB1 
Model proposed by Sanders et al., (2007). LKB1 is constitutively active and 
continuously phosphorylating AMPK at T172. When the cellular AMP:ATP ratio 
increases, AMP binds to the  subunits of AMPK causing direct allosteric activation 
and reducing the rate of dephosphorylation of T172 by phosphatases. Therefore, the 
activation status of AMPK depends on the relative rates of phosphorylation and 
dephosphorylation. 
 
 
Regulation of the ARKs by LKB1 
The AMPK related kinases share a number of common structural features (Figure 
1-7) including an N-terminal catalytic domain followed by a UBA (ubiquitin-
associated) domain, and at the C-terminus of the MARKs there is KA1 domain 
(reviewed in Bright et al., 2009). The function of the KA1 domain is not well 
understood but has been suggested to be involved in the membrane binding of 
MARK3 (Goransson et al., 2006). Incubation of a number of ARKs with the LKB1 
heterotrimer was shown to increase their catalytic activity by 50-200 fold (Lizcano et 
al., 2004).  
 
The ARKs are not thought to be regulated in the same way as AMPK and do not 
respond to the same stimuli, such as, AICAR, phenformin, muscle contraction or 
increases in intracellular calcium (Bright et al., 2008; Fogarty et al., 2009; Lizcano et 
al., 2004; Sakamoto et al., 2004). However, one group has suggested NUAK2 
activity may be affected by cellular stresses such as AICAR treatment, glucose-
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deprivation and osmotic stress (Lefebvre et al., 2001; Lefebvre and Rosen, 2005), 
and SIK2 has been shown to be activated by AICAR and the ATP synthesis inhibitor, 
oligomycin, in adipocytes (Du et al., 2008). However, another study suggested that 
neither NUAK2 or SIK2 were activated by AICAR or phenformin in MEFs (Lizcano 
et al., 2004).  
 
Mutational analysis of conserved residues within the UBA domain has shown that 
this domain is essential for efficient phosphorylation and activation by LKB1. The 
possibility that the UBA domain may act as a docking site for LKB1 was excluded. 
Instead  it was suggested that it may affect the conformation of the catalytic domain 
of the ARK so that LKB1 can recognise and phosphorylate it (Jaleel et al., 2006). 
Previously, UBA domains have been proposed to bind ubiquitin or polyubiquitin 
which can affect the localisation and activity of proteins and target them for 
Figure 1-7 Domain structure of the ARKs 
The amino acid length is shown to the right. Kinase-, UBA- and KA1- domains 
are shown.  Domain 3 in SIK1was suggested to play a role in subcellular 
localisation and suppression of the CREB transcription factor (Katoh et al., 
2004b). The Pfam-B domains in BRSK1/2 were shown to be conserved in human, 
Drosophila and C. elegans (from Katajisto et al., 2007). 
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degradation by the proteasome (Hicke et al., 2005). Therefore, it has been suggested 
that the ARKs may be regulated by this mechanism, although early studies suggested 
that this may not be the case as ubiquitin bound very weakly to the UBA domains 
(Jaleel et al., 2006; Murphy et al., 2007). Recent studies, however, have shown that 
several ARKs are polyubiquitinated, namely, BRSK1, MARK1, MARK3, MARK4, 
NUAK1 and NUAK2 (Al-Hakim et al., 2008). This polyubiquitination decreased 
their phosphorylation by LKB1 and therefore catalytic activity. No increases in 
protein degradation were observed. AMPKα1 was also shown to be 
polyubiquitinated and it was suggested that a small region of the AMPK α-subunit 
shows some similarity to the UBA domains of the related kinases (Jaleel et al., 
2006). Another study has also suggested AMPK may be ubiquitinated on the β 
subunit by Cidea in adipose tissue and that this increases its degradation by the 
proteasome (Qi et al., 2008). A model was proposed for the ARKs in which ubiquitin 
chains compete with the kinase domain for binding to the UBA domains. If 
polyubiquitin is bound, this will disrupt the interaction between the kinase domain 
and UBA domains, therefore destabilising the kinase domain and making it a worse 
substrate for LKB1. Alternatively, the ubiquitin chains may physically block access 
to the activation loop by LKB1 or cause a conformational change that increases 
dephosphorylation by phosphatases (Al-Hakim et al., 2008).  
 
Some of the AMPK related kinases have also been shown to interact with the 14-3-3 
proteins. 14-3-3 proteins are scaffolding proteins implicated in numerous signalling 
pathways, for example, by regulating the localisation of proteins and the interactions 
between them (reviewed in Sun et al., 2009). SIK1, SIK3 (QSK) and PAR1/MARK 
have been shown to associate with 14-3-3 (Al-Hakim et al., 2005; Brajenovic et al., 
2004; Goransson et al., 2006). The binding of SIK1 and SIK3 to 14-3-3 was shown 
to be dependent on LKB1 phosphorylation, and to increase their catalytic activity and 
anchor them in the cytoplasm. It was suggested that by increasing the binding of 
SIK1/3 to 14-3-3,  LKB1 may bring them into contact with substrates bound to 14-3-
3 (Al-Hakim et al., 2005). MARK3 bound to 14-3-3 in both the presence and absence 
of LKB1 phosphorylation, suggesting that LKB1 is not essential in this case (Al-
Hakim et al., 2005). However, Goransson et al. (2006) suggested 14-3-3 binding is 
regulated by simultaneous phosphorylation at multiple sites on MARK3 including 
the T211 site phosphorylated by LKB1. Binding of MARK3 to 14-3-3 was shown
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Figure 1-8 Regulation of the ARKs by LKB1 
The activity of the ARKs is thought to be affected by phosphorylation by upstream 
kinases, ubiquitination, protein phosphatases and binding to 14-3-3 (adapted from 
Bright et al., 2009). 
 
 
not to affect its catalytic activity but to cause relocalisation from the plasma 
membrane to the cytoplasm. A summary of the regulation of the ARKs by LKB1 is 
shown in Figure 1-8. 
 
To summarise the current understanding regarding the regulation of LKB1 and its 
downstream substrates; the binding of STRAD and MO25 are thought to promote the 
active conformation of LKB1 and evidence suggests this heterotrimeric complex is 
constitutively active. The LKB1-AMPK pathway is thought to be primarily regulated 
at the level of AMPK, with AMP causing allosteric activation of AMPK and 
inhibiting its dephosphorylation. Regulation of the LKB1-ARK pathway is less well 
understood and, unlike AMPK, these kinases are not thought to be regulated by 
AMP. Recent studies suggest ubiquitination may play a role by blocking 
phosphorylation by LKB1. The potential role of post-translational modification of 
LKB1 in modulating these pathways remains to be determined. 
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1.1.6 Functions of LKB1  
Cell growth and proliferation 
The first function identified for LKB1 was as a tumour suppressor. In 1998, 
mutations in the LKB1 gene were shown cause Peutz-Jeghers Syndrome (PJS) 
(Hemminki et al., 1998). PJS is a rare disease affecting 1 in 50,000-200,000 people, 
mainly due to germline mutation. Most patients have inactivating mutations, exonic 
deletions or loss of the whole gene (Hezel and Bardeesy, 2008; Volikos et al., 2006). 
The disease is characterised by benign polyps of the gastrointestinal tract 
(hamartomas), these being located mainly in the small intestine but smaller polyps 
are also common in the stomach (Hezel and Bardeesy, 2008). Patients also display an 
increased risk of going on to develop malignant tumours at other sites, with one 
estimate putting it at 93% of patients by the age of 43 (Giardiello et al., 2000). 
Cancers of the gastrointestinal tract, breast, lung, ovary, uterus and testis have been 
reported (Giardiello et al., 2000; Hearle et al., 2006; Young et al., 1995).  
 
Mutations in LKB1 have also been reported in sporadic cancers, for example, 
mutations are particularly common in non-small cell lung cancers (estimated at 1/3) 
(Sanchez-Cespedes et al., 2002) and in pancreatic cancers (Su et al., 1999). In 
addition, mice in which LKB1 has been deleted specifically in pancreas, prostate and 
endometrium show tumours at these sites (Contreras et al., 2008; Hezel et al., 2008; 
Pearson et al., 2008). 
 
Certain tumour cell lines have either no or greatly reduced expression of LKB1, for 
example, HeLa (cervical adenocarcinoma) and G361 (melanoma) cells. When LKB1 
is overexpressed in such cell lines, it causes a cell cycle arrest in the G1 phase. This 
was shown to require the catalytic activity of LKB1 and its cytoplasmic localisation, 
and was accompanied by a p53-dependent increase in levels of the cyclin-dependent 
kinase (CDK) inhibitor p21 (Tiainen et al., 2002; Tiainen et al., 1999), implicating 
the p53 pathway as a possible mechanism by which LKB1 exerts its tumour 
suppressor properties.  In another study Jiminez et al. showed that p53 responsive 
genes were upregulated following expression of LKB1 in LKB1-deficient cells, as 
well as levels of the tumour suppressor PTEN (phosphatase and tensin homolog) 
(Jimenez et al., 2003). Other studies have also implicated LKB1 in the regulation of 
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PTEN and mutations in PTEN cause a phenotype similar to PJS called Cowdens 
syndrome (Mehenni et al., 2005; Song et al., 2007; Stratakis et al., 1998). A role for 
LKB1 in the Wnt/β-Catenin pathway has also been suggested, and it has been 
proposed that activation of this pathway in PJS patients may contribute to the 
development of cancer (Lin-Marq et al., 2005; Ossipova et al., 2003). LKB1 has also 
been implicated in cell survival by causing p53-dependent apoptosis (Karuman et al., 
2001). However, in conditions of energy stress, mouse embryonic fibrobalsts 
(MEFS) lacking LKB1 expression displayed increased apoptosis (Shaw et al., 
2004b).  
 
It is believed that LKB1 may exert many of its tumour suppressor properties via the 
regulation of AMPK, thus providing a link between the regulation of energy 
metabolism and cell proliferation (reviewed in Koh and Chung, 2007; Motoshima et 
al., 2006). It makes energetic sense for cell growth and division to occur only when 
there is adequate energy available. Interestingly, the AMPK activator metformin has 
been shown to reduce the risk of cancer in diabetics (Evans et al., 2005b). AMPK 
causes cell cycle arrest via a p53 dependent mechanism, and this is accompanied by 
increased levels of the CDK inhibitors, p21 and p27 (Imamura et al., 2001; Jones et 
al., 2005; Rattan et al., 2005). However, one study suggested that this was 
independent of LKB1 as treatment of LKB1-deficient MEFS with the AMPK-
activator, AICAR, still caused cell cycle arrest (Rattan et al., 2005).  LKB1-AMPK 
signalling has also been implicated in the stabilisation of the CDK inhibitor p27, 
resulting in the induction of autophagy (catabolism of intracellular organelles and 
cytoplasm to generate energy) under conditions of stress. When p27 was deleted this 
led to apoptosis (Liang et al., 2007). 
 
AMPK acts as a negative regulator of the mTOR pathway (specifically mTORC1), 
thereby decreasing protein synthesis when energy levels are low. AMPK has been 
shown to phosphorylate and activate TSC2, an upstream inhibitor of mTOR (Inoki et 
al., 2003; Kimura et al., 2003), and also to phosphorylate the regulatory-associated 
protein of mTOR (raptor) causing it to bind 14-3-3 and thereby preventing it from 
activating mTOR (Gwinn et al., 2008).  Consistent with these findings, inhibition of 
mTOR did not occur in LKB1 deficient cells under energy stress (Corradetti et al., 
2004; Shaw et al., 2004a). Increased mTOR pathway activity has also been reported 
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in the epithelium of PJS polyps and the mTOR inhibitor rapaycin reduced polyp 
growth (Shaw et al., 2004a). However, the role of the mTOR pathway in the tumour 
suppressor properties of LKB1 has proved controversial. For example, in pancreatic 
and endometrial tumours induced by LKB1 knockout, there was no significant de-
regulation of mTOR activity even though there was no AMPK activity (reviewed in 
Hezel and Bardeesy, 2008). AMPK has also been shown to control protein synthesis 
via activation of elongation factor-2 kinase (eEF2k). Following activation, eEF2k 
phosphorylates elongation factor-2, thereby preventing it from binding to the 
ribosome and resulting in the inhibition of translational elongation (Horman et al., 
2002).  
 
Drosophila lacking expression of either LKB1 or AMPK homologues, display a 
mitotic phenotype, with problems in chromosomal segregation during mitosis 
leading to polyploidy (Lee et al., 2007) and tumour-like growths due to over-
proliferation of epithelial cells (Mirouse et al., 2007). LKB1 has been suggested to be 
involved in the formation of the mitotic spindle in drosophila neuroblasts 
(Bonaccorsi et al., 2007) and in positioning of the centrosome in mammalian neurons 
(Asada et al., 2007). 
 
In addition to AMPK, other AMPK- related kinases such as MARK3 and BRSK1 
have also implicated in cell cycle regulation (reviewed in Bright et al., 2009). The 
role of LKB1 in controlling cell polarity (see below) is also thought to contribute to 
its tumour suppressor properties (Baas et al., 2004b; Partanen et al., 2007). 
Therefore, the exact mechanism by which LKB1 exerts its tumour suppressor 
properties has not been fully elucidated. A combination of factors and downstream 
substrates may be involved, these varying between cell types.  
 
Energy metabolism 
It has long been understood that the LKB1 substrate, AMPK, plays a key role in the 
regulation of energy balance, not just at the level of the cell, but the whole body.  
When energy levels are low, AMPK turns on pathways that generate energy, for 
example, fatty acid oxidation and glycolysis, and turns off pathways that consume 
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energy, for example, fatty acid and cholesterol synthesis. It acts at both the level of 
the cell and the whole organism (reviewed in Carling, 2005). 
 
In order to restore energy balance, AMPK has both short and long term effects. A 
number of enzymes involved in protein, lipid and carbohydrate metabolism are 
directly phosphorylated by AMPK.  For example, phosphorylation by AMPK 
inhibits the activity of acetyl-CoA carboxylase (ACC) 1 and 2, which leads to 
decreased fatty acid synthesis and increased fatty acid oxidation, respectively. 
AMPK inhibits hormone-sensitive lipase (HSL) which decreases lipolysis in adipose 
tissue, and the phosphorylation of AS160 by AMPK is thought to increase glucose 
uptake in muscle via GLUT4 translocation to membranes (Kramer et al., 2006; 
Kurth-Kraczek et al., 1999) (reviewed in Hardie, 2007).  AMPK activation also has 
longer term effects, such as in the regulation of genes involved in energy 
metabolism. AMPK is involved in the repression of genes involved in 
gluconeogenesis and lipogenesis in the liver, and in the upregulation of genes such as 
GLUT4 to increase glucose uptake into tissues (reviewed in Hardie, 2007).  
 
AMPK is also regulated by various hormones implicated in the  control of whole-
body energy metabolism. A number of cytokines released from adipocytes, such as, 
adiponectin, leptin and resistin, act as signals for when energy reserves are sufficient 
or low (reviewed in Kahn et al., 2005; Towler and Hardie, 2007). For example, when 
fat stores are adequate, leptin is released from adipose tissue. It binds to receptors in 
the hypothalamus leading to an inhibition of food intake (Friedman and Halaas, 
1998). It was later shown that these effects are mediated via the inhibition of AMPK 
in the hypothalamus (Minokoshi et al., 2004).  
 
Due to its effects on the regulation of energy balance, AMPK has been implicated in 
the metabolic syndrome including type 2 diabetes and obesity. It has been suggested 
that agents that activate AMPK may have therapeutic potential in many of these 
metabolic disorders (Hardie, 2008). Many of the beneficial effects of exercise are 
also thought to involve AMPK (Hardie and Sakamoto, 2006). In addition, a number 
of plant products reported to activate AMPK, such as resveratrol and green tea 
catechins, have a number of metabolic health benefits, such as increased insulin 
sensitivity, increased lifespan and anti-obesity effects (reviewed in Hardie, 2007).  
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Deletion of both AMPKα1 and AMPKα2 in mice is embryonically lethal (Kahn et 
al., 2005). Knockout of AMPKα1 alone has no detectable metabolic phenotype 
whereas knockout of AMPKα2 causes impaired glucose homeostasis with mild-
insulin resistance and a defect in insulin secretion (Jorgensen et al., 2004; Viollet et 
al., 2003). LKB1 deletion in specific tissues also causes metabolic defects. For 
example, deletion of LKB1 in skeletal muscle leads to decreased glucose uptake 
(Sakamoto et al., 2005), and liver-specific deletion of LKB1 in adult mice causes 
hyperglycaemia, probably due to increased gluconeogenesis (Shaw et al., 2005). 
Mice lacking LKB1 expression in liver from birth show defects in cholesterol and 
bile metabolism (A. Woods, unpublished observations). 
 
In addition to AMPK, it is becoming clear that some of the ARKs may also play 
roles in energy metabolism. For example, MARK2 knockout mice display decreased 
adipose tissue, resistance to high fat diet induced weight gain, increased sensitivity to 
insulin and increased glucose uptake in adipose tissue (Hurov et al., 2007). NUAK2 
deficient mice display metabolic disorders such as mature-onset obesity and 
increased serum glucose levels (Tsuchihara et al., 2008), and SIK2 has been 
implicated in lipogenic gene expression in adipocytes (Du et al., 2008). The 
regulation of the CREB transcription factor by SIK1, SIK2 and AMPK (section 
1.1.4) has been suggested to play a role in the regulation of gluconeogenesis in the 
liver, for example, by increasing expression of phospho-enol pyruvate carboxykinase 
(PEPCK) and glucose-6-phosphatase (G6Pase) (Koo et al., 2005). In hepatocytes 
from LKB1 knockout mice, the CREB coactivator, TORC-2 is unphosphorylated and 
located in the nucleus (reviewed in Carling, 2006) (Shaw et al., 2005).  
 
Cell polarity 
When LKB1 and STRAD are overexpressed in unpolarised epithelial cells, there is a 
complete polarisation, characterised by redistribution of membrane markers, 
remodelling of the actin cytoskeleton and the formation of a brush border at the 
apical edge (Baas et al., 2004a). A recent study has implicated the Mst4-Ezrin 
pathway downstream of LKB1 in brush border formation (ten Klooster et al., 2009). 
Another study demonstrated that LKB1 was important for lamellipodia formation 
and positioning of the golgi apparatus in a lung cancer cell line. In these cells LKB1 
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was to shown interact with the actin cytoskeleton at the leading edge and to be 
important for localisation of the small rho GTPase, Cdc42, a regulator of cell polarity 
(Zhang et al., 2008). In addition, deletion of LKB1 expression specifically in the 
pancreas was accompanied by polarity defects including disrupted cytoskeletal 
organisation and an absence of tight- and adherens- junctions (Hezel et al., 2008), 
and LKB1 homologues in Drosophila (dLKB1) and Xenopus (XEEK1) play a role in 
anterior-posterior polarity development during embryogenesis (Martin and St 
Johnston, 2003; Ossipova et al., 2003). The control of polarity has been shown to 
require the catalytic activity of LKB1 and its cytoplasmic localisation (Baas et al., 
2004a; Forcet et al., 2005). 
 
The discovery that LKB1 is an upstream kinase for PAR-1/MARK suggested that it 
may be exerting its polarity effects through this pathway. Six evolutionarily 
conserved PAR proteins were discovered in C.elegans that are required for the first 
two asymmetric divisions of the zygote (PAR-1/MARK, PAR-2, PAR-3/ASIP, PAR-
4/LKB1, PAR-5/14-3-3 and PAR-6) (reviewed in Baas et al., 2004b). LKB1 is 
homologous to PAR4, sharing 42% homology with it (Watts et al., 2000). The PAR 
proteins (and their homologues in Drosophila and mammals) are thought to interact 
in the establishment of polarity, and form a hierarchical network (Baas et al., 2004b; 
Brajenovic et al., 2004). It is thought that LKB1 may sit at the top of the hierarchy 
(reviewed in Hezel and Bardeesy, 2008).  
 
The exact mechanism by which LKB1 controls polarity in mammals via the MARK 
kinases is not fully elucidated. Recent studies have shown that phosphorylation of 
MARK3 causes it to bind to 14-3-3, leading to its movement from the cell membrane 
to the cytoplasm (Goransson et al., 2006). In addition, it has been suggested that 
following phosphorylation by LKB1, PAR1/MARK phosphorylates PAR3/ASIP 
causing it to associate with 14-3-3. This would prevent PAR3 forming a 
PAR3/PAR6/aPKC complex, thus leading to alterations in cell polarity. The 
PAR3/PAR6/aPKC complex has previously been shown to play a key role in polarity 
(Baas et al., 2004b; Benton and St Johnston, 2003; Jansen et al., 2009). MARKs are 
also involved in the regulation of the microtubule cytoskeleton via phosphorylation 
of microtubule associated proteins (MAPs) such as tau, thereby causing microtubule 
instability (Kojima et al., 2007; Cohen et al., 2004; Drewes et al., 1997).  
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Both the MARKs and BRSKs have been implicated in the control of neuronal 
polarity and this was suggested to be via the phosphorylation of MAPs and alteration 
of microtubule dynamics (Barnes et al., 2007; Biernat et al., 2002; Kishi et al., 2005; 
Shelly et al., 2007). A mouse knockout of LKB1 in cortical pyramidal neurons 
showed a similar phenotype to the BRSK double knockouts and this neuronal 
polarisation involved LKB1 dependent phosphorylation of BRSKs (Barnes et al., 
2007; Shelly et al., 2007). 
 
Two recent studies of AMPK-null Drosophila have implicated AMPK in the 
regulation of polarity, and therefore linking energy status to cellular architecture. 
These mutant flies fail to develop into adults and display an epithelial polarity 
phenotype under conditions of energy stress, similar to that caused by deletion of 
LKB1, and  including an abnormal architecture of actin filaments. Expression of an 
active form of AMPK was able to rescue the phenotype of the LKB1 null flies (Lee 
et al., 2007; Mirouse et al., 2007). Furthermore, activation of AMPK following 
incubation with 2-deoxyglucose, caused polarisation of mammalian LS174T cells 
(Lee et al., 2007). The LKB1-AMPK pathway has also been implicated in tight 
junction assembly and disassembly in mammalian MDCK cells (Zhang et al., 2006; 
Zheng and Cantley, 2007). Tight junctions are believed to maintain polarity by 
creating a barrier to the diffusion of membrane components between the apical and 
basal domains of the cell and can also bind to proteins involved in cell polarity such 
as the PAR3/PAR6/aPKC complex (Matter et al., 2005). It is therefore thought that 
under conditions of energy deprivation AMPK plays an important role by diverting 
energy towards maintaining the barrier function of epithelia that is crucial to cell 
survival (Zheng and Cantley, 2007). 
 
It has been suggested that the downstream effectors of LKB1 in polarity regulation 
may depend on the cell type. In addition, deletion of LKB1 in specific tissues does 
not always cause polarity defects, for example, although tumours were found in 
LKB1-deficient endometrium, no polarity defects were observed (Contreras et al., 
2008) (reviewed in Hezel and Bardeesy, 2008; Koh and Chung, 2007). It has been 
proposed that LKB1 acts through AMPK and PAR-1 to control cell polarity in 
response to different physiological cues and this having slightly different effects. For 
example, PAR-1 and AMPK mutant Drosophila do show some differences in their 
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cytoskeletal phenotypes (reviewed in Koh and Chung, 2007). In response to energy 
deprivation, dominant negative AMPK blocked the polarisation of mammalian 
LS174T cells, whereas inhibition of PAR-1 had no effect (Lee et al., 2007). In 
addition, LKB1 may not act through AMPK in the control of polarity in the 
drosophila eye. Polarity in this organ was suggested to involve a number of related 
kinases because knockdown of the drosophila homologues of SIK, NUAK or PAR-1 
partially phenocopied the LKB1 phenotype, whereas the phenotype caused by 
AMPK deletion was quite different (Amin et al., 2009).  
 
 
To conclude this section on the functions of LKB1, this kinase has been implicated in 
a number of key processes (shown in Figure 1-9), and may act through a number of 
downstream kinases to regulate these functions. A key function now proposed for 
LKB1 is the coupling of nutrient availability to cell division/survival and cellular 
architecture. In addition, the work presented in this thesis implicates a new role for 
LKB1 in spermatogenesis, the background to which will be covered in the next 
section.  
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Figure 1-9 Key functions of LKB1 
Potential downstream  substrates for LKB1 in the control of these pathways are 
shown. 1, (Carling, 2005); 2, (Hardie, 2007); 3, (Koo et al., 2005); 4, (Horike et al., 
2003); 5, (Hurov et al., 2007); 6, (Tsuchihara et al., 2008); 7, (Lee et al., 2007); 8, 
(Zhang et al., 2006); 9, (Kishi et al., 2005); 10, (Barnes et al., 2007); 11, (Baas et al., 
2004); 12, (Kojima et al., 2007); 13, (Bright et al., 2009); 14, (Lu et al., 2004); 15, 
(Bettencourt-Dias et al., 2004); 16, (Humbert et al., 2009); 17, (Jones et al., 2005); 
18, (Motoshima et al., 2006). 
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1.2 Spermatogenesis  
The mammalian sperm is a highly specialised cell type, adapted over thousands of 
years to carry out its fundamental role as the vehicle to carry the genome to the next 
generation. Many cellular processes have to be intricately coordinated and regulated 
within the testes to transform undifferentiated cells into highly specialised motile 
spermatozoa. Many testis-specific proteins, including splice variants, are expressed 
in order to carry out these specialised roles. However, high complexity requires 
precise coordination and regulation. Mutations in genes involved in spermatogenesis 
could lead to the fundamental role of the sperm being jeopardised.  
 
1.2.1 General testis and epididymis structure 
The testis can be divided into two main compartments; the seminiferous tubules and 
the interstitial tissue (Figure 1-10). The seminiferous tubules loop up and down 
through the testis and it is within these that spermatogenesis occurs. Making up the 
walls of these tubules is the seminiferous epithelium which contains sertoli cells and 
developing germ cells. The sertoli cells are thought to play a major role in supporting 
germ cell development as will be explained further in section 1.2.2. The boundary 
layer around the edge of the tubules contains myoid cells. It is thought that these 
cells play a contractile role to move fluid and sperm along the lumen of the tubules 
(Maekawa et al., 1996). In between the seminiferous tubules is the interstitial tissue 
containing leydig cells, blood and lymphatic vessels and macrophages. The leydig 
cells are involved in androgen production (Dufau, 1988). Mature sperm are released 
into the lumen of the seminiferous tubules which connect at each end to the rete 
testis, and from here the sperm move into the epididymis. The epididymis is divided 
into three sections, the caput epididymis, corpus epididymis and cauda epididymis. It 
is in the cauda epididymis that the sperm are stored prior to release (Russell et al., 
1990) (Figure 1-10). 
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Figure 1-10 Testis and epididymis morphology 
(A) Diagram of a cross section through a testis and epididymis (adapted from Cooke 
and Saunders, 2002). (B) Diagrammatic representation of a transverse cross-section 
through a testis showing seminiferous tubules and interstitial tissue (adapted from 
Cooke and Saunders, 2002). 
A 
B 
Chapter 1 – Introduction 
 
43 
 
1.2.2 Spermatogenesis 
Spermatogenesis is the process by which undifferentiated diploid spermatogonia 
develop into haploid spermatozoa. This occurs within the seminiferous epithelium of 
the seminiferous tubules. Spermatogenesis can be divided into four main phases; 
proliferation, meiosis, spermiogenesis and spermiation (Figure 1-11). 
 
Firstly, during the proliferative phase spermatogonia divide by mitosis to increase 
cell numbers. The most mature spermatogonia divide to form spermatocytes and 
these divide by meiosis to form haploid spermatids. During spermiogenesis the 
spermatids display a huge morphological transition from round spermatids to 
elongated spermatids and finally spermatozoa (see section 1.2.4). The release of the 
elongated spermatids into the lumen is known as spermiation (see section 1.2.5) 
(Russell et al., 1990).  
 
Residual Bodies
Cytoplasmic Bridges
Cytoplasmic 
Lobes
 
Figure 1-11 Phases of spermatogenesis 
The four main phases of spermatogenesis are shown. The germ cell generations 
found at each phase are shown to the right. Germ cells remain liked via cytoplasmic 
bridges during their development. Upon release from the seminiferous epithelium at 
spermiation the excess sperm cytoplasm is retained by the sertoli cells as a ‘residual 
body’ (adapted from Gilbert, 2000). 
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A histological section taken across the long axis of the testis will display tubule 
cross-sections. The spermatogonia are found around the outer edge of the 
seminiferous epithelium resting on the basement membrane. With distance from the 
basement membrane, an increasing maturity of germ cells can be found so that the 
most mature cells are found around the lumen (Figure 1-12) (Russell et al., 1990). 
The seminiferous epithelium is divided into the basal and apical compartments by the 
blood-testis barrier (BTB). The BTB is made up of a number of cell junctions, 
including tight junctions and adherens junctions. Only pre-meiotic cells are found on 
the basal side of the BTB and during their development germ cells must cross the 
BTB which involves extensive restructuring of the cell junctions (reviewed in Cheng 
and Mruk, 2002). 
 
Sertoli cells provide an environment and framework for the developing germ cells 
and extend from the outer edge of the seminiferous tubule to the lumen. The germ 
cells develop in pockets and crypts within these cells (Wong and Russell, 1983). It is 
thought that cell junctions with each other and with germ cells allow continuous 
communication between the different cell types and the regulation and 
Figure 1-12 Seminiferous tubule structure 
Diagram of a cross-section through the seminiferous epithelium showing different 
germ cell generations at different positions within the epithelium, embedded in 
pockets within a sertoli cell (adapted from Cooke and Saunders, 2002). 
Elongated Spermatid
Round Spermatid
Spermatocyte
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synchronisation of spermatogenesis (Gilula et al., 1976; Griswold, 1995; McGinley 
et al., 1979). In addition, 10 other functions have been attributed to sertoli cells 
including; provision of nutrients and lactate (energy source) to developing germ 
cells; secretion of proteins, for example inhibin and androgen binding protein; 
phagocytosis of degenerating sperm and residual bodies; spermiation; and 
translocation of sperm from the basement membrane to the lumen of the 
seminiferous tubules (Russell et al., 1990). 
 
Germ cells remain connected to each other throughout their development via 
cytoplasmic bridges. These are formed by incomplete cytokinesis and it is thought 
that subsequent generations of germ cells derived from a single spermatogonium 
remain connected within the seminiferous epithelium (Dym and Fawcett, 1971; 
Fawcett et al., 1959; Russell et al., 1990). A number of hypotheses have been put 
forward to explain their function including transfer of mRNA, proteins, organelles 
and nutrients between germ cells (reviewed in Guo and Zheng, 2004). 
 
Spermatogenesis is regulated by a number of hormones, primarily testosterone, 
luteinising hormone (LH) and follicle-stimulating hormone (FSH), which are 
important for normal spermatogenesis (reviewed in Cooke and Saunders, 2002). 
Leydig cells, peritubular cells and sertoli cells possess the androgenreceptor 
(androgen receptor). Testosterone has been implicated in such spermatogenic 
processes as blood-testis barrier maintenance, sertoli:germ cell adhesion and 
spermiation (reviewed in Holdcraft and Braun, 2004; Walker, 2009; Wang et al., 
2006). The gonadotrophic horomones LH and FSH are released from the pituitary 
gland. LH binds to receptors on leydig cells promoting the synthesis of testosterone, 
and FSH binds to receptors on sertoli and germ cells to regulate spermatogenesis 
(reviewed in Amory and Bremner, 2003). 
 
During transit through the epididymis, further sperm maturation occurs including 
modifications to the sperm plasma membrane, changes in protein composition and 
the post-translational modification of proteins (Aitken et al., 2007; Cornwall, 2009; 
Jones et al., 2007). In addition, sperm acquire progressive motility. Although the 
processes and proteins involved in this maturation are not well understood, the 
epididymal epithelium is known to secrete a number of proteins into the lumen, and 
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those synthesised and secreted vary between different regions of the epididymis 
leading to different microenvironments (reviewed in Cornwall, 2009). 
 
1.2.3 Classifying spermatogenesis into stages 
If a transverse section is taken through a testis and the tubule cross sections are 
studied, different associations of germ cell types will be present depending on what 
stage of the cycle of the seminiferous epithelium it is at. All tubule cross sections 
will contain spermatogonia, spermatocytes and spermatids but the level of 
development of each of these will vary. This is because spermatogenesis occurs in 
waves along the seminiferous tubules. Therefore, at different lengths along the 
tubule, the point in the process of spermatogenesis will vary (Russell et al., 1990). 
The particular associations of germ cell types are called ‘Stages’. 12 stages have 
been identified in mouse (Figure 1-13).  In addition, the haploid spermatids can be 
classified into ‘Steps’ depending on their stage of development. There are 16 steps in 
mice (Oakberg, 1956). 
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Figure 1-13 The 12 Stages of mouse spermatogenesis 
The germ cell generations present at each ‘Stage’ are shown.  The 16 ‘Steps’ of 
spermatid development are shown below each spermatid image. The different types 
of spermatogonia and spermatocytes are also displayed below each image (adapted 
from Russell et al., 1990). 
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1.2.4 Spermiogenesis 
Spermiogenesis is the process by which the step 1 round spermatids formed after 
meiosis undergo a huge morphological transition to generate the characteristic sperm 
shape. An overview of spermiogenesis is shown in Figure 1-14. The main processes 
include; the formation of the acrosome from golgi-derived vesicles, chromatin 
condensation and elongation/shaping of the nucleus, formation of the flagellum at the 
opposite nuclear pole to the acrosome, elongation of the cytoplasm along the 
flagellum and the lining up of mitochondria around the mid-piece in a helical pattern. 
This is accompanied by a translocation of the spermatids towards the lumen, with 
spermatid heads pointing towards the basement membrane and tails towards the 
lumen (Russell et al., 1990). 
 
1.2.5 Spermiation 
Spermiation is the release of mature spermatids from the seminiferous epithelium 
and into the lumen of the seminiferous tubules. Originally the term was used to 
describe the final disengagement of the sperm heads from the seminiferous 
epithelium, but increasingly it is being recognised as a process requiring a series of 
co-ordinated steps that prepare the spermatids for release, up until the final 
disengagement. Each of these steps is thought vital for spermiation to proceed 
correctly (Russell, 1993). However, many of these processes and their regulation are 
not well understood.  
 
Spermiation has been described as beginning when the spermatids align around the 
edge of the lumen at around stage VII with the flagella pointing into the lumen. The 
spermatid is gradually extended into the lumen by a microtubule-containing apical 
sertoli cell expansion which connects to the spermatid head. The cytoplasm around 
the flagellum relocates to lie adjacent to the spermatid head forming a hood like 
structure, connected to the neck region. This is called the cytoplasmic lobe. The 
junctions between the spermatid heads and sertoli cells gradually break down and the 
sertoli cell cytoplasm retracts. In mid to late stage VIII the sperm are released into 
the lumen and the cytoplasmic lobe is retained by the sertoli cells (Beardsley and 
O'Donnell, 2003; Russell, 1993). The cytoplasmic lobes released from adjacent 
spermatids fuse and condense to form what are termed residual bodies. These are 
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phagocytosed by the sertoli cells and translocated towards the base of the tubule 
(Dietert, 1966).  
 
 
 
Figure 1-14 Spermiogenesis 
Diagram to show the main steps during mouse spermiogenesis, as described in 
Leblond and Clermont., (1952) and Russell et al., (1990). In early spermatids the 
perinuclear GA starts producing acrosomal vesicles, containing acrosomal 
components (1), which coalesce and spread over the surface of the nucleus (2). The 
nucleus then moves to the surface of the cell and the acrosome attaches to the cell 
membrane (3) (Abou-Haila and Tulsiani, 2000). The flagellum is formed from a 
structure called the axoneme which contains a 9+2 arrangement of microtubules. 
This attaches to the nucleus and the flagellum grows towards the lumen of the 
seminiferous tubules (3). Later the mitochondria align along the midpiece (4). The 
cytoplasm elongates along the flagellum and as it does so, the chromatin condenses 
and the characteristic falciform head shape is formed (4-5). When the spermatids are 
released, the residual cytoplasm is retained by the sertoli cells (5). 
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1.2.6 Cell junctions and spermiation 
One of the processes required for the release of spermatids into the lumen is the 
breakdown of the junctions between the sertoli cells and the spermatid heads 
(Russell, 1993). During spermatogenesis, extensive junction restructuring occurs at 
the interface between adjacent sertoli cells and at the sertoli-germ cell interface. This 
allows the transport of germ cells from the basal compartment to the luminal edge 
and their release at spermiation. Sertoli-germ cell junctions are also thought to be 
involved in the orientation of spermatid heads. Two main types of junction are 
known to be  present between the elongated spermatid head and the sertoli cell; the 
ectoplasmic specialisation  and the tubulobulbar complex (Figure 1-15) (reviewed in 
Cheng and Mruk, 2002, 2009; Mruk and Cheng, 2004a, b).  
 
 
 
 
Figure 1-15 Cell junctions between sertoli cells and spermatids 
(A) Diagram of a spermatid head showing the apical ectoplasmic specialisations and 
tubulobulbar complexes that link the spermatid head to the sertoli cell. In the apical 
ectoplasmic specialisation, bundles of actin filament are sandwiched between the 
plasma membrane and endoplasmic reticulum of the sertoli cell (from Mruk and 
Cheng, 2004a). (B) A TEM image showing a mouse spermatid head within the 
seminiferous epithelium. The ectoplasmic specialisations can be visualised by deeply 
staining actin bundles within the sertoli cell.  
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The specialised adherens junctions between the elongated spermatid heads and 
sertoli cells are called apical ectoplasmic specialisations. Ectoplasmic specialisations 
are also found at the BTB but these are thought to have a different structure and 
mechanism of regulation and are known as basal ectoplasmic specialisations. The 
general structure of the apical ectoplasmic specialisation comprises integral 
membrane proteins with adaptor proteins linking them to the actin cytoskeleton. The 
apical ectoplasmic specialisation is an atypical actin-based adherens junction and is 
thought to share components and properties of adherens junctions, focal contacts and 
tight junctions. It has therefore been described as a hybrid junction type (Wong et al., 
2008a; Yan et al., 2007). In addition to the typical adherens junction proteins 
cadherin/catenin and nectin/afadin, many proteins usually found at the focal contacts 
between cells and the extracellular matrix have also been found at the apical 
ectoplasmic specialisation, for example, integrins and focal adhesion kinase (FAK), 
(Mulholland et al., 2001). Tight junction-associated proteins are also present, for 
example, junctional adhesion molecule-C and zonula occludens-1 (Gliki et al., 2004). 
The most widely studied protein at the apical ectoplasmic specialisation is the α1β1-
integrin-laminin 333 complex (Yan and Cheng, 2006). Integrins in the sertoli cell 
plasma membrane attach to the sertoli cell actin cytoskeleton via proteins such as 
FAK and vinculin. The integrins attach to laminins on the surface of the spermatids. 
These laminins are thought to associate with signalling molecules within the 
spermatid, for example, c-src (Yan and Cheng, 2006), via an unknown 
transmembrane protein. The ectoplasmic specialisation is only visible by electron 
microscopy on the sertoli cell side of the junction. 
 
A number of factors have been implicated in the regulation of the ectoplasmic 
specialisation, for example, protein kinases, phosphatases, proteases, protease 
inhibitors, endocytosis and  polarity proteins (reviewed in Wong et al., 2008a; Yan et 
al., 2007). Knowledge regarding ectoplasmic specialisation regulation is increasing 
due to the use of various compounds that disrupt ectoplasmic specialisations in vivo, 
for example, hormone suppression, reproductive toxins, and synthetic compounds 
like adjudin (Beardsley and O'Donnell, 2003; Hew et al., 1993; Huang and Marshall, 
1983). The regulation of the cell junctions can also be studied in vitro using co-
cultures of sertoli cells and germ cells which spontaneously form cell junctions when 
cultured together (Mruk and Cheng, 2004a; Siu et al., 2005) . 
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Studies such as this have shown that a number of protein kinases associate with 
ectoplasmic specialisations and may be involved in their regulation. For example, 
protein levels of members of members of the PI3K/PKB/ERK signalling pathway are 
increased during ectoplasmic specialisation formation and co-localise with the apical 
ectoplasmic specialisation (Siu et al., 2005). In addition, following disruption of 
ectoplasmic specialisations with adjudin, protein levels of phosphorylated FAK, 
PI3K and the protein tyrosine kinase c-Src, increase at the apical ectoplasmic 
specialisation and there is an increase in the activity of ERK kinase (Siu et al., 2003; 
Wong et al., 2005).  Carboxyl-terminal src kinase and casein kinase 2 have been 
shown to localise to the apical ectoplasmic specialisation in rats (Lee and Cheng, 
2005). The lipid/protein phosphatase myotubularin related protein-2 has also been 
implicated in the regulation of sertoli-germ cell adhesion and forms a complex with 
c-src at the apical ectoplasmic specialisation (Zhang et al., 2005). 
 
Proteases and protease inhibitors, such as the matrix metalloprotease, MMP-2 and 
the tissue inhibitor of matrix metalloproteases 2 (TIMP-2), have also been found to 
be associated with the integrin-laminin complex. These are induced upon disruption 
of ectoplasmic specialisations by adjudin and may be involved in the cleavage of cell 
adhesion proteins at spermiation (Siu and Cheng, 2004). Furthermore, proteins 
previously implicated in cell polarity may play a role in ectoplasmic specialisation 
regulation. Some  polarity proteins, for example PAR6 and aPKC have been shown 
to be present at the surface of elongated spermatid heads at the apical ectoplasmic 
specialisation (Gliki et al., 2004). The PAR3/PAR6 polarity complex may also be 
involved in the regulation of spermiation as it is lost at the junction just prior to 
sperm release in rat testes (Wong et al., 2008b).  
 
In addition to ectoplasmic specialisations, tubulobulbar complexes link late 
spermatids to sertoli cells. The functions of these structures are not well understood, 
although they have been suggested to play a role in spermiation via the phagocytosis 
of excess cytoplasm to regulate spermatid volume (Russell, 1993). They have also 
been implicated in the endocytosis of apical ectoplasmic specialisation components 
before spermiation (Guttman et al., 2004). They are formed and disassembled shortly 
before spermiation and are composed of thin cytoplasmic extensions from the 
spermatid head, found at regions of apical ectoplasmic specialisations, that protrude 
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into invaginations in sertoli cells (Figure 1-15) (Russell and Clermont, 1976). 
Consistent with a role in the endocytosis of ectoplasmic specialisation components, it 
was shown that ectoplasmic specialisation markers such as espin and the integral 
membrane proteins nectin-2 and nectin-3 were present at the tubulobulbar complexes 
and within surrounding vesicles (Guttman et al., 2004).  
 
1.2.7  Metabolism and reproduction 
A link between metabolism and reproduction is becoming increasingly recognised. 
Many disorders associated with the metabolic syndrome, for example, obesity, 
diabetes and dyslipidemia, are often accompanied by reduced male and female 
fertility. In terms of male infertility, it has been suggested that these metabolic 
disorders lead to problems such as lowered gonadotropic hormone secretion and 
increased sperm DNA damage due to oxidative stress (Kasturi et al., 2008).  
 
Recently, a role for AMPK in reproduction has been proposed. AMPK has been 
implicated in granulosa cell steroidogenesis and oocyte maturation in female mice 
(Chen et al., 2006; Tosca et al., 2007). In addition, AMPK is involved in the action 
of the hormones leptin and ghrelin, which have been linked to male and female 
fertility. Male and female mice with mutations in the leptin receptor (Ob/ob) are 
obese and also sterile, and ghrelin has been implicated in leydig cell development 
and proliferation, and in germ cell survival (reviewed in Budak et al., 2006; Kahn et 
al., 2005). AMPK is involved in the production of lactate by sertoli cells, which is 
the main energy source for developing germ cells. AICAR treatment of sertoli cell 
cultures caused an increase in AMPK phospho-T172 levels and also an increase in 
lactate production (Galardo et al., 2007; Riera et al., 2009).  Moreover, a recent 
report has implicated AMPK in the inhibition of the H
+
-ATPase (V-ATPase). This 
ion channel is expressed on the surface of cells of the epididymal epithelium and is 
thought to be involved in maintaining an acidic pH in the epididymal lumen, 
important for maintaining spermatozoa in a quiescent state (Hallows et al., 2009). 
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AIMS AND OBJECTIVES 
In this thesis, the identification of a novel, C-terminal alternative splice variant of 
LKB1 is described.  
 
The aim of the project is to characterise this new form of LKB1 (LKB1S) and to 
compare its tissue distribution, activity and sub-cellular localisation to that of the 
original form of LKB1 (LKB1L). This may provide insights into the role of the very 
C-terminal region of LKB1 which, in LKB1L, contains a number of conserved 
regions. One such region comprises the S428/431 phosphorylation site, the function 
of which remains controversial. The role of phosphorylation at this site will be 
examined.  
 
Mice lacking expression of this new splice variant will be analysed in order to obtain 
data on its physiological function. These mice show male infertility. The causes of 
this will be investigated to determine what role LKB1 might play in the process of 
spermatogenesis. Mouse models provide a tool to allow research into the possible 
mechanisms behind human infertility so that treatments may eventually be found. It 
is possible that mutations in LKB1 or its downstream substrates are involved in some 
cases of human infertility.  
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2 Materials and Methods 
2.1 Materials 
2.1.1 General reagents 
AMP, ATP, ammonium persulphate, benzamidine, dithiothreitol, N,N, N’,N’-
tetramethylethylenedamine (TEMED), β-mercaptoethanol, protein A/G-Sepharose, 
and Taq DNA polymerase were obtained from Sigma (Poole, UK). Protogel 
bisacrylamide, 10x Tris/glycine/SDS buffer and EcoScint scintillation fluid were 
supplied by National Diagnostics (Atlanta, USA). Polyvinylidine difluoride 
membrane from Perkin Elmer (Beaconsfield, UK). Rainbow Markers from GE 
Healthcare (Amersham, UK). Restriction enzymes were from Promega 
(Southampton, UK) and New England Biolabs (Hitchin, UK). The Rapid DNA 
Ligation Kit was purchased from Roche (Burgess Hill, UK). Miniprep, maxiprep, 
PCR purification and gel purification kits from Qiagen (Crawley, UK). P81 
phosphocellulose paper was from Whatman (Maidstone, UK).   
 
2.1.2 Buffers 
All chemicals for buffers were obtained from commercial sources and were of at least 
reagent grade. 
SDS-PAGE Buffer – 50mM Tris-HCl, pH 8.4, 400mM glycine, 0.1% (w/v) SDS. 
Tris/Glycine Buffer – 25mM Tris, 192mM glycine, 20% methanol. 
HST – 20mM Tris, pH 7.4, 500mM NaCl, 0.5% (v/v) Tween 20 
Sample Buffer – 50mM Tris-HCl, pH 7.4, 2.5% (w/v) SDS, 1% (v/v) β-
mercaptoethanol, 10% glycerol, 0.05% (w/v) bromophenol blue. 
Buffer A (Homogenisation Buffer) - 50mM Tris, pH 7.4, 50mM sodium fluoride, 
5mM sodium pyrophosphate, 1 mM EDTA, 250mM sucrose, 1mM dithiothreitol, 
4µg/ml trypsin inhibitor,0.1mM phenylmethylsulfonyl fluoride, 1mM benzamidine. 
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Buffer B (Lysis Buffer) - 50mM Hepes pH7.4, 50mM sodium fluoride, 5mM 
sodium pyrophosphate, 1mM EDTA, 10% (v/v) glycerol, 1% Triton X-100 (v/v), 
1mM dithiothreitol, 4µg/ml trypsin inhibitor, 0.1mM phenylmethylsulfonyl fluoride, 
1mM benzamidine. 
Buffer C (HGE) - 50mM Hepes pH7.4, 1mM EDTA, 10% (v/v) glycerol and 1% 
Triton X-100, 1mM dithiothreitol, 4µg/ml trypsin inhibitor, 0.1mM 
phenylmethylsulfonyl fluoride, 1mM benzamidine. 
DNA-Loading Buffer – 0.1% (w/v) Orange G, 50% (v/v) glycerol. 
Phosphate-Buffered Saline (PBS) – 137mM NaCl, 2.7mM KCl, 4.3mM Na2HPO4, 
1.4mM KH2PO4, pH7.4. 
TAE – 40mM Tris, 20mM acetic acid, 1mM EDTA, pH 8.0. 
Luria Burtani (LB) Broth – 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 0.5% 
(w/v) NaCl. 
 
2.1.3 Bacterial cells 
JM109 competent cells (Promega) were used for the transformation and 
amplification of plasmids. Cells were grown up in LB broth. For LB agar plates 1.5% 
(w/v) agar was added to the broth.  Ampicillin (100µg/ml) or kanamycin (50µg/ml) 
were added for plasmid selection. 
 
2.1.4 Mammalian cells 
CCL13 cells (Human liver epithelial cells) and HEK293 cells (Human embryonic 
kidney cells) were obtained from American Cell Type Culture Collection 
(Middlesex, UK) and maintained at 37ºC, 5% CO2  in Dulbecco’s Modified Eagle’s 
Medium (DMEM with sodium pyruvate, 4500mg/L glucose and pyridoxine) 
(Invitrogen) supplemented with 10% (w/v) fetal calf serum, 2mM N-glutamine and 
0.5mg/ml penicillin-streptomycin. Cells were passaged twice weekly using trypsin-
EDTA.    
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2.1.5 Plasmids 
The pcDNA3 mammalian expression vector was obtained from Invitrogen (Paisley, 
UK). 
 
2.1.6 Antibodies 
LKB1 antibodies 
Mouse anti-LKB1 monoclonal antibody (Ley37D/G6), that recognizes both splice 
variants of LKB1, was from Insight Biotechnology (Middlesex, UK). A rabbit 
polyclonal antibody was raised against full-length mouse LKB1 (expressed as a His 
tagged-fusion protein in E. coli) by Dr. Angela Woods (in house). Affinity-purified 
sheep antibody raised against residues 24–39 of human LKB1 was a kind gift from 
Prof. Dario Alessi (Unversity of Dundee, UK). Anti- LKB1S antibody (termed anti-
sLKB1) was generated by GenScript Inc. (New Jersey, USA). In brief, a peptide 
(CMWKSQGAGLPGEE) corresponding to residues 390-403 of mouse LKB1S was 
used to raise anti-LKB1S antibodies in rabbit. Antibodies were affinity purified from 
the serum using the immunising-peptide coupled to thiol-activated Sepharose.  
 
Other antibodies 
Goat polyclonal anti-STRADα (STRAD N13) and goat polyclonal anti-STRADβ 
(ILPIP N12) were purchased from Insight Biotechnology. Mouse monoclonal 
antibody recognizing Ser(P)-428 in human LKB1L, monoclonal anti-MO25, 
phospho-CREB (Ser-133, 87G3) and anti-myc (9B11) were from New England 
Biolabs (Hitchin, UK). FLAG (M2) monoclonal antibody, anti-CREB and anti-actin 
were from Sigma (Poole, UK). Anti-glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), rabbit anti-MARK3, anti-tubulin (Yol1/34) and rabbit polyclonal anti-
STRADβ (ALS2CR2) were from AbCam (Cambridge, UK). Anti-NUAK2 raised 
against residues 653-673 of human NUAK2, anti-BRSK2 raised against a C-terminal 
peptide sequence of the human protein, and anti-SNRK antibody raised to residues 
737-753 of human SNRK were kind gifts from Prof. Dario Alessi (University of 
Dundee, UK). p-SIK1 antibody was  raised in rabbit against the peptide, 
CKSGEPLS(pT)WCGSPPY (Dr Fiona Lieper, in house). SIK2 antiserum was a kind 
gift from Prof. Hiroshi Takemori (Osaka, Japan). Antibodies recognizing AMPKα1 
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and AMPKα2 were a kind gift from Prof. Grahame Hardie (University of Dundee, 
UK). A pan-β specific AMPK antibody was raised against a glutathione S-transferase 
(GST) fusion protein containing the C-terminal 217 amino acids of the β1 subunit 
(Woods et al., 1996). Mouse monoclonal antibody recognising the sperm acrosome 
(Mab 18.6) was a kind gift from Prof. Harry Moore (University of Sheffield, UK). 
 
Secondary antibodies conjugated to Alexa-Fluor 488/568/680 or IRDye800 were 
purchased from Invitrogen and Li-COR respectively. 
 
2.1.7 Proteins 
The recombinant AMPK (α1β1γ1) complex for LKB1 assays was made by Dr. 
Amanda Heslegrave (in house) following the protocol of Neumann et al., (2003). A 
tricistronic plasmid containing all three rat AMPK subunits (N-terminal 
hexahistidine (His)-α, β and γ) was grown up in E.coli strain BL21-D3 codon plus 
(DE3)-RIL cells (Agilent Technologies, UK). Protein expression was induced for 5 
hours at room temperature with 1mM isopropyl b-D-thiogalactopyranoside (IPTG). 
Cells were centrifuged, resuspended in binding buffer (50mM Hepes, pH7.4, 300mM 
NaCl, 25mM Imidazole) and sonicated.  The extract was centrifuged and the 
supernatant applied to a Nickel Sepharose Column and eluted in 50mM Hepes, pH 
7.4, 300mM NaCl, 300mM Imadazole, 0.5M sucrose and 5mM spermidine. The 
protein was concentrated and dialysed against storage buffer (0.5M sucrose, 50mM 
Hepes, 5mM spermidine). 
 
The recombinant LKB1:STRADα:MO25α complex was kindly provided by Dr 
Bronwyn Hegarty (in house). Briefly, human His-LKB1, STRADα and GST 
(glutathione S-transferase)-MO25α were co-expressed using a baculovirus-insect cell 
expression system (Bac-to-Bac® Baculovirus Expression system, Invitrogen) and the 
virus used to infect SF9 cells for protein expression. The complex was purified by 
affinity chromatography on glutathione-sepharose. 
 
2.1.8 Radioactive compounds 
[γ-32P]ATP (specific radioactivity approximately 2mCi/ml) was obtained from 
Perkin Elmer. 
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2.1.9 Other reagents and compounds 
Mouse and human testis total cDNA were obtained from Applied 
Biosystems/Ambion (Warrington, UK). Forskolin, hydrogen peroxide and 
oligonucleotide primers were from Sigma. The sequence of all primers can be found 
in appendix A. 
 
2.2 General Methods 
2.2.1 Animals 
Mice were obtained from Prof. Alan Ashworth (Institute of Cancer Research, 
London, UK). The mice were re-derived on a Black 6 background at the MRC 
Clinical Sciences Centre and were bred and housed according to Home Office 
regulations (Angela Woods, Phillip Muckett).  
 
2.2.2 Tissue harvesting  
Male mice (C57/Bl6) at approximately 12 weeks were culled by cervical dislocation. 
Tissues were harvested and immediately frozen in liquid nitrogen. Prior to analysis, 
tissues were roughly chopped in two volumes of ice-cold buffer A and then briefly 
homogenized with a rotor-stator homogenizer. 1% (v/v) Triton X-100 was added and 
the homogenates were incubated on ice for 10 min, sonicated in a 4°C water bath for 
3 cycles of 20 sec, and then centrifuged at 16,000 x g for 15 min to remove insoluble 
material.  
 
2.2.3 Protein determination 
Protein concentration in cell and tissue lysates was determined using the Bradford 
assay (Bradford, 1976) with Bio-Rad reagent and bovine serum albumin (BSA) 
standards. A microplate reader was used to measure absorbance at 595nm (Bio-Rad, 
model 680). 
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2.2.4 Immunoprecipitation  
From cell lysates 
Protein samples were incubated with the appropriate antibody, 10μl of a 50% (v/v) 
slurry of protein A- or G- sepharose and lysis buffer for two hours, with agitation, at 
4°C. The resin was pelleted and washed twice with Buffer B and once with Buffer C. 
 
LKB1 from transfected cell lysates (50μg of total protein) was immunoprecipitated 
using Flag M2 Agarose (Sigma) or affinity purified anti-LKB1 sheep serum (gift 
from Dario Alessi). AMPK was immunoprecipitated with a pan-β specific antibody 
raised in rabbit (Woods et al., 1996). 
 
From tissue lysates 
All tissue homogenates were first pre-cleared of non-specific proteins by incubating 
with 10μl protein A or G sepharose resin for 60 minutes. For the 
immunoprecipitation, samples were incubated with the appropriate antibody as for 
the cell lysates (above). The resin was pelleted and washed once for 15 minutes with 
0.25M NaCl in buffer B, once with buffer B alone and once with buffer C. 
 
Total LKB1 from tissues was immunoprecipitated using rabbit anti-LKB1 serum or 
affinity purified anti-LKB1 sheep serum. LKB1S was immunoprecipitated using anti- 
sLKB1 antibody. AMPKα1 and AMPKα2 and ARKs were immunoprecipitated 
using the appropriate antibodies. 
 
2.2.5 Western blotting 
Samples were resolved on 10-12% polyacrylamide gels by SDS-PAGE (200V, 1h). 
The proteins were transferred to polyvinlidene difluoride (PVDF) membranes 
(Immobilon-FL, Millipore) (100V, 2h), which were then blocked with PBS 
containing 5% (w/v) skimmed milk powder or 5% (w/v) BSA for 30 minutes. 
Antibodies were diluted in 5ml High Salt Tween (HST) buffer (20 mM Tris, pH 7.4, 
500 mM NaCl, 0.5 % Tween (v/v)) containing 5% milk powder, and incubated with 
the membrane for two hours at room temperature or overnight at 4ºC. Primary 
antibodies were detected with the appropriate secondary antibody conjugated to either 
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Alexa-Fluor 680 or IRDye800 (1:10,000) and scanned on the Li-COR Odyssey 
Infrared Imaging System. Quantification of results was performed using Odyssey 
software 2.0 (LI-COR Biotechnology).   
 
All tissue homogenates for blotting LKB1 were first pre-cleared by incubating with 
10μl protein A or G sepharose resin for 60 minutes. 
 
2.2.6 AMPK assays 
AMPK activity was determined using the SAMS peptide assay (Davies et al., 1989). 
This assay measures the phosphorylation of a synthetic peptide substrate of AMPK 
called the SAMS peptide (HMRSAMSGLHLVKRR), corresponding to the sequence 
surrounding Ser79 of rat ACC1, by the incorporation of radiolabelled [γ-32P]ATP.  
 
Following immunoprecipitation, washed immune complexes were incubated with 
200μM SAMS peptide, in a volume of 25µl, in the presence of 50mM Hepes, pH 7.5, 
5mM MgCl2, 200μM ATP and [γ-
32
P]ATP (specific radioactivity approximately 200 
cpm/pmol), for 20-30 minutes at 37
o
C. 20µl of the reaction mixture was spotted onto 
P81 phosphocellulose paper, unincorporated radiolabelled ATP removed by washing 
in 1% (v/v) phosphoric acid, and the paper placed in scintillation vials with Ecoscint 
scintillation fluid. The number of counts per minute (c.p.m.) were determined by 
liquid scintillation counting (PerkinElmer Tri-Carb 2800 TR).  
 
2.2.7 LKB1 assays 
LKB1 activity was determined by a two-step assay that measures the in vitro 
activation of recombinant AMPK by immunoprecipitated LKB1 (Woods et al., 2003).  
 
Washed immune complexes were incubated with 0.2 - 1µg recombinant AMPK 
(α1β1γ1) in the presence of 0.2mM ATP and 5mM MgCl2 in buffer C (20 µl total 
volume) for 15 min at 37C. AMPK activation was quantified by removing an 
aliquot (5 µl) of the reaction mixture and measuring AMPK activity using the SAMS 
peptide assay (Davies et al., 1989) as described above. The number of counts per 
minute (c.p.m.) were determined by liquid scintillation counting (PerkinElmer Tri-
Carb 2800 TR).  
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2.2.8 ARK assays 
Following immunoprecipitation, activity was determined using the AMARA peptide 
assay (Dale et al., 1995) by 
32
P incorporation from [γ-32P]ATP. The sequence of the 
AMARA peptide is AMARAASAAALARRR.   
 
2.2.9 cDNA expression constructs 
FLAG tagged LKB1 constructs 
cDNA encoding LKB1S was amplified from human or mouse testis cDNA with 
LKB1S specific oligonucleotide primers (including a FLAG tag sequence in the 
forward primer) (appendix A) using Phusion High-Fidelity DNA Polymerase 
(Labtech International Ltd, Sussex, UK). The PCR conditions were as follows; initial 
denaturing step of 98ºC for 30 seconds, 35 cycles of 98ºC for 10 seconds, 55ºC for 
30 seconds and 72ºC for 1 minute, and a final extension step of 72ºC for 5 minutes. 
The PCR product was purified by agarose gel electrophoresis, digested with EcoRI 
and XhoI and cloned into the pcDNA3 mammalian expression vector. Authenticity 
of the inserts (and all others described below) was confirmed by DNA sequencing 
using the sequencing service at the MRC Clinical Sciences Centre. 
  
cDNA encoding human LKB1L was amplified from an IMAGE clone with a FLAG 
tag sequence engineered at the 5’ end, and cloned into pcDNA3 (kind gift from Dr. 
Naveenan Navaratnam, MRC Clinical Sciences Centre). cDNAs encoding wild-type 
mouse LKB1L and mouse LKB1L harbouring a mutation of aspartic acid 194 to 
alanine (LKB1D194A) were a kind gift from Prof. Alan Ashworth. The cDNAs were 
amplified by PCR to include a 5’ FLAG tag and then cloned into pcDNA3 
(performed by Dr. Angela Woods). The point mutations (S431A and S431E) were 
introduced into mouse LKB1L using the QuikChange® site-directed mutagenesis kit 
(Stratagene) according to the manufacturer’s protocol by Dr. Angela Woods. 
Mutations were verified by DNA sequencing. 
 
mCherry tagged LKB1 constructs 
Human LKB1S and LKB1L were amplified by PCR from the FLAG tagged cDNA 
constructs described above. Primers were designed so that the LKB1 would be in-
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frame with the 5’ mCherry tag (appendix A). The PCR conditions were as follows; 
initial denaturing step of 98ºC for 30 seconds, 20 cycles of 98ºC for 10 seconds, 58ºC 
for 30 seconds and 72ºC for 1 minute, and a final extension step of 72ºC for 5 
minutes. Products were purified using a QiaQuick PCR Purification kit (QIAGEN). 
PCR products were cloned into the pmCherry-C1 mammalian expression vector 
(Clontech, California, USA) using HindIII and KpnI restriction sites. 
 
STRAD and MO25 constructs 
cDNAs encoding human STRADα (5’ FLAG tagged) and MO25α (5’ Myc tagged) in 
the pCMV5 expression vector were a kind gift from Prof. Dario Alessi (University of 
Dundee). STRADβ cDNA was kindly provided by Prof. Ian Macara (University of 
Virginia, USA). It was amplified by PCR so that a 5’ FLAG tag was introduced (see 
appendix A for primer sequences) and cloned into pcDNA3 using KpnI/XhoI 
restriction sites. 
 
2.2.10  Mammalian cell transfection 
Plasmid DNA was prepared using a QIAGEN maxiprep kit according to the 
manufacturer’s instructions. Cells were seeded in 10cm dishes at a density of 1x106 
cells per plate or on glass cover slips (24-well plate) at a density of 1x10
5
 cells per 
well and transfected using the calcium phosphate precipitation method (CalPhos
TM 
Mammalian Transfection kit, Clontech), using 30µg DNA per 10cm plate (or 3µg  
per well on coverslips) and following the manufacturers standard protocol. After 
approximately 18 hours, the cells were washed in PBS and shocked with 10% (v/v) 
DMSO for two minutes. Cells were harvested or fixed 48h post-transfection. 
 
2.2.11  Mammalian cell treatments 
Cells were transferred to serum free medium two hours prior to treatment with either 
20 μM forskolin for 30 min or 0.5 mM H2O2 for 5 min.  
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2.2.12  Mammalian cell lysis 
Cells were washed briefly with ice-cold PBS and rapidly lysed in 500 µl ice-cold 
Buffer B. Lysates were centrifuged at 16,000 x g for 15 min at 4ºC to remove 
insoluble material.  
 
2.2.13  Subcellular fractionation  
HEK293 cell lysates were subjected to cell fractionation using a Qproteome Cell-
Compartment kit (Qiagen) following the manufacturer’s protocol. 
 
2.2.14  Immunofluorescence of transfected cells 
48h post transfection, cells were fixed in 4% (v/v) paraformaldehyde, permeablised 
with PBS containing 0.1% (v/v) Triton X-100, blocked with PBS containing 5% (v/v) 
donkey serum and 2% (w/v) bovine serum albumin (BSA) before incubation with 
primary antibody. After thorough washing with PBS, cells were incubated with the 
appropriate secondary antibody conjugated to a fluorophore. After further washing, 
cells were mounted on cover slips with Vectashield (Vector Laboratories Ltd., 
California, USA) and visualised on a Leica TCS SP1 confocal microscope. Image 
analysis was performed using Leica software. 
 
2.2.15  Mouse mating assays 
Wild-type and LKB1
fl/fl
 male mice (8-20 weeks old) were paired with two females 
each (various genotypes) for 14 days. Females were checked for vaginal mucus plugs 
after 2 days and pregnancies noted after the appropriate time. This work was carried 
out by Phil Muckett (MRC Clinical Sciences Centre, UK). 
 
2.2.16  Sperm counts 
Cauda epididymides were excised and placed in 1ml M2 medium (Sigma) (both 
epididymides per mouse). Several incisions were made and the sperm allowed to 
disperse into the medium for 15 minutes at room temperature. The remaining tissue 
fragments were pipetted up and down to remove as much sperm as possible. Sperm 
were stored on ice prior to counting. 50µl of the sperm solution was removed, 
avoiding the large tissue fragments. Sperm from wild-type and LKB1
fl/-
 mice were 
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diluted 1:20 in PBS. Sperm from LKB1
fl/fl
 mice were left undiluted. Sperm were 
counted on an improved Neubauer haemocytometer. Three squares were counted per 
sample and the average number of sperm collected per mouse calculated. 
 
Cells were only included in the counts if they could be recognised as a sperm at low 
magnification, i.e., a head with a flagellum attached, regardless of whether they 
looked morphologically abnormal.  Detached heads and tails, and round cells were 
not included. 
 
2.2.17  Sperm immunofluorescence 
Mouse cauda epididymides were excised and placed in 0.5ml M2 medium (Sigma) in 
a 3cm petri dish. Several incisions were made and the sperm allowed to disperse into 
the medium for 15 minutes at room temperature. 10µl aliquots of the suspension 
were pipetted onto polylysine coated glass slides, spread with a coverslip and 
allowed to air dry. Following fixation in 100% methanol for 2 minutes, the slides 
were stored at 4ºC until use. 
 
Slides were pre-wet in PBS containing 0.5M glycine and 0.5% (w/v) BSA (PBS-
GLY-BSA) prior to incubation with primary antibodies. Acrosomes were stained 
with Mab 18.6 monoclonal antibody which recognises a specific antigen on the 
acrosomal surface (Moore et al., 1987) (kind gift from Prof. Harry Moore, University 
of Sheffield, UK) diluted 1:2 in PBS-GLY-BSA, and tails stained with anti-tubulin 
Yol1/34 antibody (Abcam) diluted 1:120. After thorough washing in PBS-GLY-
BSA, primary antibodies were detected with Alexa fluor linked secondary antibodies 
diluted 1/200 (Invitrogen), followed by further washing. Nuclei were stained with 
DAPI (1.5mg/ml diluted 1/5000). Slides were viewed by sequential scanning of each 
wavelength on a Leica TCS SP1 confocal microscope and analysed with Leica 
software.  
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2.2.18  Fixation and resin embedding of testis and epididymis for    
  light microscopy (LM) and transmission electron microscopy   
  (TEM) 
Testes were harvested, cut in half with a sharp scalpel and fixed in 3% (v/v) 
glutaraldehyde in cacodylate buffer (0.1M sodium cacodylate in HCl, pH 7-7.2).  
After 30 minutes, the testes were cut into 1-2mm pieces in the fixative. Epididymides 
were dissected and fixed whole in 3% glutaraldehyde in cacodylate buffer. Tissues 
were stored in fixative for approximately 24 hours and then stored in cacodylate 
buffer until use. 
 
Tissues were resin-embedded by Mrs Margaret Mobberley (Imperial College, 
London). Briefly, tissues were post-fixed in osmium tetroxide, dehydrated through an 
ascending series of ethanol concentrations and transferred to propylene oxide. 
Tissues were embedded in araldite epoxy resin and the resin polymerised at 60ºC. 
 
2.2.19  Sectioning and staining of resin-embedded testis and   
  epididymis for LM and TEM 
Tissues were sectioned and stained by Margaret Mobberley (Imperial College, 
London). Semi-thin sections (0.5-1.0µm) for light microscopy (LM) were cut with a 
freshly broken glass knife on an ultramicrotome. Sections were transferred to a glass 
slide and a drop of toluidine blue stain added (Agar Scientific, Essex, UK). Slides 
were heated whilst staining on a hot plate at 100ºC to allow the stain to penetrate the 
resin. Excess stain was washed away with water. 
 
Ultrathin sections (60-80nm) for transmission electron microscopy (TEM) were cut 
on an ultramicrotome using a diamond knife and the sections transferred to a 
microscope grid. Sections were stained with saturated ethanolic uranyl acetate for 60 
minutes, rinsed in 50% (v/v) ethanol, and then stained with Reynold’s lead citrate 
(Reynolds, 1963) for 4 minutes and rinsed in distilled water. Sections were viewed 
on a Philips CM10 transmission electron microscope (FEI, UK, Ltd), operated at 
80kV. Images were taken with an AMT-XR40 2K side mount digital camera and 
viewed with the associated software (Deben, UK, Ltd). 
 
Chapter 2 – Materials and Methods 
 
66 
 
2.2.20  Preparation of frozen testis sections 
Testes were harvested, cut in half and then fixed in 4% (v/v) paraformaldehyde 
overnight. They were transferred into PBS containing 20% (w/v) sucrose, stored at 
4ºC until they sank and then rapidly frozen in crushed dry ice and stored at -80ºC. For 
the sectioning, tissues were immersed in Optimal Cutting Temperature (OCT) 
medium (BDH Laboratories, Leicestershire, UK), and cut at 5μM on a Leica cryostat 
at -20ºC. Sections were collected onto polylysine coated glass slides and air dried. 
 
2.2.21  Acrosomal staining of frozen testis sections 
Sections were blocked and permeabilised for 1 hour in 1% (v/v) Triton X-100 in PBS 
containing 3% (w/v) BSA and 2% (v/v) donkey serum (Sigma). Sections were 
incubated with 1.6 mg/ml peanut agglutinin (Alexa Fluor® 568 conjugate, 
Invitrogen) to stain the sperm acrosomes, and 0.17μM of the actin stain, phalloidin 
(Alexa Fluor® 488 conjugate, Invitrogen) which was used as a counter-stain. Both 
stains were diluted in PBS containing 3% (w/v) BSA and 2% (v/v) donkey serum and 
incubated with the slides for 1.5 hours at room temperature. Slides were then washed 
4x10 minutes in PBS and nuclei stained with 0.6μg/ml DAPI for 15 minutes. Slides 
were rinsed in dH2O, air dried, mounted in Vectashield and then visualised on a Leica 
TCS SP1 confocal microscope. Image analysis was performed using Leica software. 
 
2.2.22  Preparation of sperm lysates 
Cauda epididymides were placed in a 3cm petri dish containing 2ml ice-cold PBS 
and a number of incisions were made. The epididymis was gently pressed with 
forceps to remove as much sperm as possible and the sperm suspension passed 
through a 100μm nylon filter to remove any pieces of epididymis. Sperm were 
centrifuged at 16,000 x g for 15 minutes at 4°C and the resultant pellet resuspended 
in 200μl buffer A. The sperm suspension was sonicated in a water bath at 4°C for 4 x 
15 sec. 1% (v/v) Triton X-100 was added and the lysates stored at -80°C. 
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2.2.23  Statistical analysis 
Data are expressed as the mean ± standard error of the mean (S.E.M.). The Student’s 
t-test, or ANOVA followed by a Tukey posthoc test, were used to determine 
statistical significance. The means were considered to be significantly different if a 
value of p<0.05 was obtained. 
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3 Identification and Characterisation of a 
New Splice Variant of LKB1 
 
3.1 Introduction 
At the start of this project only one form of the LKB1 protein had been reported and 
characterised. This form of LKB1 has been implicated in a number of key cellular 
processes, for example, in the regulation of cell proliferation, polarity and energy 
status (reviewed in Alessi et al., 2006). The possibility that there are two forms of the 
LKB1 protein in mammals was first indicated by the data of Hawley et al., (2003) 
who purified two pools of LKB1 activity from rat liver. These were shown to contain 
different molecular mass forms of LKB1, as judged by western blotting (Hawley et 
al., 2003).  
 
In this chapter, the identification of an alternative splice variant of LKB1, which has 
a different C-terminal amino acid sequence from the previously studied form, is 
described. This new form of LKB1 has been termed LKB1S (for LKB1-short form) 
and the originally published form termed LKB1L (for LKB1-long form).  
 
cDNA constructs encoding LKB1L and LKB1S were generated and used to compare 
the activity of the two splice forms following overexpression in mammalian cells. In 
addition, the possibility that post-translational modification at the C-terminal end of 
LKB1L might lead to differences in the regulation of the two forms of LKB1 was 
investigated. Serine 431 in mouse LKB1L (equivalent to S428 in the human 
sequence) can be phosphorylated by a number of kinases, including PKA, RSK 
(Sapkota et al., 2001) and PKCδ (Xie et al., 2008). LKB1S lacks the equivalent 
residue. A number of studies have suggested that phosphorylation at this site affects 
LKB1 downstream functions, be it cell cycle regulation (Sapkota et al., 2001), axon 
specification (Barnes et al., 2007; Shelly et al., 2007) or apoptosis (Song et al., 
2008). However, at the time of writing this thesis, the role of phosphorylation at this 
site and its effects on LKB1 activity remains controversial. 
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LKB1L has previously been shown to form a complex with two other proteins, 
STE20-related adaptor (STRAD) (Baas et al., 2003) and mouse protein 25 (MO25) 
(Boudeau et al., 2003a). These enhance the catalytic activity of LKB1 and cause it to 
relocalise from the nucleus to the cytoplasm (Baas et al., 2003; Boudeau et al., 2004; 
Hawley et al., 2003). A recent report claimed that phosphorylation of LKB1 at S428 
is necessary for LKB1 export from the nucleus to the cytoplasm, and that this is 
required for LKB1-mediated phosphorylation of AMPK (Xie et al., 2008). However, 
another study reported that phosphorylation at this site does not result in 
relocalisation (Collins et al., 2000). 
 
In this chapter it is shown that LKB1S is highly expressed in testis and that this new 
form of LKB1 associates with STRAD and MO25, and can activate AMPK in cells. 
Furthermore, it is shown that phosphorylation of S428/431 has no direct effect on 
LKB1L activity. 
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3.2 Results 
 
3.2.1 LKB1 tissue distribution and activity 
LKB1 tissue distribution was investigated by western blotting of mouse tissue 
homogenates with an anti-LKB1 mouse monoclonal antibody raised to human LKB1 
recombinant protein. This revealed a band migrating with a molecular mass of 
approximately 50kDa in all tissues analysed. In addition, a second cross-reacting 
band, migrating with a molecular mass of approximately 48kDa, was strongly 
detected in testis (Figure 3-1A). A similar pattern, including the two bands in testis, 
was observed after immunoprecipitation with either an affinity purified sheep anti-
LKB1 antibody raised to full length LKB1 (Figure 3-1B) or a rabbit polyclonal anti-
full-length LKB1 antibody (data not shown) and then blotting the immune complexes 
for LKB1, thus supporting the fact that both molecular weight bands are related to 
LKB1. Protein degradation was ruled out as a likely explanation for the appearance 
of the 48kDa band, since it was only detected significantly in testis, and was 
observed in the presence or absence of protease inhibitors in the buffers used for 
immunoprecipitation (data not shown). Ovary lysates were also blotted to determine 
whether LKB1S is expressed in the equivalent female reproductive tissue to testis. 
Although LKB1L was shown to be expressed in ovary, no LKB1S was detected.   
 
Quantification of the blots shows that the 50kDa protein is most highly expressed in 
brain, testis and lung (Figure 3-1B). Intermediate sized bands, migrating just above 
the 48kDa band, were observed in spleen and lung. These may not be LKB1-related, 
as will be discussed in Section 3.2.4. The identity of a band at approximately 46kDa 
in liver crude lysates is unknown. The presence and intensity of this band appears to 
vary between different mice in western blots of both crude tissue lysates and LKB1 
immunoprecipitates.  
 
Previous studies have shown that LKB1 requires the binding of two other proteins, 
STRAD (Baas et al., 2003) and MO25 (Boudeau et al., 2003a) for activity. 
Therefore, the immune complexes were blotted with antibodies specific for the α 
isoforms of these two proteins. As can be seen from Figure 3-1C, both MO25 and
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Figure 3-1 Tissue distribution of LKB1 
(A) Mouse tissue homogenates (50µg) were analysed by western blotting with a 
monoclonal antibody raised against total LKB1. In (B-C) LKB1 was 
immunoprecipitated from the tissue homogenates (200μg total protein) by 
incubation with sheep anti-LKB1 antibody bound to protein G-Sepharose. Proteins 
in the immune complex were detected by blotting with either mouse monoclonal 
anti-LKB1 antibody (B) or with anti-STRADα and anti-MO25α antibodies (C). A 
bar chart showing quantification of LKB1 expression is shown in (B). The results 
are plotted relative to the expression of LKB1L in testis and are the mean ± S.E.M. of 
three separate blots from three individual mice. In each case a representative blot is 
shown and the molecular mass, estimated from the migration of molecular mass 
standards, is indicated. 
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STRAD co-immunoprecipitate with LKB1 in all of the tissues examined.  The 
amount of protein detected roughly correlates with the level of LKB1 expression in 
support of previous reports that the three proteins are present in a 1:1:1 complex 
(Hawley et al., 2003). In brain, a second slower migrating band was detected strongly 
by the STRAD antibody. However, this band was not detected when a different 
LKB1 antibody was used for immunoprecipitation (data not shown) and so the nature 
of this cross-reacting protein remains uncertain. 
 
Total LKB1 activity in mouse tissues, as determined by the activation of recombinant 
AMPK, was measured following immunoprecipitation of LKB1 (Figure 3-2). The 
activity detected in immune complexes from different tissues correlates with the 
expression level of LKB1 indicated by western blotting, thus supporting the 
generally accepted theory that the LKB1 heterotrimeric complex is constitutively 
active (Lizcano et al., 2004; Woods et al., 2003). The highest activity levels were 
detected in testis, brain, liver and lung. 
 
 
Figure 3-2 Activity of LKB1 in mouse tissues 
LKB1 was immunoprecipitated from mouse tissue homogenates (10μg total protein) 
by incubation with sheep anti-LKB1 antibody bound to protein G-Sepharose. LKB1 
activity in the immune complexes was determined by the activation of recombinant 
AMPK. Activities are plotted as U/mg of lysate protein, where 1 unit is the activity 
of LKB1 required to activate recombinant AMPK by 1 nmol/min/mg of protein. 
Results are mean ± S.E.M. of three independent experiments.  
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3.2.2 Identification of an alternative splice variant  
The possibility that the 48kDa protein may be a splice variant of LKB1 was 
investigated. The gene structure of LKB1 has previously been determined (Smith et 
al., 1999), and upon re-examination of the mouse gene, a potential exon was 
identified near the 3’ end, between exons VIII and IX (Figure 3-3A). This additional 
exon, which we termed IXa (exon IX becoming IXb), is conserved within the human 
and mouse LKB1 genes and contains a termination codon. Alternative splicing of the 
LKB1 gene after exon VIII would lead to the formation of two proteins (LKB1L and 
LKB1S) that are identical in sequence apart from the C-terminal extremity. This is 
encoded by exon IXb in LKB1L (68 amino acids in mouse) resulting in a protein with 
a predicted molecular mass of 49.3 kDa, and exon IXa in LKB1S (39 amino acids in 
mouse) resulting in a protein with a predicted molecular mass of 46.5 kDa, (Figure 
3-3B). The different C-terminal amino acid sequences are shown in Figure 3-3C. 
From this point onwards I will refer to the 50 kDa protein as LKB1L (for long form) 
and to the 48 kDa protein as LKB1S (for short form). 
 
3.2.3 Generation and characterisation of an LKB1S antibody 
An antibody (termed anti-sLKB1) was raised against a predicted C-terminal peptide 
sequence of mouse LKB1S. The ability of the antibody to immunoprecipitate and blot 
LKB1S from mouse tissues was investigated. Using this antibody for 
immunoprecipitation, LKB1 activity, as determined by activation of recombinant 
AMPK, was readily detectable in immune complexes isolated from testis. Low, but 
detectable, activity was also observed in lung, heart, liver, kidney and spleen, 
whereas no detectable activity was present in brain or muscle (Figure 3-4A). Figure 
3-4B shows that the 48 kDa band was depleted by 85% from testis homogenates 
immunoprecipitated using the LKB1S antibody. This confirms that the 48 kDa band 
seen in western blots corresponds to LKB1S. Immunoprecipitates of LKB1 isolated 
using an antibody raised against an N-terminal peptide sequence (which is present in 
both LKB1L and LKB1S) were analysed by western blotting using the antibodies to 
total LKB1 or LKB1S (Figure 3-4C). A doublet migrating at approximately 48 kDa, 
corresponding to the predicted molecular mass of the novel LKB1 protein, was 
recognised by both antibodies in testis but not in any other tissue tested. These results 
provide good evidence that the 48 kDa protein highly expressed in testis is an 
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alternative LKB1 splice variant, and that this form of LKB1 is capable of 
phosphorylating and activating AMPK in vitro.  
 
LKB1S is recognised as a clear doublet in western blots. The LKB1 protein has 
previously been shown to be phosphorylated at several sites (reviewed in Alessi et 
al., 2006) which may affect its migration on a polyacrylamide gel. In order to 
determine if the doublet is caused by phosphorylation of the LKB1S protein, mouse 
testes were homogenised in the presence or absence of phosphatase inhibitors 
(sodium fluoride and sodium pyrophosphate). The lysates were blotted with an 
LKB1 mouse monoclonal antibody. In the presence of phosphatase inhibitors the 
upper band in the doublet was most intense whereas in the absence of inhibitors, the 
lower band was more intense (Figure 3-4D). This suggests that the doublet is caused 
by protein phosphorylation, the upper band being the phosphorylated form and the 
lower band being the dephosphorylated form. This was also the case for LKB1L in 
testis; although the 50 kDa protein usually appears as a single band, the presence of a 
lower band became apparent in the absence of phosphatase inhibitors. In addition, 
total LKB1 protein also appeared to be reduced in the absence of phosphatase 
inhibitors, while the amount of actin in the two samples is very similar. One possible 
explanation could be that LKB1 is less stable when dephosphorylated. 
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IXa
I II III IV V VI VII VIII IXa IXb X
Ter Ter
Human
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I II III IV V VI VII VIII IXa IXb X
Ter Ter
A
1 kb
B
LKB1S Protein  (47kDa)
LKB1L Protein (49kDa) 
LKB1 Gene
III VIIII II IXaIV VIIVIV
III VIIII II IXbIV VIIVIV
III VIIII II IV VIIVIV IXb X
Ter Ter
 
 
HumanL: IIYTQDFTVPG QVPEEEASHNGQRRGLPKAVCMNGTEAAQLSTKSRAEGR--APNPARKACSASSKIRRLSACKQQ (433)
MouseL: IIYTQDFTVPG QVLEEEVGQNGQSHSLPKAVCVNGTE-PQLSSKVKPEGRPGTANPARKVCS-SNKIRRLSACKQQ (436)
HumanS: IIYTQDFTVPG G---EEASEAGLRAE----RGLQKSEGSDLSGEEASRPAPQ (404)
MouseS: IIYTQDFTVPG V---EEAAEAGLSEDACD-TCMWKSQGAGLPGEEPEEGFGALV (412)
C
 
 
 
 
Figure 3-3 Alternative splice variants of LKB1 
(A) Graphic representation of the structure of the LKB1 gene from human and 
mouse. Exons are represented by black boxes, apart from exon IXa, which is shown 
in hatched shading since the end of this exon has not been determined. The intron 
between exon IXa and IXb is shown as a dashed line to indicate that the size of this 
intron has not been determined. Exons IXa and IXb contain termination codons 
(Ter). A scale bar is indicated on the figure. The intron between exon I and exon II 
in both the human and mouse genes is not shown to scale. (B) Diagram of the 
formation of the two splice variants by alternative splicing. The calculated molecular 
masses are shown. (C) The deduced amino acid sequences of the C-terminal regions 
of human and mouse LKB1L and LKB1S are shown. A portion of the sequence 
encoded by exon VIII, common to both forms, is represented in italics. Serine 
428/431 (human/mouse) and cysteine 430/433 in LKB1L that have been shown to 
undergo post-translational modification are indicated with arrows. The number of 
amino acids in each of the full-length proteins is shown in brackets.  
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Figure 3-4 Tissue distribution of LKB1S 
(A) Mouse tissue homogenates (200μg total protein) were immunoprecipitated using anti-
LKB1S antibody coupled to protein A-Sepharose. LKB1 activity in the immune complexes 
was measured by activation of recombinant AMPK. Activities are plotted as U/mg of lysate 
protein, where 1U is the activity of LKB1 required to activate recombinant AMPK by 
1nmole/min/mg. (B) LKB1 was immunoprecipitated from mouse testis homogenate (50μg 
total protein) using anti-LKB1S antibody, and the resulting immunoprecipitate (IP) and 
depleted supernatant (LKB1S SN) was blotted with anti-LKB1 mouse monoclonal antibody. 
The supernatant from a control immunoprecipitate using protein A-Sepharose in the absence 
of antibody is also shown (Control SN). (C) Immune complexes isolated by 
immunoprecipitation of mouse lysates (200μg total protein) using sheep anti-LKB1 antibody 
were probed with anti-total LKB1 mouse monoclonal antibody and secondary antibody 
conjugated to Alexa-Fluor 680 and visualised in the red channel (above). This blot was re-
probed with anti-LKB1S antibody and secondary antibody conjugated to IRDye800 and 
visualised on the Li-COR system in the green channel (below). The bands which were 
detected at both wavelengths (indicating recognition by both antibodies) are indicated by a 
*. The migration of the 50 kDa molecular mass standard is indicated. (D) Testes were 
homogenised in the presence (+PI) or absence (-PI) of phosphatase inhibitors and the lysates 
(25µg) blotted with anti-LKB1 mouse monoclonal antibody. Actin was used as a loading 
control. 
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3.2.4 LKB1S expression in lung and spleen 
As  Figure 3-4C shows, two bands are detected in western blots of lung and spleen 
using an antibody that recognises both forms of LKB1. The lower bands migrate 
with a similar molecular weight to LKB1S in testis, and so may also correspond to 
LKB1S. They were not detected with the sLKB1 antibody, probably due to the lower 
sensitivity of this antibody compared to the total-LKB1 antibody. Tissue 
homogenates from wild-type mice were run alongside homogenates from mice that 
lack expression of LKB1S. These are known as LKB1 floxed mice (LKB1
fl/fl
) 
(Sakamoto et al., 2005). Details regarding the generation and phenotype of these 
mice will be covered in chapter 4. Although the lower band in testis was absent in the 
LKB1
fl/fl
 mice, the lower bands were still present in the spleen and lung from 
LKB1
fl/fl
 mice. It is likely that these bands are due to recognition of the endogenous 
immunoglobulin-G (IgG) heavy chain from the mouse tissues by the anti-mouse 
secondary antibodies as will be discussed in section 1.3. However, the lower band 
was less intense in spleen from LKB1
fl/fl
 mice suggesting that some LKB1S may be 
detected in this tissue. The reasons for the reduction in intensity of the band 
corresponding to LKB1L in LKB1
fl/fl
 mice will be covered in chapter 4.  
 
 
 
 
Figure 3-5 LKB1 expression in lung and spleen 
Tissue homogenates from wild-type (WT) and LKB1
fl/fl
 (fl/fl) mice which lack 
LKB1S expression, were analysed with an antibody raised to total LKB1. An anti-
actin antibody was used to show equal loading. Representative blots are shown and 
the migration of molecular mass standards are indicated. 
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3.2.5  Synthesis and expression of LKB1S and LKB1L cDNA  
constructs 
Based on the sequence of mouse and human LKB1S, specific oligonucleotide primers 
were used to amplify cDNA from mouse or human testis. The forward primers 
included a FLAG sequence so that the resulting LKB1 was FLAG tagged at the 
amino terminus. In both cases, a single product of approximately 1.3 kb was obtained 
and sequence analysis confirmed that they encoded the expected amino acid 
sequences of mouse or human LKB1S, therefore showing that LKB1S is transcribed 
in both human and mouse testis (Figure 3-6A). The cDNA products were cloned into 
a mammalian expression vector and the constructs overexpressed in CCL13 cells. 
These mammalian cells were chosen as they do not express endogenous LKB1, but 
still express endogenous STRADα and MO25α. Figure 3-6B shows that both LKB1S 
and LKB1L were well expressed in these cells. Transfection efficiency was 
approximately 80%. A catalytically inactive mutant of LKB1 which has an aspartic 
acid to alanine point mutation in the active site (LKB1D194A) was expressed as a 
negative control for LKB1 activity. 
 
3.2.6 Co-immunoprecipitation of both splice variants with STRADα 
and MO25α 
The binding of LKB1L to STRAD and MO25 has been shown to be vital for its 
activity (Boudeau et al., 2003a). Therefore, the ability of the expressed LKB1S to 
associate with MO25α and STRADα was investigated. Cell lysates were 
immunoprecipitated using an anti-FLAG antibody to isolate the expressed LKB1 and 
the resulting immune-complexes were probed with antibodies specific for MO25α 
and STRADα. LKB1S, LKB1L and LKB1D194A all co-immunoprecipitated with 
endogenously expressed MO25α and STRADα (Figure 3-6C). 
 
3.2.7 Both splice forms can activate AMPK in mammalian cells 
The activity of endogenous AMPK, immunoprecipitated from cells over-expressing 
LKB1, was measured using the SAMS peptide assay. Expression of either LKB1L or 
LKB1S resulted in activation of AMPK under basal conditions by around 8-fold, 
compared to cells over-expressing LKB1D194A. This demonstrates that both LKB1L 
and LKB1S are active under basal conditions and that activity is required for the 
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activation of AMPK (Figure 3-6D). Overexpression of LKB1D194A did not result in 
an alteration of endogenous AMPK activity as compared to untransfected controls. 
 
 
Figure 3-6 Over-expression of LKB1S and LKB1L in CCL13 cells  
(A) Specific primers were used to amplify LKB1S from human and mouse testis cDNA by 
PCR. Products of the expected size were detected on agarose gels as shown. (B-D) CCL13 
cells were transiently transfected with FLAG tagged human LKB1L, LKB1S, or catalytically 
inactive LKB1 harbouring a D194A mutation (LKB1D194A) or left untransfected (UT). (B) 
50µg total protein was blotted with anti-FLAG antibody. (C) Lysates (250µg) were 
immunoprecipitated with anti-FLAG antibody coupled to sepharose resin and proteins in the 
immune complex blotted with either anti-STRADα or anti-MO25α antibodies. The 
migration of molecular mass standards are as indicated. In each case a representative blot of 
3 similar blots from independent experiments is shown. (D) Endogenous AMPK was 
immunoprecipitated from 50µg total protein using an anti-panβ antibody bound to protein 
A-Sepharose. AMPK activity in the immune complexes was determined using the SAMS 
peptide assay. AMPK activities are expressed as pmol/min/mg of protein and are the mean ± 
S.E.M. of three independent experiments. * indicates a statistically significant increase of 
AMPK activity in LKB1S and LKB1L transfected cells compared to control cells 
(LKB1D194A and NT), (p<0.05 with one-way ANOVA and a Tukey posthoc test). 
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3.2.8 Forskolin treatment activates PKA and causes LKB1L 
phosphorylation at S428 
Previous reports have suggested that phosphorylation of S428/431 may be 
responsible for regulation of LKB1 activity (Barnes et al., 2007; Sapkota et al., 2001; 
Shelly et al., 2007). Since the S428/431 phosphorylation site is not present in either 
human or mouse LKB1S, it was hypothesised that this site could be involved in 
differential regulation of the two splice forms. In order to investigate this possibility, 
the adenylate cyclase activator forskolin was used to activate the PKA pathway and 
increase phosphorylation of S428/431 in LKB1L. Forskolin treatment of CCL13 cells 
over-expressing human LKB1L resulted in increased phosphorylation of S428 (by 
approximately 2-fold), as well as cAMP-response element binding protein (CREB) at 
S133, a known downstream target of PKA activation (Gonzalez and Montminy, 
1989) (Figure 3-7A).  
 
3.2.9 Forskolin treatment does not alter the activity of 
overexpressed LKB1 or endogenous AMPK 
LKB1 activity from cells overexpressing either LKB1L, LKB1S or LKB1D194A was 
determined. There was no change in the activity of either LKB1L or LKB1S 
following forskolin treatment, demonstrating that phosphorylation of S428 in LKB1L 
does not have a direct effect on its activity (Figure 3-7B). Since it has been reported 
previously that phosphorylation of S428 increases the association of LKB1 with 
AMPK (Xie et al., 2008), the effect of forskolin treatment on endogenous AMPK 
activity was examined. Forskolin treatment led to a slight increase in AMPK activity, 
and this was detected in cells expressing LKB1L, LKB1S or LKB1D194A (Figure 
3-7C). The finding that AMPK activity is increased with forskolin, even in cells 
expressing LKB1S, shows that this effect is not due to S428 phosphorylation, and the 
fact that it is increased in cells expressing catalytically inactive LKB1 indicates that 
LKB1 itself is not affected. Treatment with H2O2 resulted in a marked increase in the 
activity of endogenous AMPK in cells over-expressing either LKB1L or LKB1S, 
demonstrating that AMPK is not fully activated by over-expression of LKB1.  
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Figure 3-7 The effect of forskolin treatment on LKB1 and AMPK activity 
CCL13 cells were transiently transfected with FLAG tagged human LKB1L, LKB1S or 
catalytically inactive LKB1 harbouring a D194A mutation (LKB1D194A). Prior to lysis, cells 
were treated in the presence or absence of 20 µM forskolin for 30 min, or 0.5mM H2O2 for 5 
min. (A) A nuclear enriched fraction (20-50µg), prepared by centrifugation, was blotted 
with anti-phospho-CREB (S133), and cell lysates (50-100µg) were blotted with anti-
phospho-LKB1 (S428) or anti-FLAG. The blots shown are representative of those obtained 
from three independent experiments. (B) LKB1 activity in anti-FLAG immune complexes 
isolated from cell lysates (50µg  protein) was determined by activation of recombinant 
AMPK. Results are the mean ± S.E.M. of three independent experiments and are expressed 
as U/mg total lysate protein where 1U is the activity of LKB1 required to activate 
recombinant AMPK by 1 nmol/min/mg of protein. Differences between control and 
forskolin treated cells are not significant (p>0.05 with Student’s unpaired t test). (C) 
Endogenous AMPK was immunoprecipitated from 50µg total protein using an anti-panβ 
antibody bound to protein A-Sepharose. AMPK activity in the immune complexes was 
determined using the SAMS peptide assay. Results are expressed as pmol/min/mg of protein 
and are the mean ± S.E.M. of three independent experiments. $ indicates a statistically 
significant increase of AMPK activity in hydrogen peroxide treated cells compared to 
control or forskolin treated cells, and * indicates a significant increase of AMPK activity in 
forskolin treated cells compared to control (p<0.05 with one-way ANOVA and a Tukey 
posthoc test). 
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3.2.10  Expression and activity of LKB1 serine 431 mutants 
It is possible that only a small proportion of the over-expressed LKB1 is 
phosphorylated by PKA in response to forskolin treatment, meaning that the effect 
on LKB1 activity may be underestimated. Therefore, the consequence of mutating 
S431 to either a negatively charged amino acid, glutamic acid (S431E) to mimic 
phosphorylation, or an alanine (S431A) to prevent phosphorylation, was 
investigated. Figure 3-8A shows the expression of wild-type and mutated LKB1L 
protein in CCL13 cells. Mutation of S431 to either alanine or glutamic acid had no 
significant effect on the activity of LKB1 as compared to wild-type. Wild-type, 
S431A and S431E mutations all gave activities of 1500-2000U/mg as compared to 
11.7U/mg in control cells (Figure 3-8B).  Similarly, treatment with H2O2 had no 
effect on LKB1 activity, as has previously been reported (Woods et al., 2003). This 
provides evidence that LKB1 is constitutively active (when in association with 
STRAD and MO25) and that activation of AMPK by increased AMP levels is not 
caused by activation of LKB1. Furthermore, mutation of S431 had no significant 
effect on activation of endogenous AMPK under basal or H2O2 treated conditions 
(Figure 3-8C).  
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Figure 3-8 The effect of S431 mutation on LKB1 activity 
CCL13 cells were transfected with FLAG tagged mouse wild-type LKB1L (WT), or LKB1L 
harbouring a mutation of serine 431 to either alanine (S431A) or glutamic acid (S431E), or 
left untransfected (UT). Prior to lysis, cells were treated with or without 0.5mM H2O2 for 5 
min. (A) Total cell lysates (50µg protein) were blotted with anti-FLAG antibody to detect 
LKB1 expression. (B) LKB1 activity in anti-FLAG immune complexes isolated from 100µg 
total lysate protein was determined by activation of recombinant AMPK. Results are the 
mean ± S.E.M. of three independent experiments and are plotted as U/mg total lysate protein 
where 1U is the activity of LKB1 required to activate recombinant AMPK by 1 
nmole/min/mg of protein. Differences in LKB1 activity between WT, S431A and S431E are 
not significant (p>0.05 with one-way ANOVA and a Tukey posthoc test). (C) Endogenous 
AMPK was immunoprecipitated from 100µg total protein using an anti-panβ antibody 
bound to protein A-Sepharose. AMPK activity in the immune complexes was determined 
using the SAMS peptide assay. Results are expressed as pmole/min/mg of protein and are 
the mean ± S.E.M. of three independent experiments Differences in AMPK activity between 
WT, S431A and S431E transfected cells are not significant (p>0.05 with one-way ANOVA 
and a Tukey posthoc test). 
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3.2.11  Sub-cellular localisation of LKB1L and LKB1S within cells  
The sub-cellular localisation of LKB1L and LKB1S, when over-expressed in CCL13 
cells, was investigated. It is possible that the splice form-specific C-terminal end of 
the proteins directs them to different parts of the cell, for example, LKB1L possesses 
a consensus farnesylation site at Cysteine 433 which may be involved in localisation 
to cell membranes (Collins et al., 2000; Sebbagh et al., 2009). When expressed alone, 
LKB1S and LKB1L were detected in both the nucleus and cytoplasm, as shown in 
Figure 3-9A (left-hand panels). However, when co-expressed with MO25α and 
STRADα, there was a striking re-localization of both LKB1S and LKB1L from the 
nucleus to the cytoplasm. As over-expression of proteins may cause them to locate to 
compartments of the cell that are not representative of the endogenous protein, the 
localization of endogenous LKB1 was investigated. Endogenous LKB1 was 
undetectable by immunofluorescence in all cell types studied presumably due to 
limited sensitivity of the available antibodies. Therefore, cell fractionation of 
HEK293 cells was used in order to determine its sub-cellular localisation. These cells 
express moderate amounts of endogenous LKB1L. Cells treated with and without 
forskolin were fractionated into membrane, cytosol and nuclear enriched fractions 
and blotted for LKB1. Using this approach, LKB1 was detected in the cytosolic and 
membrane fractions, but not the nuclear fraction (Figure 3-9B). In addition, a slight 
reduction of LKB1 in the membrane fraction was noted following forskolin 
treatment. Western blots were carried out on each cell fraction using antibodies to 
marker proteins known to be predominantly expressed in the cytosolic (GAPDH), 
membrane (Na
+
/K
+
 ATPase) or nuclear (CREB) fractions.  
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Figure 3-9 Sub-cellular localisation of LKB1L and LKB1S 
(A) CCL13 cells were transiently transfected with FLAG tagged human LKB1L or LKB1S 
alone (left panel), or co-transfected with STRADα and MO25α constructs (right panel). 
Cells were fixed in 4% (v/v) paraformaldehyde and stained with a mouse monoclonal anti-
LKB1 antibody (Ley37D/G6) that recognises both LKB1L and LKB1S. Primary antibodies 
were detected with fluorescently linked secondary antibodies and visualised using a Leica 
TCS SP1 confocal microscope, (scale bar = 20 µm). (B) HEK293 cells were treated with or 
without 20 µM forskolin for 30 min and fractionated into cytosolic (C), membrane (M) and 
nuclear (N) enriched fractions. An equal volume of each fraction was blotted with an anti-
LKB1 antibody (Ley37D/G6). The same fractions were used to determine the expression of 
marker proteins for each of the fractions (cytosolic: glyceraldehydes-3-phosphate 
dehydrogenase (GAPDH); membrane: Na+/K+ ATPase; nuclear: cAMP-response element 
binding protein (CREB). In each case, the blots shown are representative of blots obtained 
from three independent experiments. The migration of molecular mass markers is indicated. 
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3.2.12  Association of LKB1 with STRADβ in transfected cells 
It has been previously reported that there are two isoforms of STRAD known as 
STRADα and STRADβ, and studies using overexpression in HeLa cells have shown 
that LKB1L can form a complex with both (Boudeau et al., 2003a). These isoforms 
share 55% identity to each other in humans. This study aimed to determine whether 
LKB1S is also able to form an active complex with STRADβ in transfected cells. 
LKB1 splice variants were transfected into CCL13 cells together with MO25α and 
either STRADα or STRADβ. Figure 3-10A shows the expression of the cDNA 
constructs in CCL13 cells. Two bands were detected by the anti-LKB1 antibody, but 
the identity of the lower band is unclear. Blotting with an antibody against the N-
terminal mCherry tag also detected two bands, suggesting that the lower band may 
be a C-terminal truncated form of the LKB1 protein. LKB1 expression levels were 
highest when co-expressed with STRAD and MO25 supporting previous reports that 
these proteins stabilise LKB1 (Baas et al., 2003; Boudeau et al., 2003a). Due to 
lower expression levels of STRADβ compared to STRADα, the FLAG antibody was 
not sensitive enough to detect STRADβ by western blotting in cells transfected with 
all three proteins. Therefore the lysates were also blotted with an antibody, with 
greater sensitivity, raised to STRADβ which detected a clear band in the appropriate 
lanes. In order to determine if both LKB1S and LKB1L could bind to STRADβ, 
STRAD was immunoprecipitated from the lysates with anti-FLAG antibody and the 
immune complexes blotted for LKB1 (Figure 3-10B). Both splice forms of LKB1 
were shown to form a complex with STRADα and STRADβ. In addition, MO25α 
was also present in all complexes.  
 
A further aim was to determine if there are any differences in activity between the 
LKB1 splice forms when present in a complex with STRADα or STRADβ. Anti-
FLAG antibody was used to immunoprecipitate STRAD from cell lysates and the 
activity of LKB1 in the immune complexes determined. Although LKB1 activity was 
much lower in immunoprecipitates from cells transfected with STRADβ, there were 
no significant differences between the activity of LKB1S and LKB1L (Figure 3-10C).  
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Figure 3-10 Association of overexpressed LKB1S and LKB1L with STRADβ 
CCL13 cells were transfected with mCherry tagged LKB1L or LKB1S, together with myc 
tagged MO25α and either FLAG tagged STRADα or FLAG tagged STRADβ. (A) Lysates 
were blotted with the antibodies indicated on the right. The identities of the lower bands in 
the LKB1 blot (labelled ‘?’) are unknown. Due to lower expression of STRADβ, and limited 
sensitivity of the FLAG antibody, lysates were also blotted with an antibody raised 
specifically to STRADβ. (B) STRAD was immunoprecipitated from cell lysates (50µg 
protein) and the immune complex blotted with anti-LKB1 or anti-MO25 antibodies. (C) 
Lysates (0.25µg protein) were immunoprecipitated with anti-FLAG antibody and LKB1 
activity in the immune complexes was determined by activation of recombinant AMPK. 
Activities are plotted as U/μg of lysate protein, where 1U is the activity of LKB1 required to 
activate recombinant AMPK by 1 nmol/min/mg of protein. * indicates a statistically 
significant increase in LKB1 activity in LKB1S transfected cells compared to LKB1L 
transfected cells (p<0.05 with Student’s unpaired t-test). 
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3.2.13  Association of STRADβ with LKB1 in vivo 
Although it has previously been shown that LKB1L can form a complex with 
STRADβ in transfected cells (Boudeau et al., 2003a), it has never been determined 
whether LKB1 is present in a complex with STRADβ in vivo. This was therefore 
investigated. A rabbit polyclonal, anti-STRADβ antibody was shown to recognise 
STRADβ by blotting of recombinant protein (Figure 3-10A) and this antibody was 
used to probe a western blot of various mouse tissues. A band at 38 kDa was detected 
in most tissues, the band being most intense in testis and brain (Figure 3-11A). 
Figure 3-11B shows a western blot of testis homogenate probed with either a 
STRADα antibody or STRADβ antibody to show the difference in size between the 
two isoforms. Immunoprecipitation of LKB1 from tissues followed by western 
blotting with the rabbit anti-STRADβ antibody detected a band at 40 kDa in testis. 
This band did not migrate as far as the band detected by the STRADβ antibody in 
crude lysates (38 kDa), and re-probing the blot with a STRADα antibody suggested 
that the 40 kDa band most likely corresponds to STRADα. The studies presented in 
section 3.2.12, using overexpressed STRAD, suggested that when STRADα is 
present in high amounts, the STRADβ antibody does cross-react with the STRADα 
band on western blots (data not shown). That being said, a very feint band was also 
detected below the 40 kDa band in testis (Figure 3-11C), at approximately 38 kDa. 
No bands were detected in any of the other tissues studied. This therefore suggests 
that a small amount of LKB1 may be associated with STRADβ in testis. The 
presence of STRADβ bound to LKB1 in other tissues cannot be ruled out, as it may 
be below the level of detection.  
 
3.2.14  Activity of LKB1 in complex with STRADβ in vivo 
Due to the apparent co-immunoprecipitation of a small amount of STRADβ with 
LKB1 in testis, this was investigated further in order to determine if an anti-STRADβ 
antibody could immunoprecipitate LKB1 activity from mouse testis. Initially, the 
ability of various STRADβ antibodies to immunoprecipitate overexpressed LKB1 
activity was tested. As Figure 3-12A shows, using a goat polyclonal STRADβ 
antibody, significant LKB1 activity was present in immune complexes 
immunoprecipitated from STRADβ transfected cells but not STRADα transfected 
cells. This antibody was then used to immunoprecipitate STRADβ from testis and 
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LKB1 activity determined. Whereas immunoprecipitation with the STRADα 
antibody brought down high LKB1 activity in testis, no significant activity was 
immunoprecipitated with the STRADβ antibody (Figure 3-12B). Similar results were 
obtained using a different antibody to immunoprecipitate STRADβ from testis and 
also brain (data not shown). Figure 3-12C shows the results of blotting the immune 
complexes with an anti-LKB1 antibody. Bands corresponding to LKB1L and LKB1S 
were detected after immunoprecipitation with the STRADα antibody, but not with 
the STRADβ antibody. Overall, these results suggest that very little LKB1 is present 
as a complex with STRADβ in testis. This may be due to low expression levels of 
STRADβ, as is suggested by western blotting. Blots of lysates from cells 
overexpressing STRAD suggest that the STRADβ antibody is much more sensitive 
than the STRADα antibody for western blotting (data not shown), and, as Figure 
3-11B shows, in western blots of testis with either the STRADα or STRADβ 
antibody, the band recognised by the STRADβ antibody is less intense than for 
STRADα.  
 
Overall, the results presented here suggest that complexes of STRADβ with LKB1 
may not significantly contribute to LKB1 activity in testis or indeed a number of 
other mouse tissues. Co-immunoprecipitation studies suggested that a small amount 
of STRADβ may be associated with LKB1 in testis but, by using a STRADβ 
antibody for immunoprecipitation, the activity of LKB1 in these complexes was 
below the level of detection. 
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Figure 3-11 STRADβ expression and association with LKB1 in mouse tissues 
(A) Mouse tissue homogenates (50µg protein) were analysed by western blotting 
with a rabbit polyclonal STRADβ antibody. (B) 50µg of testis homogenate was 
analysed by western blotting with either a goat anti-STRADα or rabbit anti-STRADβ 
antibody. (C) LKB1 was immunoprecipitated from tissue homogenates (200μg total 
protein) by incubation with sheep anti-LKB1 antibody bound to protein G-sepharose. 
Proteins in the immune complex were detected by blotting with an anti-STRADβ 
antibody. The cross-reactivity of the antibody with STRADα in testis is indicated. In 
the final lane 50µg of testis homogenate (crude lysate) was blotted with the STRADβ 
antibody.  
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Figure 3-12 Activity of LKB1 immunoprecipitated with STRADβ from testis 
(A) A goat polyclonal STRADβ antibody was used to immunoprecipitate STRADβ from 
CCL13 cell lysates (50µg protein) over-expressing either STRADα or STRADβ, together 
with LKB1L and MO25α. LKB1 activity in the immune complexes was determined by 
activation of recombinant AMPK. Activities are expressed as U/mg lysate protein, where 
1U is the activity of LKB1 required to activate recombinant AMPK by 1 nmol/min/mg of 
protein. The isoform of overexpressed STRAD is indicated. (B) A goat polyclonal anti-
STRADβ antibody or goat polyclonal anti-STRADα antibody were used to 
immunoprecipitate STRAD from testis homogenates (50μg protein). LKB1 activity in the 
immune complexes was determined as for (A). Results are expressed as the mean activities 
± S.E.M.  from three mice. The isoform of STRAD immunoprecipitated is indicated. * 
indicates a statistically significant decrease in LKB1 activity in STRADβ IPs compared to 
STRADα IPs (p<0.05 with Student’s unpaired t-test). (C) Immune complexes following 
immunoprecipitation of STRADα/β were blotted with a mouse monoclonal antibody that 
recognises both splice forms of LKB1. In the first lane an anti-STRADβ antibody was used 
to IP STRADβ from over-expressed -mCherry-LKB1L, STRADβ and MO25α (LSM). In 
lane 2, 50µg testis (Ts) lysate was run. In lanes 3 and 4, 50 µg of testis lysate was 
immunoprecipitated with either a STRADα or STRADβ antibody. The final lane is a 
negative control (Ctrl) in which no antibody was present in the immunoprecipitation.  
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3.3 Discussion 
The work presented in this chapter describes a previously uncharacterised splice 
variant of LKB1 (LKB1S), which has a different C-terminal amino acid sequence 
compared to that of the previously reported form of LKB1 (LKB1L) (Smith et al., 
1999). Overall, it has been shown that this novel splice variant is primarily expressed 
in mouse testis, and comparison of the two splice variants in cells has indicated that 
they are very similar in terms of activity and localisation. The possibility that 
differences in phosphorylation at the C-terminus leads to differences in the regulation 
of the splice variants has been investigated, but the results suggest that this does not 
have a direct effect on LKB1 activity towards its downstream substrates. 
 
Western blotting and activity assays of various mouse tissues show that LKB1 is 
expressed in many tissues, with particularly high expression in testis and brain. The 
activity levels roughly correlate with expression levels supporting previous reports 
that LKB1 is constitutively active (Lizcano et al., 2004; Woods et al., 2003). In 
addition, a large band at 48 kDa was detected in testis which was also seen using 
different LKB1 antibodies raised to different epitopes. The possibility that this is a 
splice variant of LKB1 was therefore investigated. Analysis of the gene structure 
suggested two protein products of the same gene, generated by alternative splicing of 
the final coding exon. LKB1S is the product of exons I-VIII and exon IXa, whereas 
LKB1L is product of exons I-VIII and exon IXb.  This was confirmed by generation 
of an antibody to the predicted C-terminus of LKB1s which was able to 
immunoprecipitate LKB1 activity and blot the band at 48 kDa. In addition, by using 
specific primers, it was possible to amplify a band of the expected size of LKB1S 
from human and mouse testis cDNA by PCR. Sequence analysis confirmed the 
identity of the PCR products as LKB1S.  
 
In an independent report published while this study was in progress, LKB1 was  
partially purified from rat testis and subsequent MS analysis identified peptides 
corresponding to the predicted amino acid sequence of both LKB1L and LKB1S 
(Towler et al., 2008). In addition, Sakamoto et al., (2005) described a faster 
migrating protein in testis, detected in western blots probed with an LKB1 antibody, 
which was absent from mice homozygous for a floxed allele of LKB1 (Sakamoto et 
Chapter 3 – Characterisation of a New Splice Variant of LKB1 
 
93 
 
al., 2005). Importantly, the method by which the floxed allele was generated in that 
study would result in the absence of LKB1S expression. This is because a cDNA 
cassette encoding exons V-VIII and IXb of LKB1L was used to replace part of the 
LKB1 gene, eliminating any possibility of alternate splicing. In the current study, 
western blots of LKB1 in testis from these ‘floxed’ mice (LKB1fl/fl) show that the 48 
kDa band is absent (see chapter 4) and in addition no activity was detected in 
immune complexes isolated from testis of these animals using anti-sLKB1 antibodies 
for immunoprecipitation (data not shown). This therefore suggests that the lower 
molecular mass band seen by Sakamoto et al.,(2005), is LKB1S.  
 
The finding that LKB1S is highly expressed in mouse testis was also confirmed in a 
recent study (Towler et al., 2008). In addition, this group showed that LKB1S is 
present in human testis by western blotting. They also detected LKB1S in other rat 
and mouse tissues, including liver, heart, skeletal muscle, spleen, kidney and brain, 
albeit much less than in testis. One likely explanation for the greater tissue 
distribution detected by Towler et al., (2008) could be that the non-commercial 
antibodies they used for the western blots were more sensitive. It is also possible that 
the different forms identified in rat liver by Hawley et al., (2003) correspond to 
LKB1L and LKB1S. In this thesis, lower molecular weight bands were also detected 
in western blots of spleen and lung probed with the total-LKB1 mouse monoclonal 
antibody but, unlike in testis where the lower band was absent in LKB1
fl/fl
 mice, this 
band was still present in lung and spleen from these mice, suggesting that it may not 
correspond to LKB1s. The band was less intense in spleen from LKB1
fl/fl
 mice 
suggesting there is some LKB1S detected in this tissue.  The reason for the lower 
band in these tissues could be because there is a lot of blood present and so high 
levels of endogenous IgG. This is likely to be recognised by the anti mouse IgG 
secondary antibodies. The IgG heavy chain migrates at a similar position as LKB1 
on western blots. Overall, although LKB1S appears to be present in other tissues, the 
amount is very low compared to that in testis.  
 
Over-expression of either LKB1L or LKB1S in cells that do not express endogenous 
LKB1 showed that both forms are able to activate endogenous AMPK to a similar 
extent suggesting that, at least under these conditions, both forms have comparable 
activities towards AMPK. A recent study showed that LKB1S is also able to activate 
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the ARKs, SIK1/2/3, NUAK2 and BRSK1/2 (Towler et al., 2008). Both forms were 
able to bind to endogenous STRADα and MO25α in CCL13 cells. Two isoforms (α 
and β) of both MO25 and STRAD have previously been identified and these can all 
bind to LKB1L (Boudeau et al., 2003a). In the present study, it has been shown that 
both LKB1L and LKB1S expressed in CCL13 cells can form active complexes with 
either STRADα or STRADβ (also known as ILPIP, PAPK, ALS2CR2) and that the 
splice variants have similar activities to each other, independent of the STRAD 
isoform they are bound to. It is not clear whether the lower activity of both LKB1 
forms with STRADβ is due to the lower expression of this isoform compared to 
STRADα. However, it has been reported using a recombinant expression system that 
LKB1L is less active in a complex with STRADβ than STRADα (Hawley et al., 2003; 
Lizcano et al., 2004). One possible reason for the low expression of STRADβ in the 
current study is that STRADβ is less stable than STRADα, as is suggested by the data 
of Boudeau et al., 2003. In that study the authors suggest that, unlike LKB1 and 
STRADα, LKB1 and STRADβ do not bind if MO25 is not co-expressed, and that 
STRADβ levels are much higher in cells with MO25 co-expression suggesting that 
MO25 stabilises it (Boudeau et al., 2003a).  One study has suggested that STRADβ is 
not able to export LKB1 out of the nucleus as efficiently as STRADα because it lacks 
the residues needed for binding to the nuclear export receptors CRM1 and Exportin-7 
(Dorfman and Macara, 2008). On the other hand, another study has shown that 
STRADβ co-expression with LKB1 causes it to relocate to the cytoplasm (Brajenovic 
et al., 2004). This was not investigated in the current study due to the low expression 
of STRADβ. 
 
Although LKB1 has previously been shown to form a complex with STRADβ in 
transfected cells, this has not been demonstrated in vivo. The data presented in this 
thesis suggest that very little LKB1 is present in a complex with STRADβ in mouse 
testis and possibly other tissues, which may be due to low levels of STRADβ 
expression. A previous study detected high STRADβ RNA expression in brain, heart, 
liver, kidney and testis (Nishigaki et al., 2003), and another detected very high 
expression in muscle, liver and heart (Sanna et al., 2002). The data on STRADβ 
expression presented here suggest the highest protein expression in testis and brain, 
but low in kidney, liver and muscle. The reason for STRADβ running as a doublet on 
western blots may be due to post-translational modification or splice variants. It has 
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been reported that there are a number of splice variants of STRADα, and it has been 
suggested that these may have different abilities to bind LKB1 and have different 
effects on its activity and localisation (Dorfman and Macara, 2008; Marignani et al., 
2007). It cannot be ruled out therefore, that that LKB1S binds to different STRAD 
splice variants compared to LKB1L in vivo. 
 
At present, there is some controversy regarding the regulation of LKB1 by post-
translational modification. LKB1L is phosphorylated on at least nine serine/threonine 
residues. Four of these are autophosphorylation sites, whereas the remaining five 
sites are phosphorylated by other kinases (Alessi et al., 2006; Xie et al., 2009). To 
date, there is no evidence to suggest that phosphorylation at any of these sites has a 
direct effect on the activity of LKB1 in vitro (Sapkota et al., 2002a; Sapkota et al., 
2001). Moreover, several studies have reported that LKB1 activity is unaltered by 
stimuli that cause significant activation of AMPK (Lizcano et al., 2004; Sakamoto et 
al., 2004; Woods et al., 2003), suggesting that LKB1 is constitutively active. Two 
amino acids have been identified at the C-terminus of LKB1L which are post-
translationally modified and which are not present in LKB1S. S428/431 of 
mouse/human LKB1L has been shown to be phosphorylated by PKA (Collins et al., 
2000), RSK (Sapkota et al., 2001) and PKCδ (Xie et al., 2006a), and a cysteine 
residue, four amino acids from the C-terminus (C430/433), forms a  farnesylation 
site (Collins et al., 2000).   
 
There have been several reports in the literature specifying a role for phosphorylation 
of S428/431 by upstream kinases. Two recent studies have suggested an important 
role for phosphorylation of S428/431 in axon differentiation (Shelly et al., 2007) and 
neuronal polarisation via activation BRSK1 and 2 (also known as SAD-A and SAD-
B) by LKB1 (Barnes et al., 2007). However, two other reports have suggested that 
phosphorylation at this site has no effect on the activity of these kinases (Bright et 
al., 2008; Fogarty and Hardie, 2009). Another study has reported that the S431A 
mutation abolished the ability of LKB1 to arrest cell growth (Sapkota et al., 2001), 
but a recent study by Fogarty and Hardie has suggested that this site is not involved 
in cell cycle arrest (Fogarty and Hardie, 2009). S428 phosphorylation has also been 
suggested to lead to increased apoptosis in endothelial cells via activation of the 
LKB1-AMPK pathway (Song et al., 2008). In contrast, another study has proposed 
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that phosphorylation has an inhibitory role on the LKB1-AMPK pathway in 
melanoma cells with B-Raf mutations, and that phosphorylation increases 
tumourigenesis in these cells (Zheng et al., 2009). However, a subsequent study 
suggested that this inhibition may involve mechanisms other than S428 
phosphorylation (Esteve-Puig et al., 2009).  
 
In a recent study it was proposed that peroxynitrite treatment, which leads to S428 
phosphorylation, increases the association of LKB1 with STRAD, but not when S428 
is mutated to alanine (Xie et al., 2009). However, it is surprising that these authors 
did not see an increase in the intrinsic catalytic activity of LKB1 with peroxynitrite 
treatment as it has previously been shown that STRAD and MO25 binding greatly 
increases LKB1 activity (Baas et al., 2003; Boudeau et al., 2003a). Furthermore, a 
study by Boudeau et al. demonstrated that a similar amount of STRAD was bound to 
S431A mutants as WT LKB1, and there was no increase in the binding with 
forskolin treatment (Boudeau et al., 2003a).  
 
The data presented in this thesis have shown that activation of the PKA pathway by 
forskolin increases S431 phosphorylation of LKB1, but this has no effect on LKB1 
activity. A small increase in AMPK activity upon forskolin treatment was observed, 
but this appears to be independent of LKB1, since the effect is also seen following 
expression of a catalytically inactive form of LKB1. This is in agreement with a 
number of previous studies which have suggested that PKA-activating agents 
increase AMPK activity in adipocytes (Daval et al., 2005; Koh et al., 2007; Yin et 
al., 2003). This is thought to be due to the AMP generated by the re-esterification of 
fatty acids following PKA-mediated triglyceride breakdown (Daval et al., 2005). 
Conversely, a study by Hurley et al. suggested the opposite effect on AMPK activity 
in various cell lines treated with these agents, and suggested this was due to the 
inhibitory phosphorylation of AMPK at S485 as well as inhibition of CAMKK 
(Hurley et al., 2006). In addition, a recent report suggested that PKA phosphorylation 
of AMPK at S173, in response to agents such as forskolin, reduced AMPK activity in 
adipocytes (Djouder et al., 2009). Further work will be needed to resolve this issue. 
Overall, the results presented in this thesis show that phosphorylation of LKB1 on 
S428/431 does not alter its activity and therefore does not support the notion that this 
site is involved in differential regulation of LKB1L relative to LKB1S. This work has 
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subsequently been supported by data from another independent study (Fogarty and 
Hardie, 2009). 
 
Recent studies by the group of M.H. Zhou have suggested that phosphorylation of 
S428 by PKC- causes translocation of LKB1 from the nucleus to the cytoplasm, 
bringing it into contact with its downstream substrates (Choi et al., 2008; Song et al., 
2007; Song et al., 2008). In this thesis, LKB1L or LKB1S expressed alone were 
shown to be distributed in both the cytoplasm and the nucleus. Co-expression with 
MO25α and STRADα resulted in a striking re-distribution of both LKB1L and 
LKB1S to a largely cytoplasmic localisation. This has also been shown by others 
(Boudeau et al., 2003a). These results could be interpreted as follows; when LKB1 is 
expressed alone, a proportion of it forms a complex with endogenous MO25 and 
STRAD and is localised in the cytoplasm, whereas some remains unassociated and 
localises to the nucleus. In these heterologous expression systems, the amount of 
LKB1 that is unassociated and localised in the nucleus will depend on the level of 
expressed LKB1 relative to endogenous MO25 and STRAD. When all three proteins 
are co-expressed the amount of unassociated LKB1 is relatively low and therefore 
LKB1 localises predominantly to the cytoplasm. A recent study reported that 
STRADα prevents shuttling of LKB1 from the cytoplasm to the nucleus by 
competing with importin-α for binding of LKB1 (Dorfman and Macara, 2008) which 
could explain that if STRADα is limiting, LKB1 localises to the nucleus. In addition, 
in HEK293 cells which express endogenous LKB1, LKB1L was detected in the 
cytosolic and membrane fractions but not the nuclear fraction. This finding suggests 
that LKB1L is excluded from the nucleus independently of the level of S428/431 
phosphorylation, and this is supported by previous studies (Boudeau et al., 2003a; 
Collins et al., 2000; Sapkota et al., 2001).  
 
The possibility that LKB1 is nuclear in certain cell types, however, cannot be ruled 
out. If so, this may be due to different STRAD and/or MO25 isoforms being present. 
As mentioned previously, other studies have implicated different variants of STRAD 
in differential localisations (Dorfman and Macara, 2008; Marignani et al., 2007). In 
fact, a study by Conde et al., (2007) used immunohistochemistry to look at LKB1 
localisation in different human tissues and although they found LKB1 staining to be 
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cytoplasmic in most cell types, nuclear staining was detected in certain cells of the 
cerebral cortex. In addition, Barnes et al., (2007) found LKB1 to be concentrated in 
the nucleus of neurons of the cerebral cortex. Potential roles for LKB1 in the nucleus 
in transcriptional regulation have previously been suggested (Scott et al., 2007; Zeng 
and Berger, 2006). In addition, previous studies have suggested that AMPK 
complexes containing the α2 isoform may show a significant nuclear localisation 
(Salt et al., 1998a), and the ARKs, NUAK2 and SIK1 have also been shown to be 
localised in the nucleus (Kuga et al., 2008). 
 
Another difference between LKB1L and LKB1S is the presence of a farnesylation site 
(C430/433) in LKB1L that is not present in LKB1S. Farnesylation of C430/433 has 
been shown previously to be involved in the membrane localisation of LKB1L 
(Collins et al., 2000). Whatever the role of the farnesylation modification in LKB1L 
it is clearly not required for a functional LKB1 complex, since LKB1S in complex 
with MO25 and STRAD activates AMPK with a similar efficiency to the LKB1L 
complex.  A study by Collins et al., (2000) has shown that C433 localises LKB1 to 
the membrane and this was reported to be independent of phosphorylation at S428. 
On the other hand, in the present study treatment with forskolin appeared to cause a 
decrease in the amount of LKB1L in the membrane fraction in HEK293 cells. Given 
these conflicting results it will be important to investigate further whether 
phosphorylation of S428/431 could play some role in membrane localisation of 
LKB1L. A recent study by Towler et al. detected both LKB1S and LKB1L in the 
membrane fraction of transfected NG108 and HeLa cells, suggesting that LKB1S 
may be able to associate with the membrane fraction even though it lacks a 
farnesylation motif (Towler et al., 2008). 
 
In conclusion, in this chapter a new form of LKB1, which is generated by alternative 
splicing, has been described. The finding that this form is predominantly expressed 
in testis suggests that it may play a specific role in this tissue. Biochemical studies 
suggest that the splice forms are very similar in terms of activity and localisation. 
Two previous studies have hinted that complexes containing LKB1S may have a 
higher intrinsic catalytic activity than LKB1L complexes (Hawley et al., 2003; 
Towler et al., 2008). However, in this current study, no significant difference in the 
activity of the different complexes was detected.  Further biochemical studies using 
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recombinant proteins will be required to resolve this issue. The role of post-
translational modification at the C-terminus of LKB1L is unclear and it has recently 
been suggested that S428 is a marker of activated LKB1 rather than having any 
direct effect on its activity (Lan et al., 2008). It has also been argued that LKB1 may 
not be rate-limiting for AMPK activation in vivo, as suggested by studies of skeletal- 
and cardiac- muscle (Sakamoto et al., 2005; Sakamoto et al., 2006). If this is the 
case, activation of LKB1 would have little, if any physiological effect (Fogarty and 
Hardie, 2009). However, as S428 and C430 are conserved in human, mouse and 
Xenopus LKB1L proteins (Collins et al., 2000), it seems likely that they do have 
some important functional role in vivo. The exact nature of this role will require 
further investigation and deciphering this may be an important step towards 
discovering functional differences between the two LKB1 splice forms.  
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4 The Role of LKB1S in Spermatogenesis  
4.1 Introduction 
Mice lacking expression of LKB1S were generated in the laboratory of Professor 
Alan Ashworth (Institute of Cancer Research, UK), as previously described 
(Sakamoto et al., 2005). The mice were originally made to provide a system for 
deleting LKB1 in specific tissues using a Cre-lox  recombination system (Figure 
4-1). We later determined that LKB1 floxed mice (LKB1
fl/fl
), do not express the 
48kDa form of LKB1, i.e., LKB1S. The reason for this is that in order to generate the 
LKB1
fl/fl
 mice, exons 4-7 of the LKB1 gene were replaced by a lox-P flanked 
cassette encompassing exon 4 plus cDNA encoding the rest of the long form of 
LKB1. Therefore the LKB1
fl/fl
 mice still express full length LKB1L, but not LKB1S, 
as the cDNA inserted is already spliced. It was reported that the LKB1
fl/fl
 male mice 
are infertile but this was not investigated further (Sakamoto et al., 2005). However, 
one complication with the LKB1
fl/fl
 model is that the expression of LKB1L is reduced 
in some tissues. This has been termed the hypomorphic effect (Sakamoto et al., 
2005).  
 
 
 
Figure 4-1 The generation of LKB1
fl/fl
 mice 
Adapted from Sakamoto et al. (2005). Exons 4-7 (encoding the kinase domain) of the 
LKB1 gene (LKB1
WT
) were replaced by a cassette encompassing exon 4 plus cDNA 
encoding the rest of LKB1L. This cassette was flanked by lox-P cre excision sites 
(►) and contained a neomycin (Neo) gene for selection. Mice homozygous for 
expression of this cassette are termed LKB1 floxed (LKB1
fl/fl 
mice). When LKB1
fl/fl
 
mice are crossed with mice expressing cre recombinase under a tissue specific 
promoter (LKB1
fl/fl
Cre
+/+
), exons 4-7 are deleted resulting in loss of expression of 
functional LKB1. 
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Spermatogenesis takes place within the seminiferous tubules of the testis and 
involves four main phases. Firstly, there is a mitotic phase which increases germ cell 
numbers. This is followed by a meiotic phase in which the genome size is halved. 
The third phase is known as spermiogenesis and this involves the morphological 
transformation of germ cells to generate the characteristic, polarised sperm shape. 
Finally there is the spermiation phase. This is the process by which the mature 
spermatids are released into the lumen of the seminiferous tubules. Little is known 
about the regulation of spermiation. The earliest germ cell generations 
(spermatogonia) are found around the outer edge of the seminiferous tubules at the 
basement membrane, with the more mature germ cells (elongated spermatids) found 
around the lumen (Russell et al., 1990). 
 
Previous studies that looked at total LKB1 expression in testis (prior to the discovery 
that there are two splice forms) have suggested high RNA expression in the 
seminiferous tubules and less in the surrounding interstitial region (Luukko et al., 
1999; Rowan et al., 2000). Another study using immunohistochemistry showed high 
staining in the cytoplasm of developing germ cells in the luminal region of the 
seminiferous tubules, with less in spermatogonia and sertoli cells. The authors were 
unable to detect LKB1 in leydig cells (Conde et al., 2007). 
 
The aim of this study was to characterise the reproductive phenotype of LKB1
fl/fl
 
mice in order to gain an understanding of how LKB1 may be involved in male 
fertility. This involved the morphological analysis of mature sperm as well as 
histological studies of both the testis and epididymis using light microscopy (LM) 
and transmission electron microscopy (TEM). In addition, possible downstream 
substrates for LKB1S in the testis were investigated in order to determine the 
mechanism by which LKB1S is acting. 
 
It is shown that LKB1
fl/fl
 mice have dramatically reduced numbers of mature sperm. 
A defect in the release of mature sperm from the seminiferous epithelium 
(spermiation) during sperm development may be a major cause of the infertility 
phenotype, possibly due to a defect in the breakdown of junctions between the germ 
cells and sertoli cells.  
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4.2 Results 
 
4.2.1 LKB1 expression in LKB1fl/fl mice  
The absence of the LKB1S protein in LKB1
fl/fl
 mice was confirmed by western 
blotting of various tissues from wild-type and LKB1
fl/fl
 mice using a monoclonal 
antibody that recognises both splice forms (Figure 4-2). Quantification of the blots 
showed that LKB1L expression is reduced by approximately 83% (±2%) in testis, 
51% (±8%) in brain and 93% (±5%) in liver (Figure 4-2). The identity of the lower 
band in wild-type liver is unknown. As also noted in section 3.2.1, this band appears 
to run slightly further than the band corresponding to LKB1S and often varies in 
intensity between mice. The band has never been detected in western blots from 
LKB1
fl/fl
 mouse liver (n=4) (see figure Figure 4-2) suggesting that it may be LKB1 
related, perhaps another splice variant.  
 
LKB1 is believed to exist as a heterotrimer with STRADα and MO25α (Baas et al., 
2003; Boudeau et al., 2003a). Therefore, the expression of these proteins was 
analysed by western blotting to determine if expression was reduced in testis in the 
absence of LKB1S. Whereas MO25 expression appeared not to be significantly 
altered in the LKB1
fl/fl mice, quantification of STRADα expression showed it to be 
reduced by 53±5% (Figure 4-3). A possible reason for this may be that the STRAD 
protein is unstable in the absence of LKB1. 
 
4.2.2 Male infertility in LKB1fl/fl mice 
Sakamoto et al., (2005) reported that 30% fewer LKB1
fl/fl
 mice were born than the 
expected mendelian frequency. In this study, analysis of mendelian ratios also 
suggested fewer LKB1
fl/fl
 mice were born than expected. Of 19 pairs set up with 
various combinations of male and female genotypes, 5% of the total combined litter 
were LKB1
fl/fl
, whereas the expected proportion was 12% (data not shown). 
 
Other than male infertility, there were no overt phenotypic differences between wild-
type and LKB1
fl/fl
 mice, for example, body weight (Figure 4-3) and general 
behaviour were not noticeably altered. In order to confirm the male infertility, mating 
assays were conducted. Males were paired with two females each for 14 days, and 
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mating determined by the presence of copulation plugs in the mated females. This 
indicated that although LKB1
fl/fl
 mice did attempt to mate, no pregnancies were 
observed in the females paired with LKB1
fl/fl
 males, whereas around 70% of females 
paired with wild-type mice became pregnant (Table 4-1). No fertility problems were 
noted in female LKB1
fl/fl
 mice. 
 
 
 
 
Figure 4-2 LKB1 expression in wild-type and LKB1
fl/fl
 mouse tissues 
Mouse tissues homogenates (50µg) were analysed by western blotting with a 
monoclonal antibody raised against total LKB1.  An anti-actin antibody was used to 
show equal loading. Representative blots are shown and the migration of molecular 
mass standards are as indicated. Quantification of the relative intensity of the LKB1L 
band between wild-type and LKB1
fl/fl
 mice is shown in the bar graph below. Results 
are plotted as the percentage expression of LKB1L in LKB1
fl/fl
 mice compared to 
wild-type and are the means ± S.E.M. of three separate blots from three individual 
mice. * indicates a statistically significant difference in LKB1 expression in brain 
compared to testis or liver (p<0.05 with Student’s unpaired t-test). 
 
 
Chapter 4 – The Role of LKB1S in Spermatogenesis 
 
104 
 
 
 
Figure 4-3 STRADα and MO25α expression in wild-type and LKB1fl/fl mouse 
testis 
Mouse testis homogenates (30µg) were analysed by western blotting with anti-
STRADα or anti-MO25α antibodies.  Actin is shown as a loading control. 
Representative blots are shown. A bar chart showing quantification of expression is 
shown underneath. The results of the LKB1
fl/fl
 mice are plotted relative to expression 
in wild-type testis and are the means ± S.E.M. of three separate blots from three 
individual mice. * indicates a statistically significant difference in expression in 
LKB1
fl/fl
 mice compared to wild-type (p<0.05 with Student’s unpaired t-test). 
 
 
 
 
Table 4-1 Mating assays  
Male Genotype 
Number of females 
plugged after 2 days 
Pregnancies 
WT 9 18 
LKB1
fl/fl
 8 0 
         n=26 females 
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4.2.3 Testis size and weight  
Testis weight can give an indication of whether there is a severe disruption of 
spermatogenesis, for example, if there is an arrest in spermatogenesis at a particular 
point resulting in the absence of subsequent germ cell generations. Therefore, testes 
were harvested and weighed. Figure 4-4  shows the average weight for wild-type and 
LKB1
fl/fl
 testes. Samples were taken from age-matched wild-type and LKB1
fl/fl
 mice 
ranging from 11-26 weeks. There was no significant difference in testis weight 
between any of the genotypes. In addition, the overall size and appearance of the 
testes were not altered in LKB1
fl/fl
 mice. The epididymal tubules and vas deferens of 
LKB1
fl/fl
 mice did appear more translucent than those from wild-types, presumably 
due to the relative absence of sperm within them. Figure 4-5 shows photographs of 
wild-type and LKB1
fl/fl
 mouse testes and epididymides.  
 
 
 
 
 
Figure 4-4 Body and testis weights 
Wild-type (WT) and LKB1
fl/fl
 mouse body and testis weights are presented as mean 
± S.E.M. from nine age-matched mice per genotype. Mice ages ranged from 11-26 
weeks. There is no significant difference between WT and LKB1
fl/fl
 testis weight 
(p>0.05 with Student’s unpaired t-test). 
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Figure 4-5 Photographic images of testes and epididymides  
Testes and epididymides were dissected from wild-type (WT) and LKB1
fl/fl
 (fl/fl) 
mice. Representative photographs were taken using an Olympus SMZ-16X 
microscope with Olympus DP-71 colour camera. The genotype is shown below each 
image. A region of the epididymis indicated by ‘*’ highlights the translucent 
appearance of LKB1
fl/fl
 epididymal tubules compared to WT. This is likely due to a 
relative absence of sperm. This is also apparent in the vas deferens. 
 
 
4.2.4 Analysis of mature sperm 
In order to elucidate the reason for the infertility of LKB1
fl/fl
 mice, mature sperm 
were collected from the cauda epididymides into 1ml of media and the approximate 
sperm count calculated. An average of 27x10
6
 sperm cells were collected from each 
wild-type mouse, whereas only 28x10
4
 sperm cells were collected from each 
LKB1
fl/fl
 mouse, a reduction of 96.4% (±3%), (Figure 4-6). There was no significant 
difference in sperm counts between wild-type mice and mice heterozygous for the 
floxed allele (LKB1
wt/fl
).  
 
Mature sperm were affixed to glass slides and the morphology analysed by 
fluorescence microscopy. An anti-tubulin antibody was used to stain the flagellum 
and DAPI used to stain the nucleus. In addition, the sperm were stained with an 
antibody that recognises an antigen within the sperm acrosome. The acrosome is a 
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secretory organelle containing digestive enzymes which are released upon binding to 
the ovum (Abou-Haila and Tulsiani, 2000). Wild-type sperm are shown in Figure 
4-7A. The nucleus is falciform in shape and the acrosome appears as a crescent-
shaped structure extending over the anterior nuclear surface. Sperm from LKB1
fl/fl
 
mice display a number of abnormalities (Figure 4-7 B-F). Heads and tails are often 
separated and many tails appear fragmented (Figure 4-7B). Tails are frequently 
coiled, sometimes around the head, and sometimes appearing as a ‘lasso’-type 
structure (Figure 4-7 C,D). Approximately 70% of sperm heads from LKB1
fl/fl
 mice 
have no detectable acrosome staining at all, many of the remainder displaying an 
abnormal staining pattern, with the acrosomes often being reduced in size (Figure 4-7 
B,E). Only 10-15% of sperm from wild-type mice have no acrosomal staining. 
Furthermore, approximately 50% of sperm heads from LKB1
fl/fl
 mice show a visibly 
abnormal morphology compared to less than 5% in wild-type sperm. Overall, more 
cellular debris is visible amongst the LKB1
fl/fl
 sperm (Figure 4-7 E,F).  There were 
no differences apparent between the morphology of wild-type and LKB1
wt/fl
 sperm 
(data not shown). 
 
Figure 4-6  Sperm counts 
Sperm from the cauda epididymides of 20-25 week old mice were collected in 1ml of 
media. The number of sperm collected from each WT, heterozygous floxed (LKB1
wt/fl
) and 
homozygous floxed (LKB1
fl/fl
) mouse was estimated, using a haemocytometer to count 
small aliquots. Sperm counts are shown as the mean ± S.E.M. from three individual mice 
per genotype. . * indicates a statistically significant decrease in sperm count in LKB1
fl/fl
 
mice compared to WT and LKB1
wt/fl
 (p<0.05 with one-way ANOVA and a Tukey posthoc 
test). 
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Figure 4-7 Fluorescence microscopy images of mature spermatozoa  
Wild-type (A) and LKB1 floxed (B-F) sperm were taken from the cauda epididymis, 
affixed to glass slides and visualised by immunofluorescence. Tails were stained 
with an anti-tubulin antibody and detected with an Alexa 568 conjugated secondary 
antibody (red). Acrosomes were stained with an anti-acrosomal monoclonal antibody 
and visualised using an Alexa 488 conjugated secondary antibody (green). Nuclei 
were stained with DAPI (blue). Slides were viewed on a Leica TCS SP1 confocal 
microscope. Images are representative of at least three mice (Scale bar = 20µM). 
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4.2.5 Histology of the cauda epididymis 
Mature sperm are stored in the cauda epididymis prior to release. Light microscopic 
(LM) analysis of cauda epididymis sections showed dramatic differences in the 
contents of the lumen between wild-type and LKB1
fl/fl
 epididymis. Sections were 
stained with toluidine blue dye which stains chromatin and cytoplasm with differing 
intensities.  In control sections (Figure 4-8A), the lumen shows an abundance of 
sperm, as recognised by deeply staining sperm nuclei, whereas in the LKB1
fl/fl
 mice 
(Figure 4-8B), there are very few identifiable sperm. Instead the lumen contains 
numerous deeply staining round structures of various sizes (approximately 2-6μm in 
diameter) and regions of what appears to be viscous material. No obvious differences 
in the structure of the tubule walls (epididymal epithelium) were apparent between 
LKB1
fl/fl
 and control animals. 
 
To investigate this further, cauda epididymis sections were viewed by transmission 
electron microscopy (TEM). Comparison of Figure 4-8C (wild-type) and Figure 
4-8D (LKB1
fl/fl
) highlights the dramatic differences between the luminal contents. In 
many tubules from LKB1
fl/fl
 mice, the luminal fluid appears very dense and contains 
abnormal cellular debris, most of which may be degrading germ cells.  For example,  
Figure 4-8E shows the remnants of a spermatozoon, the flagellum coiling around a 
number of abnormal-looking organelles. Other structures within the lumen are 
unidentifiable. Figure 4-8F shows a higher magnification image of two of the round 
deeply staining structures. It is possible that these are immature germ cells at a very 
late stage of degradation.  
 
4.2.6 Histology of the caput epididymis 
Before reaching the cauda epididymis, the post-testicular sperm firstly pass through 
the caput epididymis followed by the corpus epididymis. Caput epididymis sections 
were viewed by LM and TEM to determine whether the luminal contents of this 
region are similar to the cauda epididymis or whether the sperm phenotype becomes 
more severe with distance through the epididymis.  The images displayed in Figure 
4-9 show that whereas in wild-type, the tubular lumen is usually packed with sperm 
(Figure 4-9A,C), the vast majority of lumens from LKB1
fl/fl
 animals appear empty 
(Figure 4-9B). In some LKB1
fl/fl
 tubules a small number of sperm cross-sections are 
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visible, as shown in Figure 4-9D, and in others the lumen is full of spherical cells 
(Figure 4-9E,F). Analysis of the nuclear morphology of these cells in TEM images 
suggests that some may be immature germ cells that have sloughed off into the 
lumen of the seminiferous tubules of the testis. Possible spermatocytes and round 
spermatids were identified (Figure 4-9F). Whereas the luminal fluid of the cauda 
epididymis appears very dense, in the caput epididymis this was not apparent. As for 
the cauda epididymis, no obvious abnormalities in the epithelium were observed. 
Taken together these data suggests that with distance through the epididymis there is 
a visible change in the general luminal environment in which the sperm are found, 
but the reason for the low sperm counts and infertility appears to arise before the 
sperm reach the epididymis.  
 
4.2.7 Overall testis histology 
Due to the low sperm counts and abnormalities of sperm in the epididymis, it was 
hypothesised that there may be a defect of spermatogenesis in the testes of LKB1
fl/fl
 
mice. Testis sections were stained with toluidine blue dye in order to view the 
seminiferous tubules by LM. At low magnification, there appears not to be any gross 
histological abnormality; there are no obvious differences in the thickness of the 
tubule walls between wild-type (Figure 4-10A) and LKB1
fl/fl
 (Figure 4-10B) 
sections, and darkly staining elongated spermatid nuclei are seen around the luminal 
edge in both. However, at higher magnifications the region around the tubule lumens 
appears more disordered in the LKB1
fl/fl
 mice (Figure 4-10D, compared to Figure 
4-10C).  Analysis of tubule structure in LM and TEM images did not show any 
major differences in the appearance of early germ cell generations, i.e., those 
undergoing the proliferation and meiotic phases; no obvious abnormalities were 
detected in spermatogonia, spermatocytes and round spermatids. However, there may 
be more subtle abnormalities that were not detected. In normal spermatogenesis, cells 
in the post-meiotic phase (spermiogenesis) are found closest to the tubular lumen. As 
it is this region that appears disrupted in the LKB1
fl/fl
 animals, it may be that the 
infertility is caused by a problem during spermiogenesis. However, it cannot be ruled 
out that a problem occurring earlier in spermatogenesis does not become visible until 
a later phase.   
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Figure 4-8 Histology of the cauda epididymis 
Cauda epididymis sections of were visualised by light microscopy (A-B) and TEM (C-F). 
Representative images are shown from observations of three mice per genotype. (A) A 
section through wild-type epididymis showing an abundance of sperm within the lumen. (B) 
A section through LKB1
fl/fl
 epididymis showing abnormal structures within the lumen and 
very few sperm. (C-D) TEM images of the epididymal lumen from a wild-type mouse (C), 
showing numerous head and tail cross-sections, and a LKB1
fl/fl
 mouse (D) showing dense 
luminal fluid, cellular debris, abnormal round structures and an absence of recognisable 
sperm cross sections. In (E) and (F), higher magnification TEM images of degrading cells 
are shown within the lumen from LKB1
fl/fl
 animals. In (E) the remnants of a flagellum are 
indicated by an arrow.  (A,B, scale bar = 50 µm; C,D, scale bar = 5µm; E,F, scale bar = 
1µm). 
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Figure 4-9 Histology of the caput epididymis 
Caput epididymis sections were visualised by light microscopy (A,B,E) and TEM 
(C,D,F).  The sections show many sperm to be present in the lumens from wild-type 
mice (A,C), whereas in most tubules from LKB1
fl/fl
 mice no sperm are visible (B), 
although occaisionally a few are present (D).  (E-F) Numerous round cells are shown 
in a tubule lumen from a LKB1
fl/fl
 mouse, as indicated by an asterisk in (E). A 
possible spermatocyte, ‘S’, and round spermatids, ‘RS’, are indicated in (F). 
Representative images are shown, (A,B,E, scale bar = 20µm; C,D,F scale bar = 
2µm). 
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Figure 4-10 Overall testis histology  
Testis sections were stained with toluidine blue dye and viewed by LM. The wild-
type is shown on the left (A,C) and LKB1
fl/fl 
on the right (B,D). Images were obtained 
using a Zeiss Axiophot light microscope fitted with a colour digital camera at either 
10x magnification (A,B) or 20x magnification (C, D). Elongated spermatid nuclei can 
be identified around the lumen by their relatively dark staining. Representative 
images are shown (scale bar = 100µm). 
 
 
4.2.8 Abnormal structures around the lumen of the seminiferous 
tubules 
The region around the lumen of the seminiferous tubules was analysed in more detail 
to try and establish the reason for the disorganised appearance. Analysis of LM 
images showed that there are numerous, often quite large, darkly staining bodies 
present around the lumen of virtually all LKB1
fl/fl 
tubules. Some tubules show only a 
few whereas others have a very large number. Figure 4-11B and Figure 4-11D show 
the presence of these bodies in stage V and VIII tubules respectively from LKB1
fl/fl
 
mice. Wild-type tubules at an equivalent stage are shown alongside for comparison 
(Figure 4-11 A,C). In wild-type mice, spermiation occurs in tubules at stage VIII and 
as the sperm are released, the lobe of excess cytoplasm pinches off from the 
WT LKB1fl/fl 
Chapter 4 – The Role of LKB1S in Spermatogenesis 
 
114 
 
spermatid and remains attached to the seminiferous epithelium. These lobes then fuse 
together to form residual bodies which are phagocytosed by the sertoli cells, meaning 
that by stage X they are usually no longer visible within the tubule walls (Russell, 
1993). Normal residual bodies are shown in Figure 4-11C in which a late stage VIII 
wild-type tubule is displayed, and are in the process of translocation from the edge of 
the lumen to the base of the tubule. In the LKB1
fl/fl 
tubules, the dense bodies look 
similar to residual bodies. However, in LKB1
fl/fl 
tubules, these bodies can be seen at 
all stages and are often very big and are mainly seen very close to the lumens. The 
continued presence of many elongated spermatids around the lumen in the stage VIII 
LKB1
fl/fl
 tubule in Figure 4-11D will be discussed in the next section. 
 
TEM images of the dense bodies also show them to be similar in appearance to the 
residual bodies in wild-type mice (Figure 4-12A), which contain vacuoles, RNA, 
mitochondria etc, but unlike normal residual bodies, they frequently contain at least 
one condensed sperm nucleus along with several cross-sections of flagella. Dense 
granular material is also often visible. Acrosomes are often completely detached 
from the spermatid nucleus, frequently remaining attached to the sertoli cells at the 
cell periphery (Figure 4-12 B,C).  The multi-nucleation of these bodies suggests that 
there is either a problem with meiosis or that maturing spermatids have fused 
together during spermiogenesis. In order to answer this question, early (round) 
spermatids were analysed in LM sections to determine if they possessed more than 
one nucleus. Overall, no obvious differences were detected between the number of 
multi-nucleated round spermatids visible in wild-type and LKB1
fl/fl
 mouse tubules 
(data not shown), therefore, suggesting that the spermatids fuse together later in 
spermiogenesis in the LKB1
fl/fl
 animals. Figure 4-12D shows an abnormal elongated 
spermatid with the head embedded in cytoplasm, a detached acrosome, and two 
flagella extending from it. An immature elongating spermatid is also seen alongside. 
These cells should be embedded within the seminiferous epithelium, not close to the 
lumen.  
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Figure 4-11 Histology of the luminal region of the seminiferous epithelium 
Seminiferous tubules from wild-type mice are shown on the left (A,C) and LKB1
fl/fl 
mice on the right (B,D). Wild-type and LKB1
fl/fl 
sections are displayed at roughly 
equivalent stages for comparison; approximately stage V (A,B), or stage VIII (C,D), 
as shown to the right of the figure. A number of dense, round bodies of varying sizes 
can be seen around the lumens from LKB1
fl/fl
 mice. Examples of these are indicated 
by black arrows. Wild-type residual bodies (white arrows) can be seen translocating 
from the luminal- to the basal- edge of the tubule in (C). Photographs were taken 
using a Zeiss Axiophot light microscope fitted with a colour digital camera. 
Representative images are shown (scale bar = 20µm). 
 
 
 
 
 
 
 
WT LKB1fl/fl 
V 
VIII 
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Figure 4-12 TEM images of abnormal elongated spermatids in LKB1
fl/fl
 mouse 
testis 
(A) Several residual bodies are shown around the seminiferous tubule lumen from a 
wild-type mouse. Two of these are indicated (RB). (B) and (C) show abnormal 
structures found in the seminiferous tubules from LKB1
fl/fl
 mice. These are similar to 
the wild-type residual bodies, but often contain at least one condensed spermatid 
nuclei (N) and several cross sections of flagella (F) as indicated in (C). Detached 
acrosomes are indicated with an arrow. In (D) abnormal spermatids are shown 
around the lumen of a tubule from a LKB1
fl/fl 
mouse. The cell indicated by an 
asterisk appears to be formed from the fusion of at least two spermatids and there is a 
large amount of cytoplasm around the nucleus (N), (scale bar = 2µm). 
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4.2.9 There is a defect in spermiation in LKB1fl/fl mice 
As mentioned above, sperm are released into the lumen at stage VIII of 
spermatogenesis, (Russell, 1993). Figure 4-13 shows tubules at stages VIII, IX, X 
and XI. Stages were assigned to the images based on the developmental appearance 
of the spermatids. In wild-type sections, at stage VIII the elongated spermatids are 
still visible around the lumen attached to the sertoli cells. The cytoplasmic lobes can 
be seen, as identified by the more deeply staining cytoplasm now positioned basally 
to the sperm heads (Figure 4-13A). In the stage IX, X and XI tubules, the mature 
spermatids have been released into the lumen, as noted by a lack of densely staining 
nuclei around the lumens (Figure 4-13 C,E,G). Figure 4-13C shows that even by 
stage IX, most of the residual bodies have been phagocytosed in this wild-type 
tubule. Immature spermatids can be seen embedded within the sertoli cells and a 
progressive condensation and elongation of the nucleus can be seen from stage IX to 
stage XI.  In contrast, elongated spermatids can be seen at all four stages in the 
tubules from LKB1
fl/fl
 animals, showing a failure of spermiation. There are fewer by 
stage XI suggesting many of the sperm have either been released or phagocytosed by 
the sertoli cells by this stage (Figure 4-13 B,D,F,H). Overall, elongated spermatids 
were seen in all seminiferous tubules analysed from LKB1
fl/fl
 mice, whereas they 
were only present in stage I-VIII tubules from wild-type mice (data not shown).  
 
In the stage VIII LKB1
fl/fl
 tubule shown in Figure 4-13B, many sperm heads can still 
be seen embedded in crypts within the sertoli cell, with the cytoplasm distributed 
along the flagellum. They therefore appear more like the elongated spermatids shown 
in the wild-type stage V tubule in Figure 4-11A. By stage VIII the sperm heads 
should be positioned around the edge of the lumen, with the cytoplasm basal to the 
sperm head, ready to be released. This therefore gives the impression of asynchrony 
in the development of the different germ cell types in LKB1
fl/fl
 mice.  
 
Overall, no obvious qualitative differences were detected in the number of elongated 
spermatids visible in stage I to VIII tubules between wild-type and LKB1
fl/fl
 
seminiferous epithelium, or the numbers of round and elongating spermatids present 
in the appropriate stages. 
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Figure 4-13 LM images showing ‘failure of spermiation’ in LKB1fl/fl mice 
Representative seminiferous tubules are shown at stage VIII (A-B), when spermiation 
normally occurs; and stages IX, X, and XI (C-H), after spermiation has normally 
taken place. The stage numbers are shown to the right of the images. Sections from 
wild-type mice (WT) are displayed on the left, and show that there are no elongated 
spermatids present around the lumen after stage VIII. In tubules from LKB1
fl/fl 
(fl/fl) 
mice, shown on the right, elongated spermatids are visible around the lumen at all 
stages displayed. Elongated spermatids are identifiable by their darkly-staining, 
condensed nuclei. The nuclei of round and elongating spermatids are less deeply 
stained (scale bar = 20µm). 
WT LKB1fl/fl 
VIII 
IX 
X 
XI 
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4.2.10  Analysis of cell junctions 
The reason for the failure of spermiation is unclear. In order for spermiation to occur, 
the junctions between spermatid heads and sertoli cells, known as ectoplasmic 
specialisations , must break down (Russell, 1993). These ectoplasmic specialisations 
can be recognised at the EM level by the presence of deeply staining actin bundles 
around the spermatid heads. The regulation of these junctions is not well understood 
although a number of protein kinases have previously been shown to be involved 
(reviewed in Wong et al., 2008a). Analysis of ectoplasmic specialisation structures 
by TEM shows that they appear normal in LKB1
fl/fl
 mice. Figure 4-14A and 4-14B 
show the ectoplasmic specialisations around the nuclei of wild-type and LKB1
fl/fl
 
elongating spermatids (the abnormal head shape of an elongating spermatid in Figure 
4-14B will be discussed in the next section). However, it appears that they are not 
breaking down at the correct stage. Figure 4-14C shows elongated spermatids from a 
stage VII/VIII wild-type tubule just prior to spermiation. The excess cytoplasm has 
formed a ‘hood’ over the nucleus and the ectoplasmic specialisations are beginning 
to break down. Figure 4-14D shows a stage X tubule from a LKB1
fl/fl
 mouse. The 
spermatids should have been released by this stage but partial regions of the actin 
bundles from ectoplasmic specialisations can still be seen adjacent to the mature 
spermatid heads. This suggests that a defect in the breakdown of ectoplasmic 
specialisations is playing a role in the failure of spermiation.  
 
4.2.11  Defects in sperm head development 
Alternatively, the failure of spermiation may occur because the spermatids are 
abnormal in some way. This may be detected by the sertoli cells, which retain them 
within the seminiferous epithelium so that they can be removed by phagocytosis. 
Immunofluorescence studies of mature sperm taken from the cauda epididymis 
showed a number of abnormalities which may have their origins during 
spermatogenesis in the testis (section 4.2.4). These studies suggested that 
approximately 50% of sperm head shapes are abnormal in the LKB1
fl/fl
 mice. This 
may indicate that there is a problem with the elongation and condensation of the 
nucleus during spermiogenesis.  Although many heads in the LKB1
fl/fl
 sperm have a 
normal looking morphology during development, a number were observed with a 
very strange shape, as can be seen in Figure 4-14B. Analysis of elongating 
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spermatids by LM, suggests that overall more variation is present in the head 
morphology of LKB1
fl/fl
 sperm (Figure 4-13F) compared to wild-type sperm (Figure 
4-13E).  
 
 
 
Figure 4-14 Cell junctions between sertoli cells and spermatids 
Wild-type (A) and LKB1
fl/fl
 (B) elongating spermatids are shown. The actin bundles of  
ectoplasmic specialisations around the sperm heads can be clearly seen in both (indicated by 
arrows). One of the LKB1
fl/fl
 elongating spermatid nuclei has an abnormal morphology as 
indicated by a white asterisk ‘*’.  (C) Spermatids are shown around the lumen from a wild-
type stage VII tubule before spermiation. The residual spermatid cytoplasm can be seen 
around the spermatid head as a cytoplasmic lobe, ‘CL’. Although ectoplasmic specialisations 
are still visible around some spermatids (arrow), they are beginning to break down around 
others as indicated by an asterisk. (D) Spermatids are shown around the lumen from a stage 
X LKB1
fl/fl
 tubule. These spermatids should have been released at stage VIII. Areas of 
ectoplasmic specialisations are still visible around the retained spermatid heads as indicated 
by an arrow. 
WT LKB1fl/fl 
*
 
CL
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4.2.12  Acrosome development 
Another abnormality noted in the sperm immunofluorescence studies was that most 
sperm from LKB1
fl/fl
 mice had no acrosomal staining at all (Section 4.2.4). 
Therefore, acrosomal development was analysed to see if their formation was normal 
during spermiogenesis or whether they are becoming detached at a later point. 
Acrosomes are derived from vesicles budding from the golgi apparatus 
(proacrosomal granules). These fuse to form the acrosomal granule which makes 
contact with the nuclear envelope and spreads out over the surface of the nucleus 
(Abou-Haila and Tulsiani, 2000). In Figure 4-15, testis cryosections were stained 
with peanut agglutinin which stains the terminal β-galactosyl residues of 
glycoproteins in the acrosomal membrane (Mortimer et al., 1987). The results 
suggest that the acrosomes develop normally in LKB1
fl/fl
 mice. The left hand panel 
shows acrosomes at a very early stage of development (Figure 4-15 A,D). The 
acrosomal granule is visible as a round structure on the nuclear surface. Figure 4-15 
B and E show acrosomes forming on the nuclei of round spermatids. These have now 
flattened across the surface of the nucleus. In Figure 4-15 C and F, the acrosomes are 
seen on the nuclei of elongating spermatids. There are no obvious differences 
detected between the staining of the wild-type and LKB1
fl/fl
 tubules in terms of 
number of spermatids stained or the pattern of peanut agglutinin staining.  
 
Acrosomal development was also analysed by TEM. Figure 4-16A shows early 
acrosomal development in a step 4/5 round spermatid from a LKB1
fl/fl
 mouse. The 
golgi cisternae can be seen close to the surface of the nucleus producing new vesicles 
which are coalescing on the nuclear surface. The acrosomal granule is visible as a 
densely staining round structure. No obvious abnormalities were identified with this 
process.  Figure 4-16B shows a number of step 7 round spermatids in which the 
acrosome is seen spreading across the nuclear surface. This again shows no obvious 
abnormalities. The acrosome appears to remain attached to the nucleus as the nucleus 
elongates and condenses (as can be seen in the step 9 spermatids in Figure 4-14C), 
but then in later steps, when the nucleus appears fully condensed, many spermatid 
heads lose their acrosomes. Figure 4-16C and Figure 4-16D show this at lower and 
higher magnification respectively, the acrosomes appearing to ‘peel away’ from the 
Chapter 4 – The Role of LKB1S in Spermatogenesis 
 
122 
 
nuclear surface. The acrosomes often remain at the spermatid plasma membrane, 
attached to the sertoli cells, with the detached nucleus left surrounded by cytoplasm.   
 
 
 
 
 
Figure 4-15 PNA staining of acrosomal glycoproteins in testis sections 
Testis cryosections were incubated with Alexa 568-conjugated peanut agglutinin 
(red) which stains a specific glycoprotein within the acrosomal membrane. Nuclei 
were stained with DAPI (blue) and actin (used as a counter-stain) was stained with 
Alexa 488-conjugated phalloidin (green). Wild-type  sections are shown in the upper 
panel (A-C) with LKB1
fl/fl
 (fl/fl) below (D-F). Acrosomal development is shown at 
different stages of spermatogenesis; (A) and (D) show acrosomes at a very early 
stage of development; (B) and (E) show round spermatids in which the acrosome has 
spread across the surface of the nucleus; and (C) and (F) show acrosomes on 
elongated spermatids (Scale bar = 30µm). 
 
 
 
 
 
 
 
WT 
fl/fl 
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Figure 4-16 Acrosomal development in LKB1
fl/fl
 mice 
TEM images showing development of the acrosome in step 4/5 round spermatids (A) 
and step 7 round spermatids (B), in the seminiferous epithelium of LKB1
fl/fl
 mice. 
There are no obvious abnormalities at these steps. (C) and (D)  show step 14-16 
elongated spermatids at lower and higher magnification with acrosomes becoming 
detached from the nucleus. Representative images are shown, (Scale bars = 2µm). 
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4.2.13  LKB1 localisation in testis 
In order to determine whether LKB1S is also expressed in the epididymis and in 
mature sperm taken from the cauda epididymis, these were analysed by western 
blotting.  As can be seen in Figure 4-17, in wild-type sperm (lanes 7 and 8) a series 
of bands were detected between 48 kDa and 38 kDa.  Due to their molecular weight 
and their absence in LKB1
fl/fl
 sperm, it is tempting to conclude that these bands 
correspond to LKB1S. The multiple bands may be due to degradation of LKB1S by 
digestive enzymes released from the acrosome. Unfortunately, the LKB1S specific 
antibody was not sensitive enough to detect LKB1S in sperm.  There were no bands 
detected at 50 kDa, which may be because there is no LKB1L in mature sperm, or 
alternatively it may be below the level of detection, perhaps due to having been 
degraded. In lanes 3 and 4 of Figure 4-17, total epididymis lysate was blotted. In this 
case the epididymis was homogenised whole and therefore still contained sperm. A 
strong band was detected at the predicted size of LKB1L in wild-type and this was 
reduced in LKB1
fl/fl
 epididymis, probably as a result of the hypomorphic effect. A 
band was also detected at 48 kDa, although it is not clear whether this LKB1S 
originated from the epididymal epithelium, epididymal fluid or the mature sperm. To 
try and answer this question, the epididymis was chopped up and washed in order to 
remove as much sperm as possible before homogenisation. Lanes 5 and 6 of Figure 
4-17 show the results of this. A similar amount of LKB1L was detected after 
washing, indicating that this splice form may be expressed in epididymal tissue. A 
band at 48 kDa (LKB1S) was also still present in the washed, wild-type epididymis. 
It is unlikely, however, that the washing of the epididymis removed all of the sperm; 
therefore it is not clear whether the epididymal epithelium contains LKB1S or 
whether the 48 kDa band in lane 5 is from residual sperm.  
 
In order confirm the presence of LKB1S in mature sperm, LKB1S was 
immunoprecipitated from sperm lysates using the LKB1S antibody. LKB1 activity in 
the immune complexes was determined by the activation of recombinant AMPK in 
vitro. Significant LKB1S activity was detected in wild-type sperm (469 U/mg of 
lysate protein, where 1U is the activity of LKB1 required to activate recombinant 
AMPK by 1nmol/min/mg of protein) whereas no activity was detected in the sperm 
from LKB1
fl/fl
 mice.  
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The testes have a number of different cell types and it is possible that LKB1S and 
LKB1L are expressed in different ones. The finding that LKB1S is present in mature 
sperm lead us to hypothesise that LKB1S is also present in developing germ cells. In 
order to investigate this, immunhistochemistry was carried out on testis cryosections. 
However, the available antibodies were not sensitive enough to detect LKB1 by this 
means. Therefore, in situ hybridisation was performed in order to detect LKB1S and 
LKB1L mRNA. RNA probes were designed against the differing C-terminal ends of 
the proteins. However, no signal was detected using either the LKB1S or LKB1L 
probe. A number of modifications to the protocol were attempted but no signal was 
obtained. This work is ongoing in collaboration with Dr Lee Smith (MRC Human 
Reproductive Sciences Unit, Edinburgh). 
 
 
 
 
 
 
 
Figure 4-17 LKB1 expression in mature sperm and epididymis 
Testis, epididymis and mature sperm were analysed by western blotting with a 
monoclonal antibody raised against total LKB1. In lanes 1 and 2, wild-type and 
LKB1
fl/fl
 testis homogenates are shown for comparison. In lanes 3 and 4, 
epididymides were homogenized whole (with sperm still present). In lanes 5 and 6, 
epididymides were chopped up and washed to remove as much sperm as possible 
before homogenisation. Actin is shown as a loading control. Representative blots are 
shown for three individual mice and the migration of molecular mass standards are as 
indicated. 
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4.2.14  AMPK and ARK activities in LKB1fl/fl mouse testis 
In order to determine possible downstream substrates of LKB1S in testis, the activity 
of AMPK and various ARKs was compared in wild-type and LKB1
fl/fl
 mice. 
Antibodies raised against AMPKα1, AMPKα2, NUAK2, BRSK2, SIK1, SIK2, 
MARK3 and SNRK were used to immunoprecipitate the proteins from testis 
homogenates and activity in the immune complexes was determined using the 
AMARA peptide assay. The activity of other ARKs was not determined due to a lack 
of suitable antibodies.  Figure 4-18 shows the activity detected in LKB1
fl/fl
 testis as a 
percentage of wild-type activity. Of the eight kinases measured, the activities of 
AMPKα2, NUAK2, BRSK2 and SNRK were most reduced in LKB1fl/fl mice, by 
approximately 60-75% compared to wild-type.  
 
Interestingly, SNRK has previously been shown to be specifically expressed in testis 
(Jaleel et al., 2005), making it a potential candidate for an involvement in the 
infertility phenotype. That being said, another paper has reported that SNRK protein 
is expressed in the nucleus of rat cerebellar granule neurons (Yoshida et al., 2000). 
The activity of SNRK in testis, brain and liver was determined following 
immunoprecipitation with an antibody raised to the C-terminus of the SNRK protein. 
SNRK activity was detected in testis and brain, with very low activity detected in 
liver (Figure 4-19). In order to confirm these results, a western blot was carried out 
using the SNRK antibody to blot both crude tissue lysates and SNRK 
immunoprecipitates from tissues. However, high background meant the antibodies 
were unsuitable for this application.  
 
In order to further investigate the likelihood that SNRK is a downstream kinase for 
LKB1S in testis/sperm, SNRK was immunoprecipitated from mature sperm lysates 
from wild-type and LKB1
fl/fl 
mice, and its activity towards the AMARA peptide 
determined. As Figure 4-20 shows, SNRK activity was detected in wild-type sperm, 
but very little activity was detected in sperm lysates from LKB1
fl/fl
 mice. AMPKα1 
and AMPKα2 activities were also measured for comparison. AMPKα2 activity was 
reduced in LKB1
fl/fl
 mouse sperm by about 80% whereas AMPKα1 activity was 
reduced by less that 50% (Figure 4-20).   However, this assay was not repeated due 
to a limitation of SNRK antibodies and it was also not clear what was being 
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measured in the LKB1
fl/fl
 sperm homogenates. This is because there is very little 
mature sperm present in the LKB1
fl/fl
 epididymis and most of the luminal fluid of the 
cauda epididymis appears to be full of degrading cells of unknown identity. 
Therefore, although SNRK activity can be detected in mature sperm, it is hard to 
make any comparisons between the relative activities in wild-type and LKB1
fl/fl
 
mice. 
 
A SNRK mRNA probe was also used to localise SNRK within testis by in situ 
hybridisation, in order to see if there was any co-localisation between SNRK and 
LKB1S. However, as for LKB1 (section 4.2.13), the in situ hybridisation was 
unsuccessful, possibly due to problems with detection sensitivity. This work is 
ongoing. 
 
 
 
 
 
Figure 4-18 AMPK and ARK activities in LKB1
fl/fl
 mouse testis 
AMPKα1, AMPKα2, NUAK2, BRSK2, SIK1, SIK2, MARK3 and SNRK were 
immunoprecipitated from wild-type and LKB1
fl/fl 
testis homogenates (100µg or 
200µg total protein) using the appropriate antibodies bound to protein A- or protein 
G-sepharose. Activity in the immune complexes was determined using the AMARA 
peptide assay. Results are plotted as the mean ± S.E.M. from three individual mice. 
* indicates a statistically significant difference in activity in LKB1
fl/fl
 compared to 
wild-type samples (p<0.05 with Student’s unpaired t test). 
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Figure 4-19 SNRK activity in testis, brain and liver 
An antibody raised to the C-terminus of SNRK was used to immunoprecipitate 
SNRK from wild-type testis, brain and liver lysates (250µg protein). SNRK activity 
in the immune complexes was determined using the AMARA peptide assay. Results 
are plotted as pmol/min/mg of protein and are the mean ± range of two individual 
mice. 
 
 
 
 
 
Figure 4-20 SNRK, AMPKα1 and AMPKα2 activity in mature sperm 
Antibodies recognising SNRK, AMPKα1 and AMPKα2 were used to 
immunoprecipitate the proteins from mature sperm lysates from the cauda 
epididymis (100µg protein). Activity in the immune complexes was determined 
using the AMARA peptide assay. Results are from one experiment and are plotted 
as pmol/min/mg of protein. 
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4.3 Discussion 
In this study, the phenotype of mice lacking expression of LKB1S was investigated in 
order to elucidate what role LKB1S may be playing in vivo. The data presented have 
confirmed the lack of LKB1S expression in these mice and that the males are 
infertile. The causes of this infertility have been investigated. Overall, a major cause 
of the infertility appears to be an almost complete absence of sperm in the 
epididymis due to a defect in the release of mature sperm from the seminiferous 
epithelium of the testis.  During the collection of data presented in this thesis, another 
study was published on the preliminary characterisation of LKB1
fl/fl
 mice (Towler et 
al., 2008). Although reporting a similar sperm phenotype, the authors were unable to 
detect any abnormalities in the histology of the testes using hematoxylin and eosin 
staining.  
 
One disadvantage with the mouse model is that the LKB1
fl/fl
 mice also show reduced 
expression of LKB1L due to what has been termed the hypomorphic effect 
(Sakamoto et al., 2005). Quantification of the hypomorphic effect in testis, liver and 
brain suggested that LKB1L protein expression was reduced by over 80% in testis 
and liver and around 50% in brain; similar to the levels reported by Sakamoto et al. 
(2005). This group also showed that in skeletal muscle, heart and kidney, LKB1 
protein and activity were reduced by 80-90% (Sakamoto et al., 2005). The 
hypomorphic effect makes the phenotype of the LKB1
fl/fl 
mice harder to interpret 
because it is not clear whether the defects seen are a result of absence of LKB1S 
expression, downregulation of LKB1L expression, or a combination of both. In 
addition, there is also the possibility that some of the abnormalities seen in LKB1
fl/fl
 
testis are as a result of reduced LKB1 expression in other tissues, for example, 
tissues involved in gonadotropin secretion. Therefore, although it can be concluded 
that LKB1 does play a role in fertility, it cannot be certain that this is entirely due to 
the short splice variant. Despite this, there is good evidence to suggest LKB1S plays 
a significant role in spermatogenesis due to its high expression in testis and the fact 
that male infertility is the only overt phenotypic abnormality detected in these mice. 
An explanation for the lack of an observable phenotype caused by downregulation of 
LKB1L in other tissues is provided by previous studies, which suggest that LKB1 
may not be a rate limiting enzyme in cells (Sakamoto et al., 2005). Large reductions 
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in LKB1 and AMPK activity have been reported in tissues without significant 
reduction in the phosphorylation of downstream substrates. For example, although 
knockout of LKB1 specifically in the liver of mice is lethal by 21 days, there are no 
significant phenotypic differences detected between wild-type and LKB1
fl/fl
 animals, 
even though LKB1L expression in liver is reduced by approximately 85% (A. 
Woods, unpublished observations) (Sakamoto et al., 2005). This suggests that 
LKB1/AMPK may be present in excess compared to downstream substrates or that 
these enzymes have a high KCat. 
 
As LKB1 is present as a heterotrimer in cells with STRAD and MO25, the 
expression of these proteins in testis was also investigated by western blotting. 
Whereas the expression of MO25α was not significantly altered in the LKB1fl/fl mice, 
the expression of STRADα was reduced by approximately 50%. A possible reason 
for this may be that the STRADα protein is unstable in the absence of LKB1. 
 
Sperm from the cauda epididymis of LKB1
fl/fl
 mice were immotile and abnormal in 
terms of morphology, for example, often showing coiled and fragmented tails, 
absence of an acrosome and abnormal head shapes. In addition, numbers of mature 
sperm from the cauda epididymis were reduced by approximately 99% compared to 
wild-type, as also reported by Towler et al. (2008). Therefore, the question as to 
whether sperm are actually being made during spermatogenesis or whether they are 
degraded during transit through the epididymis was investigated. Microscopic studies 
of the caput epididymis (where sperm first enter after leaving the testis) showed that, 
like the cauda epididymis, sperm numbers were very low suggesting that the problem 
arose during spermatogenesis in the testis. Testis weight gives an indication of the 
number of germ cells present and if there is a severe disruption of spermatogenesis 
(Russell et al., 1990). If there is a block in spermatogenesis, certain generations of 
germ cells can be completely absent. However, testis weight was not altered in 
LKB1
fl/fl
 mice and, in addition, analysis of testis histology did not show any obvious 
reductions in different germ cell types. However, as no quantitative analysis was 
performed, it cannot be ruled out that a more thorough analysis will show differences 
in numbers of certain germ cell generations.  
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The release of mature sperm into the lumen of the seminiferous tubules occurs at 
stage VIII of spermatogenesis (Russell, 1993). Analysis of tubules at different stages 
of the spermatogenic cycle indicated that spermiation was not occurring at the 
correct stage in the LKB1
fl/fl
 mice. Deeply staining elongated spermatid nuclei could 
be seen in the adluminal compartment of all LKB1
fl/fl
 seminiferous tubules whereas 
in normal mice spermiation results in an absence of elongated spermatids in tubules 
in the two or three stages following spermiation. However, it was not clear whether 
there is just a delay in spermiation or whether most spermatids are never released. 
The relative absence of sperm reaching the epididymis would suggest the latter and 
that the sperm are instead phagocytosed by the sertoli cells. This is also supported by 
the observation of many deeply staining degenerating elongate spermatids around all 
observed tubule lumens. These resemble residual bodies but usually at least one 
nucleus and flagellum is present within them. They are often multinucleate 
suggesting the cytoplasm from adjacent spermatids has fused together. It is likely 
therefore, that a failure of spermiation accounts for the apparent disorganised 
appearance of the luminal region of the seminiferous epithelium due to degrading 
spermatids and that most spermatids are never released and instead degrade and fuse 
together, eventually to be phagocytosed by the sertoli cells.   
 
Multinucleated cytoplasmic bodies similar to those in LKB1
fl/fl
 mice have been 
reported previously, for example, in hormone sensitive lipase (HSL) deficient mice 
(Chung et al., 2001). However in the case of HSL deficient mice, multinucleation 
was observed from early spermatid generations whereas in the case of LKB1
fl/fl
 mice 
it is only the late spermatids that appear multinucleated. The authors report that a 
defect in the integrity of cytoplasmic bridges between neighbouring spermatids 
results in them fusing together, which they suggest may be due to disrupted 
cholesterol metabolism (Chung et al., 2001). It cannot be ruled out that cytoplasmic 
bridges are disrupted in LKB1
fl/fl
 mice causing the large cytoplasmic bodies. 
Interestingly, HSL has previously been identified as a target for AMPK 
phosphorylation at serine-565 in adipose tissue and skeletal muscle, although this has 
been shown to inhibit HSL activity (Daval et al., 2005; Sullivan et al., 1994; Watt et 
al., 2006). 
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So what might be the reason for this apparent failure of spermiation? The regulation 
of spermiation is still poorly understood. A number of processes thought vital for 
efficient spermiation have been identified (Russell, 1993). These are as follows: 
translocation of germ cells to the luminal edge; relocalisation and removal of residual 
cytoplasm; breaking down of the sertoli:germ cell adherens junctions, known as 
ectoplasmic specialisations ; formation and removal of tubulobulbar complexes; and 
the final disengagement of the germ cells into the lumen.  
 
In terms of the first step, the spermatids must be translocated from the blood-testis 
barrier to the luminal edge of the seminiferous epithelium so that they are in a 
position to be released at spermiation. It has been suggested that this process is due 
to the association of the ectoplasmic specialisation with microtubule motor proteins 
within the sertoli cells which are then involved in transporting the junctions and 
therefore germ cell to the lumen (Guttman et al., 2000). Interestingly, whereas in 
stage VII and VIII tubules from wild-type mice the elongate spermatids are aligned 
around the lumen ready for release, in tubules from LKB1
fl/fl 
mice many elongate 
spermatids still appear to be buried within the seminiferous epithelium and it is 
possible that this is due to problems with the translocation process. An alternative 
explanation is that the buried spermatids are in the process of being translocated by 
the sertoli cells towards the basement membrane during phagocytosis. This will 
require further investigation to determine whether these spermatids are found within 
the sertoli cell cytoplasm to show they have been phagocytosed. In addition, the fact 
that the cytoplasmic bodies are only found around the lumen is interesting as often 
residual bodies are translocated from the lumen towards the basement membrane 
during phagocytosis by the sertoli cells. A previous paper that used taxol to stabilse 
microtubules in the sertoli cells also reported that translocation of residual bodies 
was blocked and it is interesting to speculate that microtubule dynamics could be a 
cause of this phenomenon in LKB1
fl/fl
 mice (Russell et al., 1989). The regulation of 
microtubule dynamics is something that LKB1 has previously been implicated in via 
the MARK family of ARKs (Drewes et al., 1997; Kojima et al., 2007). The 
possibility that a defect of spermatid translocation is occurring in LKB1
fl/fl
 mice will 
require further investigation.  
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Many reports of mouse models showing a failure in spermiation have suggested that 
there is a defect in the breakdown of the ectoplasmic specialisations between the 
sertoli cells and sperm heads. The main membrane components of these testis-
specific adherens junctions are; cadherin/catenin, nectin/afadin, integrin/laminin, 
junctional adhesion molecule-C/zonula occludens-1, and coxsackie and adenovirus 
receptor (CAR) complexes. Adaptor proteins link these membrane proteins to the 
actin cytoskeleton (reviewed in Wong et al., 2008a; Yan et al., 2007). Analysis of the 
junctions around retained spermatids in the LKB1
fl/fl
 mice by TEM suggests that 
these junctions are still present, as identified by actin filament bundles adjacent to the 
spermatid heads. The mechanism by which these juctions are regulated is still not 
well understood. A number of peripheral protein kinases and phosphatases have been 
shown to associate with them, such as the tyrosine kinase c-Src, focal adhesion 
kinase and myotubularin related protein-2, a lipid/protein phosphatase (Siu et al., 
2003; Wong et al., 2005; Zhang et al., 2005). A recent paper also implicated 
members of the 14-3-3 (PAR5) protein family in recruiting proteins to the apical 
ectoplasmic specialisation and acting as a scaffold (Sun et al., 2009).  In addition, 
special germ cell cytoplasmic extensions known as tubulobulbar complexes have 
been suggested to play a role in the breakdown of the junctions (Guttman et al., 
2004). Whether these are forming properly in the LKB1
fl/fl
 mice remains to be 
investigated.   
 
Interestingly, LKB1 has previously been implicated in the regulation of tight 
junctions and adherens junctions (Amin et al., 2009; Hezel et al., 2008; Zheng and 
Cantley, 2007) and it is therefore tempting to speculate that LKB1 may play a role in 
junction dynamics in testis. In the drosophila eye, loss of LKB1 was shown to cause 
an expansion of adherens junctions (Amin et al., 2009), whereas in the LKB1-
deficient pancreas of mice, tight junctions and adherens junctions were absent (Hezel 
et al., 2008). Furthermore, LKB1 phosphorylation of some of the ARKs has been 
shown to regulate their binding to 14-3-3 (Al-Hakim et al., 2005). The PAR3/PAR6 
polarity complex has been implicated in ectoplasmic specialisation restructuring and 
spermiation (Wong et al., 2008b), and it is interesting to note that PAR1, the 
homolog of the mammalian MARK kinases which are substrates of LKB1 (Lizcano 
et al., 2004), has been shown to phosphorylate PAR3 to induce 14-3-3 binding in 
drosophila (Benton and St Johnston, 2003). Whether disregulation of these proteins 
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are involved in the phenotype of the LKB1
fl/fl
 mouse model remains to be 
determined.  
 
It is also possible that there is a defect in the removal of residual cytoplasm from the 
spermatids. This could be a reason why spermatid heads and tails around the lumen 
often appear buried in large amounts of cytoplasm. If the cytoplasmic lobes are not 
released properly from the spermatids, they may become fused together with the 
spermatids still attached. In normal spermatogenesis, during stage VII the cytoplasm 
around the flagellum relocates to lie adjacent to the spermatid head forming a hood 
like structure over the head, connected to the neck region. This is called the 
cytoplasmic lobe and is detached from the spermatid just before the spermatids are 
released into the lumen (Beardsley and O'Donnell, 2003). More work is required to 
determine if this process in disrupted in LKB1
fl/fl
 mice. Excess retained cytoplasm 
could also be an explanation for the detachment of the acrosomes from sperm nuclei. 
Incubation of testis sections with peanut agglutinin, which stains the acrosomal 
membrane, showed that the acrosomes did initially form on the surface of sperm 
nuclei and acrosomal development also appeared normal in TEM images. Acrosomes 
remained attached during spermiogenesis and then appeared to ‘peel off’ the nuclei 
of many late spermatids. A similar phenomenon of acrosome detachment has also 
been reported in mice that have a deletion of histone H1 variant, H1T2. The authors 
suggested that, in the case of H1T2 deletion, this is due a defect in the elimination of 
residual cytoplasm during elongation. This pulls the outer membrane, with the 
acrosome attached, away from the sperm head (Martianov et al., 2005). This is 
similar to the situation in LKB1
fl/fl
 mice where the detached acrosome usually stays 
attached to the outer membrane, with the ectoplasmic specialisation still visible 
linking it to the sertoli cells.  Alternatively, the reason for the detached acrosomes 
could be that there is a problem with the attachment of the acrosome to the spermatid 
nucleus or that the retained spermatids are degraded and therefore the acrosome has 
become detached.  
 
Overall, there are a number of processes that may be disrupted in the LKB1
fl/fl
 mice 
which cause the failure of spermiation, and further investigation of this provides a 
focus for future work in this area. It was apparent that the few sperm that do reach 
the epididymis are often abnormal in terms of morphology suggesting that problems 
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in spermiogenesis may have occurred prior to the defect in spermiation. In 
immunofluorescence studies of mature sperm from the cauda epididymis, the sperm 
tails often appeared either coiled or fragmented and often detached from the sperm 
heads, although TEM images of sperm tails suggested no overt abnormalities in 
structure. The tail coiling and fragmentation may be because of degradation within 
the epididymis. Around half of the sperm heads possessed a normal falciform 
morphology, whereas the rest showed variations in shape ranging from completely 
deformed to more subtle abnormalities. This is in contrast to the study looking at 
LKB1
fl/fl
 mice by Towler et al., (2008) in which it was reported that all sperm heads 
possessed a rounded morphology. This may be due to the different genetic 
background of the mice. Spermatids with abnormal head shapes were apparent 
within the seminiferous epithelium by LM and TEM. This may be due to defects in 
polarity, something that LKB1 has previously been implicated in (Baas et al., 
2004b).  Spermatid head shaping has also been shown to rely on the microtubular 
manchette, a ring of microtubules around the nucleus (Cole et al., 1988). As 
mentioned previously, LKB1 has been implicated in the regulation of microtubule 
dynamics (Kojima et al., 2007). Therefore, it is possible that sertoli cells are able to 
detect that the spermatids are abnormal and therefore retain them for phagocytosis. 
However, is not clear whether the abnormalities in spermatid morphology would be 
enough to cause a failure of spermiation. It may be that various mechanisms are 
responsible for the phenotypic defects seen in LKB1
fl/fl
 mice.  
 
In addition to an almost complete lack of mature sperm in the lumen of the cauda 
epididymis, the luminal fluid appears very dense. The abnormalities detected in the 
epididymis may be secondary to the abnormalities detected in the testis. It has 
previously been suggested that factors secreted into the lumen of the testis can have a 
major effect on epididymal function. This has been termed the ‘Lumicrine effect’, 
(Hinton et al., 1998) (reviewed in Cornwall, 2009). Studies have also suggested that 
sperm themselves can affect gene expression in the epididymal epithelium and the 
proteins it secretes (Garrett et al., 1990; Reyes-Moreno et al., 2008) (reviewed in 
Cornwall, 2009), and so the relative absence of sperm in LKB1
fl/fl 
mice may affect 
this.  It is also possible that the abnormalities of the luminal fluid could be the result 
of a build-up of the breakdown products from degraded sperm. The round bodies 
apparent in the lumen are likely to be degraded germ cells and the presence of many 
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round cells and cytoplasmic fragments in the caput epididymis suggested that 
sloughing of immature germ cells and sertoli cell cytoplasm may be occurring. The 
reasons for this are not clear, although it could indicate problems with cell junction 
integrity in the testis. AMPK has also been implicated in the regulation of the 
epididymal V-ATPase which is involved in acidification of the luminal fluid 
(Hallows et al., 2009) and it is possible that disregulation of this ion transporter is 
contributing to the epididymal phenotype.  
 
Although in this study, LKB1S was shown to be present in mature sperm from the 
epididymis, the cell type in which LKB1S is present in testis could not be determined, 
i.e., if it is also present in developing germ cells.  However, during the preparation of 
this thesis, a study by Towler et al., (2008), investigated this. LKB1 expression was 
studied in rats of different ages corresponding to different developmental stages of 
the male reproductive system when different germ cell generations begin to appear. 
They were unable to detect LKB1S protein expression in rat testis prior to 28 days, 
i.e., before meiosis begins to produce haploid spermatids, but in 30 day and 60 day 
rat testis, LKB1S was detected. This suggests that LKB1S is expressed in post-
meiotic germ cells. In addition, no LKB1S was detected by western blotting of sertoli 
and leydig cells, but was clear in isolated germ cells from 31 day old mice (much less 
in 26 day old mice). In addition to rat and mouse testis, it was shown that both 
LKB1S and LKB1L were present in human testis by western blotting, as also 
suggested by the PCR data presented in this thesis. 
 
So what could be the downstream kinase for LKB1 in testis? Of the 14 Kinases 
shown previously to be substrates of LKB1, there have been few studies 
characterizing the tissue distribution of the proteins. So far, AMPKα1/α2 (Cheung et 
al., 2000), BRSK1/2 (Lizcano et al., 2004), SNRK (Jaleel et al., 2005) and NUAK2 
(Lefebvre and Rosen, 2005) proteins have been shown to be present in testis. In the 
current study, activity was detected for a number of ARKs in testis. Comparison of 
the relative activities of AMPK and several other related kinases in wild-type and 
LKB1
fl/fl
 testis showed that, perhaps unsurprisingly, the activities were all reduced. 
The greatest reductions in activity were seen for BRSK2, NUAK2 AMPKα2 and 
SNRK. However, due to there being a number of different cell types in testis it is 
hard to draw any firm conclusions. For example, in wild-type mice some kinases 
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may be expressed in a number of different cell types that normally express different 
relative amounts of LKB1L and LKB1S. If the activity of one kinase was completely 
lost in developing sperm due to the absence of LKB1S, it may still be highly 
expressed and active in another cell type where LKB1L is still present, thus masking 
the loss in germ cells.  
 
Interestingly, SNRK has previously been suggested to be testis-specific in rats (Jaleel 
et al., 2005) making this a potential candidate for playing a part in the infertility 
phenotype. The data presented in this thesis suggest that SNRK is present and active 
in mature sperm along with LKB1S. It will be interesting to determine if both are 
present in developing germ cells in testis. Comparison of SNRK activity in wild-type 
and LKB1
fl/fl
 testis suggest that activity is reduced by approximately 50% in LKB1
fl/fl
 
mice.  However, preliminary results presented here suggest that SNRK may not be 
testis-specific in mice. Previous papers have also reported that SNRK may play a 
role in apoptosis of cerebellar granule neurons in rats (Yoshida et al., 2000). 
Comparison of SNRK activity in testis, liver and brain suggested that the activity in 
brain was very similar to that detected in testis, with very low activity in liver. 
Further studies are therefore needed to clarify the tissue distribution of SNRK.  
 
LKB1 has previously been described as a ‘master kinase’ with many different 
functions. It is therefore very possible that a number of downstream kinases and 
pathways are affected in LKB1
fl/fl
 mouse testis. BRSK1, BRSK2 and NUAK2 
knockout mice have been made but there are no reports of them showing any fertility 
defects (Kishi et al., 2005; Tsuchihara et al., 2008). MARK2 knockout males and 
females on the other hand, do show reduced fertility. The male defect in fertility 
however, is only apparent when males are crossed with homozygous females. Unlike 
LKB1
fl/fl
 mice, there were no reported reductions in sperm concentration or motility, 
and sperm and testis morphology were normal. Testis and ovary weights were 
reduced and some histological abnormalities in ovaries and uterus were observed. 
Serum testosterone levels were normal, but intra-testicular testosterone was reduced 
(Bessone et al., 1999). Reductions in intra-testicular testosterone have previously 
been implicated in spermiation defects (Beardsley and O'Donnell, 2003; Saito et al., 
2000), so it will be important to determine if levels are reduced in LKB1
fl/fl
 mice.  
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There was no visible sperm phenotype shown by mice heterozygous for the floxed 
allele, even though only 50% of germ cells after meiosis will have a functional 
LKB1S allele. This is probably due to the fact that spermatids derived from a single 
spermatogonium remain connected to each other by cytoplasmic bridges through 
which mRNA transcripts are shared until late in differentiation (Braun et al., 1989; 
Dym and Fawcett, 1971).  Therefore, all spermatids are likely to contain the LKB1S 
transcript, albeit probably in reduced amounts. If this is the case, it does show that 
there is no haploinsufficiency for LKB1S. Nonetheless, the fact that LKB1
fl/fl
 mice 
appear to be born at a reduced mendelian frequency than expected, as also reported 
by Sakamoto et al., (2005), could imply that the haploid sperm carrying the LKB1
fl 
allele have a reduced fitness compared to sperm with the wild-type LKB1 allele. It is 
not clear what stage this reduced viability occurs and it may be that there is a 
reduction in embryo viability, or that the mice die very shortly after birth. A previous 
paper implicating LKB1 in placental development may explain reduced embryo 
survival (Ylikorkala et al., 2001). 
 
Overall, the phenotype of LKB1
fl/fl
 mice is most similar to the human condition of 
oligoasthenoteratozoospermia, meaning that sperm counts, motility and normal 
morphology fall below certain defined parameters (Cooke and Saunders, 2002). In 
the case of LKB1
fl/fl
 mice, the data suggest that this may to due to a defect in the 
process of sperm release from the seminiferous epithelium. It is possible that similar 
mechanisms such as this account for human conditions of infertility.  
Chapter 5 - Summary 
139 
 
5 Summary and Future Perspectives 
The work presented in this thesis identifies a novel alternative splice variant of LKB1 
which is highly expressed in testis. This new splice variant (LKB1S) differs from the 
originally identified form of LKB1 (LKB1L) only at the C-terminus of the protein. 
The function of LKB1S has been investigated in cells and in vivo. 
 
In chapter 3, the splice forms were compared in terms of their general biochemical 
properties. The main finding from this work was that the splice variants are very 
similar in terms of their catalytic activities and localisation. Both forms are also able 
to form an active complex with STRADα or STRADβ and MO25α in cells. Recent 
studies have suggested that different STRAD isoforms and splice variants may 
differentially affect the localisation and/or activity of LKB1 (Dorfman and Macara, 
2008; Marignani et al., 2007). Although this requires further investigation, including 
an analysis of the tissue distribution of different STRAD variants, it may be that 
LKB1L and LKB1S have different interactions with different STRAD variants in 
vivo. There are also two isoforms of MO25 (α and β) (Hawley et al., 2003), and the 
physiological relevance and tissue distribution of these variants also remains to be 
investigated. 
 
The C-terminus of LKB1L contains conserved regions that are post-translationally 
modified. The phosphorylation at S428 was investigated to determine if it affected 
LKB1L catalytic activity and therefore if it could potentially lead to functional 
differences between the splice variants. Studies presented here and by others (Collins 
et al., 2000; Fogarty and Hardie, 2009), suggest that phosphorylation at this site does 
not directly affect LKB1 activity, or its localization. It remains to be determined 
whether phosphorylation at this site has a role in specific cell types under certain 
conditions. There is some evidence that this may be the case, for example in neurons 
phosphorylation has been implicated in axon initiation (Barnes et al., 2007; Shelly et 
al., 2007). In addition, phosphorylation of this site has been reported to alter sub-
cellular localization of LKB1 in endothelial cells, increasing apoptosis (Song et al., 
2007; Song et al., 2008). Overexpression of LKB1S in these cell types may be useful 
to determine if it is able to play a role in these processes.  
Chapter 5 - Summary 
140 
 
The role of farnesylation at C430/433 also remains to be determined. One study 
suggested that LKB1S may be localised at cell membranes even though it lacks this 
farnesylation site (Towler et al., 2008). LKB1 has also been shown to be acetylated 
at a number of sites and this was proposed to alter its interaction with STRAD, 
localisation and activity (Lan et al., 2008). The sites identified as being acetylated 
included K416, K423 and K431 in the C-terminal region of human LKB1L. There is 
only one lysine residue within the C-terminus of mouse and human LKB1S and 
whether this is acetylated requires further investigation. Interestingly, K431 is in the 
CAAX motif, and therefore there may be interactions between these two post-
translational modifications. A thorough understanding of the role of acetylation of 
LKB1 will be required in order to determine whether differences affect the functions 
of the two splice variants in vivo. 
 
In chapter 4, the phenotype of mice deficient in LKB1S expression were 
characterised. Overall, these studies showed that spermatogenesis is disrupted 
leading to male infertility. Although, the specific localisation of LKB1S in testis was 
not determined, another study has suggested that LKB1S is most highly expressed in 
post-meiotic, developing spermatids (Towler et al., 2008). In support of this, 
abnormalities were first detected during this post-meiotic phase of sperm 
development in the current study. Further studies using immunohistochemistry, in 
situ hybridisation or laser capture microdissection to separate individual cell types, 
will help further delineate the expression patterns of the two splice variants in testis. 
 
Analysis of testis histology at various stages of the spermatogenic cycle showed that 
there is a defect in the release of mature sperm from the seminiferous epithelium. 
Analysis of the spermatid:sertoli cell adherens junctions (ectoplasmic specialisations) 
suggested that these were not breaking down at the correct stage, although 
morphologically they looked normal. A possible reason for this is that there is a 
dysregulation in the proteins that are involved in their regulation (Wong et al., 
2008a). LKB1 itself has previously been implicated in the regulation of tight 
junctions and adherens junctions (Amin et al., 2009; Hezel et al., 2008; Zheng and 
Cantley, 2007). Members of the PAR family of kinases have also been implicated in 
junction formation (Ohno, 2001), including ectoplasmic specialisations in rat testis 
(Wong et al., 2008a). One possible way to investigate whether LKB1 is playing a 
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role in the regulation of ectoplasmic specialisations would be to co-culture sertoli 
cells and germ cells. This leads to the spontaneous formation of cell junctions such as 
ectoplasmic specialisations (Siu et al., 2005).  Knockdown of LKB1 expression or 
ARKs would allow the study of ectoplasmic specialisation dynamics in the absence 
of these proteins. Spermiation is not a well-understood process, so the identification 
of proteins involved in its regulation will be informative. 
 
Withdrawal of reproductive hormones such as follicle stimulating hormone and 
testosterone have previously been shown to inhibit spermiation (Beardsley and 
O'Donnell, 2003; reviewed in McLachlan et al., 2002; Saito et al., 2000).  Seminal 
vesicle size and mating activity can give an indication of whether serum testosterone 
levels are disrupted in mice (Cunha et al., 1992).  LKB1
fl/fl
 mice did attempt to mate 
and the visual assessment of seminal vesicle size did not show any obvious 
differences in morphometry. However, measurement of testosterone, follicle 
stimulating hormone and luteinising hormone in the serum, as well as intratesticular 
testosterone, using ELISA or radioimmunoassay, will be required to determine if 
there are any disruptions.  
 
Studies of LKB1 in various other cell types have implicated the kinase in three key 
processes: polarity, energy metabolism and cell proliferation (reviewed in 
Shackelford and Shaw, 2009). It is possible that one or more of these processes is 
disrupted in LKB1
fl/fl
 mice. For example, the sperm is a very polarised structure and 
initial histological studies of LKB1
fl/fl
 mice suggests that there could be defects in the 
relocation and detachment of residual cytoplasm at around the time of spermiation. 
In terms of energy metabolism, AMPK has previously been implicated in the 
provision of lactate to germ cells, their main energy source, via the regulation of 
glucose and lactate transporters on the surface of sertoli cells (Galardo et al., 2007) 
(Riera et al., 2009). Whether these processes are disrupted in LKB1
fl/fl
 mice requires 
further investigation. Overall, there was no obvious visible defect in mitosis or 
meiosis, but abnormalities here cannot be ruled out. 
 
Analysis of the relative activities of AMPK and ARKs in wild-type and LKB1
fl/fl
 
testis showed that the activities of all those investigated were reduced. The 
downstream kinase(s) of LKB1that are involved in spermatogenesis, however, 
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remain unclear. In order to investigate this further, one possibility would be to make 
knockout mice of individual ARKs to determine if they show fertility defects. 
Knockout of SNRK would be an obvious candidate for initial studies due to its high 
expression in testis (Jaleel et al., 2005). Embryonic stem cells carrying a targeted 
allele for deletion of SNRK are available from the Knockout Mouse Project 
Repository (California, USA) which could be used to generate a global deletion of 
SNRK. However, it is possible that dysregulation of a number of downstream 
kinases may be involved in the phenotype of LKB1
fl/fl
 mice. To further elucidate the 
downstream pathways of LKB1S in testis, a microarray has been performed in 
collaboration with Unilever Discover, UK, to compare RNA expression in wild-type 
and LKB1
fl/fl
 mice. A summary of the data is shown in appendix 2 and analysis of 
this data is ongoing. 
 
The question remains as to why there is expression of an alternative splice variant of 
LKB1 in testis? Testis specific proteins are common. They include those that are 
transcribed from genes unique to the testis, and testis-specific transcripts produced 
by the use of alternative promoters, alternative polyadenylation or by splicing (Eddy, 
2002). Alternative splicing itself is common in testis compared to other tissues (Yeo 
et al., 2004), although one suggestion for this is increased splicing errors because a 
lot of transcripts are not conserved across species (Kan et al., 2005). LKB1S, on the 
other hand, has been detected in rat, mouse and human testis (Towler et al., 2008). 
One functional reason for high numbers of testis specific proteins is due to the 
complex germ specific processes that are not present in other tissues (Eddy, 1998). 
Addition of new domains to proteins may allow for new functions or subcellular 
localisation (Eddy, 2002). Another reason for testis-specific transcripts is that there 
are differences in secondary structure, length of the poly-A tail or interactions with 
RNA binding proteins, which allow them to be efficiently post-transcriptionally 
regulated (Hecht, 1998). Post-transcriptional regulation is important in testis because 
transcription ceases half way through spermiogenesis as the chromatin condenses. 
Therefore, mRNA is often stored to be translated at a later point. RNA-binding 
proteins are thought to be important in this process of translational regulation and 
often bind to the 3’ or 5’ UTR (Hecht, 1998). 
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In terms of LKB1 splicing in testis, whilst there is 98% identity between the regions 
encoded by exons I to VIII in mouse and human LKB1, there is only 36% identity 
between the regions coded by exon IXa (LKB1S).  This low conservation may suggest 
the region encoded by exon IXa is not playing an important function. The similar 
biochemical properties between the two splice variants supports the theory that the 
splice forms are functionally equivalent. Splicing may simply be the by-product of a 
specific component of splicing regulators in testis that are not present in other tissues 
(Hecht, 1998). However, it cannot be ruled out that LKB1S does have a specific role 
in testis, or that the region encoded by exon IXb plays a deleterious function and so 
removal of this is preferable. Alternatively, RNA structure, stability or interactions 
with RNA binding proteins may differ between the splice variants. Therefore, the 
function of LKB1S may be at the mRNA level rather that the protein level. 
 
Overall, an understanding of the biochemical properties and regulation of the short 
splice variant may provide insights into the possible function of the C-terminus of 
LKB1 which, in LKB1L, contains a number of conserved regions. Due to the role of 
LKB1 in cancer and its potential link to metabolic diseases such as type 2 diabetes, 
an understanding of this will be valuable. The recent crystal structure of the LKB1 
heterotrimer only included residues 43 to 347 of LKB1, hence this C-terminal region 
was absent (Zeqiraj et al., 2009a). Studies of the role of LKB1 in spermatogenesis 
could provide insights into possible molecular mechanisms behind human infertility. 
At present, IVF is the main technique available to cope with male infertility but it has 
many drawbacks, for example, it is expensive, often unsuccessful and can be very 
traumatic for the couple (Cooke and Saunders, 2002). Therefore, understanding some 
these mechanisms will be invaluable in the generation of new therapies. In addition, 
other than vasectomy there are at present no completely reliable male contraceptives. 
Hormonal based male contraceptives have been developed but these often have 
undesirable side effects. Testis specific proteins such as LKB1s or downstream 
substrates such as SNRK, that may play a specific role in spermiation could be 
attractive targets for male contraceptives (reviewed in Cheng and Mruk, 2002; Mruk, 
2008).  
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Appendix 1 Table of oligonucleotide primers used for the amplification 
of cDNA by PCR. FLAG tag sequences are shown in red.  
 
 
 
cDNA Construct Direction Sequence (5’- 3’) 
Human LKB1S 
(FLAG) 
Forward  
AAGCTTGAATTCATGGATTATAAAGATGATGACGATAAA 
GCCATGGAGGTGGTGGACCCGCAG 
Reverse TCTAGACTAGTCTCGAGCTACTGCGGCGCCGGCCGAGAGG 
Mouse LKB1S 
(FLAG) 
Forward  
AAGCTTGAATTCATGGATTATAAAGATGATGACGATAAA 
GCCATGGACGTGGCGGACCCCGAG 
Reverse TCTAGACTAGTCTCGAGCTACACTAAAGCCCCAAACCCC 
Human LKB1L 
(mCherry) 
Forward  AGATCTAAGCTTCTATGGAGGTGGTGGACCCG 
Reverse TTGAATTCGGTACCTCACTGCTGCTTGCAGGC 
Human LKB1S 
(mCherry) 
Forward  AGATCTAAGCTTCTATGGAGGTGGTGGACCCG 
Reverse TTGAATTCGGTACCCTACTGCGGCGCCGGCCG 
Human STRADβ 
(FLAG) 
Forward  
AGATCTGGTACCATGGACTACAAGGACGACGATGACAA 
GTCTCTTTTGGATTGCTTCTGC 
Reverse CGTCTAGACTAGTCTCGAGCTAGAATTCCCAGTATGAGTC 
Mouse LKB1 S431A 
(site directed mutagenesis) 
Forward  GATCCGCCGGCTCGCGGCCTGCAAGCAG 
Reverse CTGCTTGCAGGCCGCGAGCCGGCGGATC 
Mouse LKB1 S431E 
(site directed mutagenesis) 
Forward  GATCCGCCGGCTCGAGGCCTG 
Reverse CTGCTTGCAGGCCTCGAGCCGGCGGATC 
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Appendix 2 Microarray Analysis  
 
Table showing differential gene expression in the testis of wild-type versus 
LKB1
fl/fl
 mice 
Microarray analysis was carried out to determine changes in gene expression in the 
testis of LKB1
fl/fl
 mice compared with that of wild type. Those genes with a fold 
change (FC) of greater than 1.5 compared with wild type and a p < 0.01 are listed. 
The accession numbers are shown in brackets. Negative values refer to decreased 
expression in LKB1
fl/fl
 relative to wild-type. 
 
 
Gene Name Description FC p value
Usp44 Ubiquitin specific peptidase 44, [NM_183199] 25.66 7.37E-05
Ntn4 Netrin 4, [NM_021320] 13.59 3.04E-04
Rtkn2 Rhotekin 2, [AK045134] 6.70 1.47E-07
Eva1 Epithelial V-like antigen 1, [NM_007962] 6.27 7.56E-04
Robo4 Roundabout homolog 4 (Drosophila), [NM_028783] 4.90 6.48E-03
Hal Histidine ammonia lyase, [NM_010401] 4.34 2.90E-03
Klrb1a Killer cell lectin-like receptor subfamily B member 1A, [NM_010737] 3.81 3.08E-03
Cadps Ca2+ dependent activator protein for secretion, [NM_012061] 3.59 6.47E-04
Atf3 Activating transcription factor 3, [NM_007498] 3.51 5.80E-03
Padi2 Peptidyl arginine deiminase, type II, [NM_008812] 3.41 1.84E-03
Tcra T-cell receptor alpha chain precursor V-J region, [AK037357] 3.23 1.55E-03
Lcp1 Lymphocyte cytosolic protein 1, [NM_008879] 2.99 6.67E-03
Slc6a8 Solute carrier family 6, member 8, [NM_133987] 2.84 6.51E-03
Rab3b RAB3B, member RAS oncogene family, [NM_023537] 2.75 2.37E-03
Cfi Complement component factor I, [NM_007686] 2.70 2.37E-03
Prss12 Protease, serine, 12 neurotrypsin (motopsin), [NM_008939] 2.31 5.80E-03
Timp3 Tissue inhibitor of metalloproteinase 3, [NM_011595] 2.20 2.07E-03
P2ry2 Purinergic receptor P2Y, G-protein coupled 2, [NM_008773] 2.15 5.80E-03
Phlda1 Pleckstrin homology-like domain, family A, member 1, [NM_009344] 2.09 5.80E-03
Insc Inscuteable homolog (Drosophila), [NM_173767] 2.05 7.72E-03
Gpc4 Glypican 4, [NM_008150] 2.02 2.90E-03
U90926 Putative TNF-resistance related protein, [U90926] 2.00 1.55E-03
Rab3b RAB3B, member RAS oncogene family, [NM_023537] 1.98 2.90E-03
Trip6 Thyroid hormone receptor interactor 6, [NM_011639] 1.81 6.48E-03
Scarb2 Scavenger receptor class B, member 2, [NM_007644] 1.81 6.48E-03
1700025G04Rik RIKEN cDNA 1700025G04 gene, [NM_197990] 1.77 5.80E-03
Nfkb2 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, [NM_019408] 1.69 5.80E-03
Ubash3b Ubiquitin associated and SH3 domain containing, B, [NM_176860] 1.67 5.80E-03
Crim1 Cysteine rich transmembrane BMP regulator 1, [NM_015800] 1.59 8.83E-03
Rnd3 Rho family GTPase 3, [NM_028810] 1.57 5.13E-03
Sema7a Sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, [NM_011352] 1.56 5.13E-03
Pibf1 Progesterone immunomodulatory binding factor 1, [NM_029454] -1.53 7.72E-03
Prtg Protogenin homolog (Gallus gallus), [AK039115] -1.64 8.78E-03
Hcfc2 Host cell factor C2, [AK040565] -1.67 6.56E-03
Clstn3 Calsyntenin 3, [NM_153508] -1.79 8.16E-03
Glt8d2 Glycosyltransferase 8 domain containing 2, [NM_029102] -1.81 7.18E-03
Txnrd1 Thioredoxin reductase 1, [NM_015762] -1.83 6.47E-04
4930547N16Rik RIKEN cDNA 4930547N16 gene, [BC070476] -1.93 9.21E-03
Plagl1 Pleiomorphic adenoma gene-like 1, [BC065150] -1.97 6.13E-03
1810014B01Rik RIKEN cDNA 1810014B01 gene, [AK004515] -2.38 7.56E-04
Pappa2 Pappalysin 2, [NM_001085376] -2.82 6.08E-03
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Microarray Analysis Methods 
All products were purchased from Agilent Technologies UK Ltd (Wokingham, 
Berkshire,UK) unless otherwise noted. RNA labelling and hybridisation/scanning 
were performed by Dr Fei-Ling Lim (Unilever Discover, UK). Data extraction, 
deposition into GEO and gene expression analysis were performed by Dr Natalie 
Hiscock (Unilever Discover, UK). 
 
RNA extraction 
RNA was extracted from whole mouse testis using TRIzol reagent (GibcoBRL) 
according to the manufacturers instructions, followed by purification on an RNeasy 
column (Qiagen) according to the standard manufacturers protocol.  
 
Labelling  
RNA quality and concentration was assessed using an Agilent bioanalyser. 1µg RNA 
and 5µl (1:2500 dilution) Agilent One-Color RNA Spike-In RNA were labelled with 
reagents supplied in the Agilent Low RNA Input Linear Amplification Kit PLUS, 
One-Color according to Manufacturer’s instructions. The labelled cRNA was 
purified with the RNeasy Mini Kit (Qiagen Ltd, Crawley, UK) according to 
Manufacturer’s protocol. 
 
Hybridisation and scanning 
The Agilent Hybridisation Kit was used in conjunction with Agilent Mouse whole 
genome Oligo Arrays. 2μg of the labelled sample RNA were used for hybridisation 
according to the Agilent One-Color Microarray-Based Gene Expression Analysis 
Protocol. The hybridisation was performed for 17 h at 65 ºC with 10 rpm rotation. 
Slides were then washed as described in the manufacturer’s manual. Slides were then 
washed in acetonitrile for 1 min followed by 30s in Agilent Stabilisation and Drying 
Solution. The slides were scanned with the Agilent G2565BA Microarray Scanner 
System. 
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Data extraction and deposition into GEO 
For data extraction and quality control, the Agilent G2567AA Feature Extraction 
Software (v.9.1) was used.  Data files were deposited into the NCBI Gene 
Expression Omnibus (GEO) in order to comply with MIAME requirements.   
 
Gene expression analysis 
The data were analyzed using Genespring GX 7.3 Expression Analysis software 
(Agilent Technologies).  Text tab delimited raw files were imported into Genespring.  
Standard data transformation, chip and gene normalisations were applied, in addition 
to standard QC procedures.  Differences in testis gene expression between the two 
groups were identified using Volcano Plot analysis.  Data were corrected for multiple 
testing corrections with adjusted P values using the method of Hotchberg and 
Benjamini with a user-defined false discovery rate of 5%.     
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